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Introduction
The shape of animal cells is determined and maintained by the formation of an 
intracellular scaffold of protein polymers, called the cytoskeleton. Three different 
groups of polymers contribute to form the cytoskeleton: microtubules, intermedi-
ate filaments, and actin filaments. In this chapter (and throughout the thesis), only 
the latter will be discussed. 
Rapid adjustment of cell morphology, mediated by dynamic reorganization of 
the cortical actin filament network, facilitates the functional activities of many cell 
types. Remodeling of the actin cytoskeleton also underlies some mechanisms of 
disease progression, e.g. cancer cell metastasis. The organization of the actin cyto-
skeleton in healthy or transformed cells is, thereby, influenced by numerous cues 
from the extracellular environment of the cell, e.g. interaction with the extracellular 
matrix, cytokines, growth factors, and nutrient availability. In addition, reorganiza-
tion of the actin cytoskeleton strongly depends on efficient ATP-supply and perhaps 
other aspects of energy-redox metabolism. 
This complex regulation is especially relevant for the migratory and adhesive 
capacity of macrophages, which live throughout tissues under dramatically differ-
ent physiological conditions and are involved in immune surveillance, phagocytosis, 
wound healing, tissue homeostasis and, modulation of tumor cell growth and inva-
sion. This work focuses on the link between remodeling of the actin cytoskeleton 
and metabolism, with special attention directed toward the morphodynamic be-
havior of these cells. 
1. The actin cytoskeleton
1.1 Actin polymerization 
Actin (together with myosin) was discovered during the 1940’s in muscle but soon 
thereafter also in other cells 1. The monomers of this 42 kDa protein are called glob-
ular (G-) actin and can spontaneously assemble to form double helical filamentous 
(F-) actin 1, 2. Polymerization starts with unfavorable dimer formation (nucleation), 
followed by the formation of a stable trimer and rapid elongation of the actin fila-
ment 3. Since the subunits all point in the same direction, actin filaments are po-
larized, containing a “pointed” end and a “barbed” end. Although association and 
dissociation of G-actin can occur on both ends, filament elongation mainly occurs 
at the barbed end while disassembly is mostly associated with the pointed end. 
Since nucleation is unfavorable, actin nucleation factors are required to overcome 
this first step. Three classes of actin nucleating factors are known: Arp2/3-complex, 
formins, and Spire proteins. Regulation of actin polymerization by Arp2/3 and 
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formins are the best studied and has been extensively reviewed by Pollard 4. While 
formins produce unbranched filaments for actin bundles that are found in filopodia, 
the Arp2/3 complex forms branched filaments which push forward the leading edge 
of migrating cells. The Arp2/3 complex consists of seven polypeptides, ARPC1-5, 
Arp2, and Arp3, and has to be activated by nucleation promoting factors (NPFs) 
before it can give rise to new actin filaments. These NPFs include, amongst others, 
WASp, Scar/WAVE proteins, WIP, N-WASp, and cortactin proteins.  In turn, NPFs are 
regulated by Rho-family GTPases (Figure 1 and paragraph 1.3 below) and contain 
three short functional segments, the verprolin (V-), connecting (C-), and acidic (A-) 
motifs, through which interaction with monomeric actin and the Arp2/3 complex is 
established. The V- and C-motifs interact simultaneously with actin, while the CA-
Figure 1. Regulation of actin polymerization. Activation of receptors by extracellular stimuli induces 
signaling pathways that lead to the activation of Rho-family GTPases. NPFs (nucleation promoting 
factors) are activated by GTPases and facilitate the interaction between Arp2/3 and the first actin 
monomer of the daughter/branch filament. Elongation of the filament occurs at the barbed end of 
the filament, until elongation is terminated by binding of a capping protein. Filament growth at the 
barbed end pushes the membrane forward. Within the filament, ATP on the actin monomers is hydro-
lyzed (yellow subunits become grey) after which the inorganic phosphate is released (grey subunits 
become blue). ADF/Cofilin promotes the release of the phosphate from actin, severs actin filaments, 
and promotes the dissociation of ADP-actin from actin filaments. Phosphorylation of cofilin by LIMK 
inactivates cofilin and leads to stabilization of actin filaments. Profilin facilitates the exchange of ADP 
for ATP on the free actin monomers (blue subunits become yellow), so that they can be incorporated 
at the barbed end of a new actin filament. GTPases also activate formins like mDia which nucleate 
unbranched actin filaments. Formins remain attached to the barbed end while new actin monomers 
are incorporated during filament growth. (Adapted from Pollard and Cooper 1, Pollard 4, Pollard and 
Borisy 5; see also references in the main text).
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motif interacts with the Arp2/3 complex, thereby bringing together the first subunit 
of the daughter filament and the Arp2/3 complex. During filament elongation, the 
Arp2/3 complex stays associated at the pointed end while new subunits are being 
added to the barbed end until the elongation is terminated by binding of a capping 
protein. Of importance for this thesis study is that both Arp 2 and 3 contain nucleo-
tide binding sites and occupation of this site by ATP increases the affinity of the 
Arp2/3 complex for the VCA-domains of NPFs. Hydrolysis of the ATP on Arp2 and 
3 contributes to dissociation of the complex from the actin network and promotes 
network disassembly 6.
Formins (e.g. mDia1 and mDia2) are single-polypeptide, multi-domain proteins 
that form dimers via their formin homolog 2 (FH-2) domains. Their FH-1 domains con-
tain a proline-rich sequence which associates with the actin monomer-binding pro-
tein, profilin, thereby enhancing the elongation efficiency of the actin filament. Dur-
ing elongation, the FH-2 domain stays associated with the barbed end of the filament 
(Figure 1) but how actin subunits are inserted between the formin and the barbed end 
is not exactly clear 2, 4. Formins are regulated by autoinhibition through intramolecu-
lar interaction between the N-terminal Rho-GTPase binding domain (GBD) and the C-
terminal Dia autoinhibitory domain (DAD) 7. Rho-family GTPases relieve this autoin-
hibition by binding to the GBD and displacing the C-terminus of the formin molecule.
Actin polymerization further involves the subsequent binding, hydrolysis, and 
release of ATP-molecules on the actin subunits. Monomeric G-actin contains a nu-
cleotide binding site which is almost exclusively associated with ATP. Shortly after 
incorporation into an actin filament, the ATP is hydrolyzed in two sequential steps: 
ATP-F-actin → ADP-Pi-F-actin → ADP-F-actin + Pi. The release of inorganic phosphate 
is the slowest step of the reaction, yielding ADP-Pi-F-actin, the major intermediate 
in actin polymerization 8. Dissociation of the phosphate causes a conformational 
change in the actin subunits 9, rendering ADP-F-actin susceptible for disassembly 
by regulatory proteins (see 1.3 below). After the release of ADP-G-actin from the 
pointed end, ADP is substituted for ATP. The small actin monomer-binding protein 
profilin catalyzes this exchange and directs the incorporation of newly formed ATP-
G-actin onto free barbed ends (Figure 1). This ‘flow’ of actin monomers from the 
barbed to the pointed end of the filament is known as treadmilling and signifies the 
universal mechanism that drives actin dynamics in eukaryotes 10.
1.2. Cell morphodynamics 
Polymerized actin filaments provide internal mechanical support, tracks for move-
ment of intracellular cargo, and force to drive cell movements 1. Dynamic remod-
eling of the actin network forms the basis of the morphological adaptations that 
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motile cells undergo in order to crawl, adhere, engulf particles, or probe their en-
vironment. These processes are collectively referred to as cell morphodynamics or 
morphodynamic processes through the remainder of the thesis. 
Cell motility is a defining characteristic of animal cells and involved in a num-
ber of physiological and pathophysiological processes. These include immune cell 
migration to search and destroy pathogens, migration of cells during embryonic 
development, migration of cancer cells during metastasis and tissue invasion, nerve 
cell migration and formation of cellular processes to reach their targets, and tis-
sue development and wound healing 1, 5. The crawling motility of cells is signified 
by a cycle of four steps: (1) protrusion of the leading edge, (2) adhesion to the 
substratum, (3) retraction of the rear, and (4) de-adhesion 5. The surface-attached, 
sheet-like membrane protrusion that is formed during the first step is called the 
lamellipodium and results from the assembly of a network of actin filaments under-
neath the cell membrane. These filaments are orientated with their barbed ends 
to the plasma membrane, pushing the membrane forward as actin monomers are 
added to the growing filament 2. Although some evidence has been provided that 
long, unbranched, overlapping filaments are abundant in the lamellipodium 11, 12, 
dendritically branched actin filaments are believed to be the dominant structural 
component in these structures2, 13.
The intracellular actin cytoskeleton interacts with the extracellular matrix (ECM) 
through four different adhesive structures: focal adhesions and complexes, invado-
podia, and podosomes. Focal adhesions are large adhesion contacts that are an-
chored to the ECM and the end of tangentially oriented actin stress fibers inside the 
cell via trans-membrane receptors of the integrin family. Adhesion complexes are 
smaller and found at the tips of protrusions such as filopodia and lamellipodia 14. In-
vadopodia are actin rich membrane protrusions comprising a core of actin filament 
bundles growing out perpendicular to the plasma membrane from a branched actin 
filament basis15. These structures are formed by invasive cancer cells and serve to 
degrade to ECM during migration. Many cells, especially osteoclasts and macro-
phages, form adhesion structures on their ventrala side that are called podosomes. 
These consist of bundles of actin filaments that form the core perpendicular to the 
substratum, surrounded by a multimeric protein complex of integrins and integrin-
associated proteins (talin, vinculin, paxilin), and an actin cloud of radial actin fila-
ments that lie parallel to the substratum. Podosomes are dynamic structures that 
assemble and disassemble and have a lifespan of 2-4 minutes 15.
Cells can form thin finger-like membrane protrusions, called filopodia, through 
which they probe the extracellular environment for adhesion sites or foreign 
matter 16, 17. Filopodia contain parallel bundles of 10-30 actin filaments with their 
a ventral – refers to the bottom (adhesive side) of a cell in a 2D environment
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barbed ends oriented towards the plasma membrane, and are adhered to the sub-
stratum or another cell. Their assembly entails filament nucleation, sustained barbed 
end growth along the length of the protrusion, and filament bundling by fascin 
proteins 2. Membrane ruffles are another type of sheet-like actin-dependent mem-
brane protrusions and differ from lamellipodia in that they do not attach to the 
substratum at all. They either form at the leading edge of a motile cell from where 
they move backward (peripheral ruffles), or assemble on the dorsalb surface and 
constrict into a circular structure before they disappear again (circular dorsal ruf-
fles), thereby affecting receptor internalization and possibly macropinocytosis 2, a 
process highly active in macrophages.  
The structures described above are commonly present in many different cell 
types. One actin-rich cellular structure that is not so common and only found in 
certain cell types (particularly neutrophils and macrophages), is the phagocytic cup. 
Phagocytosis is the internalization of particles > 0.5 µm that may include inorganic 
material, cell debris, micro-organisms, and necrotic and apoptotic cells. Receptors 
on the cell surface recognize and bind these particles, triggering the activation of 
Rho GTPases and leading to actin polymerization underneath the plasma mem-
brane18, 19. This results in the formation of membrane protrusions that surround 
and, eventually, enclose the particle for internalization. Although the mechanism of 
phagocytosis (see 2.3 below) has been studied intensively the morphology of the 
actin filaments forming the phagocytic cup is still not known 2.
A distinct feature of the phagocytic cup is that it is locally formed at a specific 
site on the cell periphery (where contact is established with an extracellular par-
ticle) and its formation is locally triggered and regulated. Another example of the 
significance of local formation and function of actin-rich protrusive structures is the 
small, actin rich protrusions formed by neuronal cells. These structures are called 
dendritic spines and are found on neuronal dendrites that form the postsynaptic 
part of most excitatory synapses and are major sites of information processing and 
storage in the brain. The size and morphology of the spines depend on local actin 
dynamics and determine synaptic activity 20.
Other structures that comprise actin and myosin filaments include the cytoki-
netic contractile ring in dividing cells which pinches the mother cell in two, actin 
cables for transport of organelles, and stress fibers (contractile actomyosin bundles) 
that play a role in cell adhesion and morphogenesis 1, 21. Finally, cells can also form 
protrusive membrane structures that are devoid of polymerized actin. These struc-
tures are called membrane blebs and are formed when the plasma membrane lo-
cally detaches from the actin cortex due to actomyosin contraction of the cortex. 
The hydrostatic pressure from the cytoplasm then pushes the membrane outwards 
b dorsal – refers to the top (non-adhesive side) of a cell in a 2D environment
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causing it to expand. When expansion of the membrane slows down, the actin cor-
tex is reassembled underneath the bleb membrane, myosin is recruited, and the 
bleb is retracted again 22, 23. In order to precisely control the assembly and disas-
sembly of all these structures, cells are equipped with a multitude of actin binding 
proteins (ABPs) which, in concert with Rho-family GTPases, cellular redox state, pH, 
and posttranslational modification of actin, regulate actin dynamics.
1.3. Regulation of actin dynamics
Rho-family GTPases
The nucleation of actin is triggered by Ras-related GTP-binding proteins of the Rho-
family, including Rho, Rac, and Cdc42 24. Formin autoinhibition has been shown to 
be (partially) relieved by binding of Rho to its GBD 7, 25, 26. The NPFs WASp and WAVE 
mediate the activation of the Arp2/3 complex via direct interaction with Cdc42 and 
Rac, respectively.  Similar to formins, WASp and N-WASp are controlled by intra-
molecular interaction of a GBD with the C-motif, causing autoinhibition. Rho-family 
GTPases in cooperation with phosphatidylinositol 4,5-biphosphate (PIP2), release 
this autoinhibition by binding to GBD and replacing the VCA-domain which can then 
interact with actin and the Arp2/3 complex 4. The WAVE-complex is activated by bind-
ing to Rac and to acidic phospholipids (PIP3) in the cell membrane, and phosphoryla-
tion of the WAVE complex 24. The distinct signaling pathways, regulated by Rho, Rac, 
and Cdc42 respectively, link activation of plasma membrane receptors to the forma-
tion of the specific actin-based cellular structures described above. Stress fibers, for 
example, are regulated by Rho, lamellipodia and membrane ruffles by Rac, while 
filopodia are regulated by Cdc42 27-29. However, cross-talk does exist between Rho 
GTPases, as has been shown for Cdc42 and Rac in integrin-dependent adhesion and 
spreading in NIH3T3 cells 30. The activation of Rho GTPases is regulated locally 31-34 
and the timing and location of activation differs between the various GTPases.  This 
differential regulation of GTPases has been visualized, for example, during cell pro-
trusion 35, FcγR-mediated phagocytosis 36, and neurite outgrowth 37, and coordinates 
the rearrangement of the actin cytoskeleton and the cell membrane.
Actin-binding proteins
Once actin filaments have been formed, they can be modified by interaction with 
specific actin-binding proteins (ABPs) to match the specific requirements of the cell. 
Filament elongation is terminated by the binding of capping proteins (e.g. CapG/C 
and Hsp70) to filament barbed ends. This involves the degradation of polyphos-
phoinositides at the barbed end and activation of the capping proteins by Ca2+ or 
phosphorylation 38. Filaments can also be severed or cut to expose fresh barbed 
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ends for polymerization. Severing proteins include the gelsolin-family of ABPs which 
disrupt the interaction between actin subunits in response to Ca2+ and tyrosine 
phosphorylation 39 and cofilin. Stabilization, cross-linking, and bundling of filaments 
is achieved by interaction with tropomyosin, filamin, α-actinin, fascin, and dyna-
min1/cortactin complexes, amongst others 3, 40-42. These proteins are responsible for 
the formation of actin filament bundles that are found in filopodia but also for the 
formation of actin filament scaffolds underneath the plasma membrane in protru-
sive structures. While polymerization mainly occurs at the barbed end, filament dis-
assembly and monomer recycling is mainly associated with the pointed end. Here, 
members of the ADF/cofilin-family of proteins bind to the actin filament, causing 
the filament to twist. This leads to changes in the thermodynamic stability of the 
filament and subsequent dissociation of actin subunits. The activity of ADF/cofilin is 
regulated by phosphorylation, phosphoinositides, acidity, and interaction with other
proteins 3, 43, 44. After actin monomers are released from the pointed end of fila-
ments, they are bound by a number of actin monomer-binding proteins which regu-
late the size, location, and dynamics of the monomer pool 43. Thymosin β-4 and 
twinfilin inhibit actin polymerization and nucleotide exchange on actin monomers, 
while profilin promotes it. Another protein, Srv2/CAP (cyclase-associated protein), 
recycles ADF/cofilin for another round of depolymerization and makes actin mono-
mers again available for polymerization.
ROS, pH, phosphorylation, and arginylation 
Actin dynamics are further influenced by changes in cellular redox status, pH, and 
posttranslational modification of ABPs or of actin itself. Oxidation alters the physio-
chemical properties of actin and can thereby adversely affect actin polymerization 45. 
 In addition, the activity of two actin depolymerizing proteins is regulated in a redox-
dependent fashion. In Drosophila, Mical has been shown to associate with Sema-
bound plexin and disassemble actin in a redox reaction with NADPH as co-enzyme 46. 
The other protein, cofilin, is activated through dephosphorylation by slingshot-1L 
(SSH-1L) which is in turn activated by reactive oxygen species (ROS) 47. Cofilin ac-
tivity is additionally controlled by local changes in cellular pH. This is established 
through modulation of the inhibitory phosphoinositide binding to cofilin, where an 
increase in pH is associated with reduced binding and, thus, increased cofilin activ-
ity 48. On the other hand, low pH has been shown to induce the actin severing activ-
ity of gelsolin 49. Very recently, actin filament nucleation and elongation have been 
shown to be enhanced at acidic pH, reaching a maximum close to the iso-electric 
point of actin, suggesting an important role for electrostatic forces between actin 
subunits in filament formation 50. As mentioned in the foregoing text, ABPs are of-
ten phosphorylated or dephosphorylated in order to regulate their activity in actin 
1 
∙ I
nt
ro
du
cti
on
17
filament assembly and disassembly. In addition, actin itself can be phosphorylated, 
as has been shown in Dictyostelium 51. Phosphorylation of Tyr-53 causes alloste-
ric modification of the nucleotide binding-cleft conformation, reducing the rate of 
nucleotide exchange on actin 52, 53. Finally, β-actin is N-terminally arginylated and 
arginylation seems to be important for normal actin polymerization and filament 
structure, as well as interaction with several ABPs 54, 55.   
1.4. Actomyosin contractility
The interaction of actin with myosin is responsible for the movement of cells.  Myo-
sins are motorproteins that convert chemical energy into mechanical energy, there-
by generating force and movement 56. Together, the myosins form a huge superfam-
ily of proteins, which are categorized in 18 different classes, based on phylogenetic 
analysis of their head (i.e. motor) domains. Some of the best known myosins belong 
to class II and are main cytoskeletal components for the generation of cellular trac-
tion force, a process that is ATP-dependent. In the absence of ATP, the head of the 
myosin molecule is bound to actin. This activates the ATPase activity of the myosin 
head. Upon binding of ATP to myosin, the myosin-actin complex dissociates. Hy-
drolysis of the ATP induces a conformational change in the myosin molecule that 
causes the head to change position. In this state the myosin head can bind again to 
the actin filament at a different position. Binding of myosin to actin results in the 
release of the hydrolysis products ADP and Pi, which in turn causes the myosin head 
to return to its original position, thereby sliding the actin filament in one direction 
(the so-called “power stroke”) 56.
Myosin II has been implicated in a number of morphodynamic processes, in-
cluding phagocytosis 57, 58 and shown to regulate the activity of the Rho-family GTP-
ases Rac 1 and Cdc42 59. However, other unconventional myosins have also been 
shown to be involved in phagocytosis and protrusion formation, for example myo-
sin I, V, IX and X 57, 60-63. While myosin II is mostly responsible for the contraction of 
actin filaments, the most important role of other myosins is to power the directed 
transport of protrusion components towards the cell membrane, and to mediate 
the adhesion of actin filaments to the inner leaflet of the plasma membrane.
Our current knowledge on the mechanisms and regulation of actin dynamics is 
based on studies of different processes in many different cell types. Although these 
cells share certain commonalities, they may also be quite unique in their morpho-
dynamic behavior. Stress fibers, for example, are formed by many cell types in cul-
ture but are especially prominent in fibroblasts 21, while cancer cells like glioblas-
toma cells are highly motile and typically form lamellipodia and invadiopodia to 
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mediate migration 64. Cells of the immune system exhibit again another unique type 
of morphodynamic behavior 65. In order to fulfill their function in immunity and tis-
sue homeostasis, macrophages, for example, have to undergo extensive morphody-
namic changes which rely on proper regulation of actin cytoskeletal reorganization. 
2. Macrophages
2.1. Origin, distribution, and polarization
Macrophages are mediators of the immune system that provide a first line of de-
fense against pathogens and help to maintain steady-state tissue homeostasis by 
eliminating foreign matter and apoptotic cells via phagocytosis and secreting cyto-
kines and growth factors 66-68. They are derived from peripheral blood mononuclear 
cells (PBMCs) which develop from a common haematopoietic stem cell (HSC) in the 
bone marrow.  The HSC gives rise to myeloid progenitor cells called granulocyte/
macrophage colony-forming units (CFU-GM) which in turn give rise to monoblasts, 
pro-monocytes, and finally monocytes which are released from the bone marrow 
into the blood 67, 68. Monocytes undergo differentiation after entering the surround-
ing tissue in the steady state or in response to inflammatory signals, giving rise to 
macrophages. Recent work by several groups has now also provided evidence for 
self-renewal of macrophages formed from embryonic progenitors independent of 
haematopoetic stem cells, via proliferation of cell populations that are already pre-
natally established in various tissues 69-79. These new findings suggest that two sub-
sets of tissue macrophages can be distinguished: those of bone marrow-dependent 
and -independent origin 80. 
Macrophages are present in all tissues and can undergo tissue-specific differ-
entiation. This leads to the generation of specific macrophages of the bone (os-
teoclasts), the alveoli, the central nervous system (microglial cells), connective 
tissue (histiocytes), the gastrointestinal tract, the liver (Kupffer cells), the spleen, 
the peritoneum, the eye (intraocular macrophages), the lymph nodes (subcapsu-
lar sinusoidal and medullary macrophages), and tumor associated macrophages 
(TAMs)66, 68. When macrophages encounter foreign material (e.g. bacterial products 
like lipopolysaccharide (LPS)) or are exposed to stimuli like inflammatory cytokines 
(IFN-g, TNF, or IL-4) and immunoglobulin G (IgG) immune complexes they gain spe-
cific functional properties and become polarized 81. Mills et al. 82 were the first to 
observe that macrophages obtain a different activation state when exposed to cyto-
kines from lymphocytes of the Th1 immune response and those of the Th2 immune 
response and classified these macrophages as “M1” and “M2”, respectively. How-
ever, since M2 macrophages make up a very heterogeneous group of cells, Mosser 
and Edwards 68 suggested that this group be further divided in “Wound healing” 
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and “Regulatory” macrophages based on their fundamental function. The identifi-
cation of a third polarization state has been accepted in the field and macrophages 
are now broadly classified as classically activated (M1), alternatively activated (M2 
or M2a), and regulatory macrophages (M2b&c) 83-85. However, after differentia-
tion macrophages retain plasticity and further adapt their functional phenotype in 
response to microenvironmental cues 86. Therefore, “polarization of macrophage 
function should be viewed as an operationally useful, simplified, conceptual frame-
work describing a continuum of diverse functional states” 81.
2.2. Macrophage function
Macrophages constantly survey their environment for signs of tissue injury, dying 
cells, toxic materials, or invading organisms 66. When these signals are detected 
by phagocytosis or by surface receptors, macrophages may activate a response in 
other immune cells, like lymphocytes. Following infection or injury, macrophages 
can also assume an immune suppressive role, in order to restore tissue homeosta-
sis. Whether macrophages take on a pro-inflammatory, anti-inflammatory, tissue 
remodeling, or regulatory phenotype depends on the environmental cues they en-
counter and the corresponding polarization state they obtain.
Classically activated (M1) macrophages emerge in response to interferon γ 
(IFNγ) and tumor necrosis factor (TNF) and products associated with bacterial 
pathogens (e.g. LPS). These cells have enhanced microbicidal and tumoricidal ac-
tivity through the production of nitric oxide (NO) and phagocytosis of bacteria and 
tumor cells. In addition, they produce pro-inflammatory cytokines (e.g. IL-1, IL-6, 
and IL-23) and are involved in the stimulation of other immune cells 66, 68. 
Alternatively activated (M2) macrophages develop in response to IL-13 and 
IL-4 87 and are involved in wound healing, tissue remodeling, and angiogenesis. IL-4 
is one of the first innate signals released during tissue injury and triggers the pro-
duction of extracellular matrix (ECM) by stimulating arginase-mediated conversion 
of arginine to ornithine which is a precursor of polyamines and collagen 68. Growth 
factors that are secreted by these macrophages include transforming growth fac-
tor β1 (TGFβ1) and platelet derived growth factor (PDGF), which promote fibro-
blast differentiation into myofibroblasts and stimulate the synthesis of interstitial 
fibrilar collagens 88. M2 macrophages additionally have a immunoregulatory role 
by antagonizing toxic M1 responses, and suppressing inflammation and antitumor 
immunity 84. Although TAMs in the early stages of cancer have a M1 phenotype, 
TAMs from solid metastatic tumors obtain a suppressive M2 phenotype due to 
changes in the tumor microenvironment and thereby contribute to tumor progres-
sion 66, 68. 
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Finally, regulatory macrophages are characterized by the production of high 
levels of the immune-suppressive cytokine IL-10 in response to a combination of 
two stimuli, e.g. a TLR agonist in the presence of IgG immune complexes. These 
macrophages have a role in suppressing antimicrobial immunity, for example in the 
gut, but they can also arise during the later stages of adaptive immune responses to 
dampen the immune response and limit inflammation 68, 84. 
2.3. Macrophage morphodynamics
Of all macrophage effector functions, their occupation as professional phagocytes 
stands central. Their ability to internalize relatively large (>0.5 µm) particles is vital 
to the host for the clearance of pathogens, dead erythrocytes, apoptotic cells, and 
debris generated during tissue remodeling. Through these processes macrophages 
fulfill their primary function in host defense and maintaining tissue homeostasis. 
Surveillance and phagocytosis efficiency relies on the ability to adhere, migrate, and 
produce cell surface protrusions, processes that involve active cell shape changes 
and depend on dynamic actin remodeling underneath the plasma membrane 2, 65. 
Macrophage migration
After extravasation of monocytes into target tissues, the differentiated macro-
phages may undergo further directed migration (chemotaxis) in response to che-
moattractants, like chemokines and bacterial peptides. Macrophages can migrate 
by squeezing through pores (amoeboid mode) or by adhering to and degrading 
the ECM (mesenchymal mode) 89. At first, the density of the ECM was thought to 
determine the migration mode, but more recently Cougoule et al.90 have shown 
that all macrophages can use the amoeboid migration mode, but only M2 polarized 
cells can adopt a mesenchymal migration mode. Instead of large, stable adhesion 
structures linked to actin stress fibers, macrophages form small, short lived point 
contacts, focal complexes and podosomes for traction 89, 91. Podosomes have been 
implicated in cell migration and ECM degradation 92 and in line with this Cougoule 
et al.90 demonstrated that mesenchymal migration of M2 macrophages correlates 
with the formation of podosome rosettes and degradation of the ECM by these 
cells. Inflammatory M1 macrophages formed podosomes with increased lifetimes 
and did not migrate at all, confirming much earlier observations 93. Similar to other 
cells, migrating macrophages extend a lamellipodium at the front which depends 
on actin polymerization 65. Point contacts are most strikingly formed in the leading 
lamellipodium of migrating macrophages, along with scattered focal complexes at 
the peripheral region 89. Detachment of the uropod at the rear of the cell involves 
actomyosin contraction and is regulated by RhoA 65. 
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Phagocytosis
Macrophages continuously probe their environment through the formation of pro-
trusive actin-dependent membrane structures. These structures include filopodia 
and membrane ruffles and facilitate the binding of foreign molecules 17, 94, 95. For-
mation of these structures are driven by Rho-family GTPases and require PI(4,5)P2 
and PI(3,4,5)P3 
96. Macrophages may encounter and bind foreign molecules via dif-
ferent receptors on their cell surface. These include pattern recognition receptors 
(PRRs) that recognize pathogen-associated molecular patterns (PAMPs), scavenger 
receptors that recognize phosphatidylserine on apoptotic cells, Fc-receptors and 
complement receptors that recognize, respectively, immunoglobulins and comple-
ment molecules on opsonized pathogens 18. Binding and activation of these recep-
tors stimulate the phagocytic uptake of a particle via specific signaling pathways. 
The Fcγ-receptor (FcγR) and complement receptor 3 (CR3) are the best studied and 
mediate two distinct mechanisms of phagocytic uptake 97 (Figure 2A,B). Particles 
that are opsonized with IgG are bound by the Fc-domain of FcγR. Ligand binding 
leads to receptor clustering and phosphorylation of the cytoplasmic ITAM (Ig gene 
family tyrosine activation motive) on the receptor by Src-family protein tyrosine 
kinases. This leads to docking and phosphorylation (activation) of Syk on ITAM and 
the initiation of transcriptional activity, actin remodeling, and release of inflamma-
tory mediators 18. Actin polymerization is triggered by the recruitment of Cdc42 and 
Nck, which bind and activate WASp/N-WASp to stimulate Arp2/3 36, 98, 99. Growing 
actin filaments underneath the plasma membrane causes receptor-guided advance 
of the membrane over the particle surface, enclosing it in a “zipper-like” fashion 100 
and yielding a continuous F-actin cup 97, 101. 
Unlike FcRs, complement receptors require an additional stimulus to internalize 
a particle after binding 102. Examples are PKC-activators like phorbol myristate ac-
etate (PMA) 103 and LPS. Activation of CR3 leads to clustering of the receptor which 
is required for particle binding, and the association of its cytoplasmic domain to cy-
toskeletal proteins, like α-actinins 98. Complement-opsonized particle binding acti-
vates RhoA, which in turn activates ROCK. Actin polymerization is then triggered by 
recruitment and activation of mDia (downstream target of ROCK) 104 and the ROCK/
myosin II mediated recruitment of Arp2/3 complex 58. In some cells the formation 
of a CR3-phagosome may resemble the “zippering” model, but in macrophages the 
phagosome forms as a depression in the cell surface, consisting of discrete patches 
of actin and other cytoskeletal proteins100.
Closure of the phagosome is triggered by the PI3K-mediated conversion of 
PI(4,5)P2 to PI(3,4,5)P3 
98 and followed by the disassembly of actin filaments. De-
polymerization of the actin cage around the phagosome is essential to allow fu-
sion with digestive enzyme-containing lysosomes. Hydrolysis of PI(4,5)P2 from the 
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phagosomal membrane have been shown to be involved in the disassembly of the 
actin network and completion of phagocytosis 105, although the inactivation of the 
Rho GTPases that induce actin polymerization also seem to play a role 106. 
Figure 2. Mechanisms of phagocytosis in macrophages. (A) Particles opsonized with IgG are bound 
by Fcγ-receptors on the cell surface. This leads to clustering and activation of the receptors and the 
initation of signaling pathways that ultimately result in polymerization of actin filaments. (B) Comple-
ment opsonized particles are recognized by the complement receptor. For internalization to take place, 
the CR has to be activated by an additional stimulus (e.g. LPS or PMA). This results in the initiation of 
GTPase-mediated signaling to the actin cytoskeleton. FcγR, Fcγ-receptor; pFcγR, phosphorylated (acti-
vated) Fcγ-receptor; CR, complement receptor.
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Macropinocytosis
Another process characteristic of macrophages is macropinocytosis. This process 
involves the uptake of extracellular fluid through relatively large vacuoles that are 
formed by membrane ruffles that close back against the plasma membrane. Like 
phagocytosis, macropinocytosis is actin-dependent, although no receptor-binding 
is involved. Macropinocytosis enables macrophages to sample the surrounding flu-
id for nutrients and pathogens 107, 108.
Given the nature and diversity of processes that support their biological roles, mac-
rophages can be best classified as morphodynamically hyperactive cells.  The con-
stant remodeling of the actin cytoskeleton that drives this activity may place consid-
erable pressure on the cellular energy demand in these cells 109, 110.
3. Cell metabolism
3.1. The cellular energy currency: ATP
Adenosine triphosphate (ATP) is a high energy compound that serves as energy 
shuttle within living cells. The production of ATP comprises the addition of a high-
energy phosphoryl group to adenosine diphosphate (ADP) and is catalyzed by py-
ruvate kinase and phosphoglycerate kinase during glycolysis, and by ATP synthase 
during OXPHOS (see 3.2 below). ATP-consumption does not involve cleavage of the 
molecule but only hydrolysis of the phosphate group at the gamma-position to yield 
ADP and Pi (inorganic phosphate). Hydrolysis of ATP is highly exergonic, releasing 31 
kJ/mol of chemical energy 111. In some metabolic reactions ATP may be hydrolyzed 
into adenosine monophosphate (AMP) and pyrophosphate (PPi). In order to recycle 
ATP from AMP, the adenine nucleotides may be interconverted via an enzyme called 
adenylate kinase as follows: 
AMP + ATP → 2 ADP
Cell viability and functionality strongly depends on sufficient energy (ATP) sup-
ply to drive cellular processes and on the availability of biosynthetic material to 
provide building blocks for macromolecule synthesis. In order to supply this ATP 
and biosynthetic material, carbohydrates, proteins, and lipids are taken up from the 
extracellular environment or acquired from intracellular stores, and broken down 
(catabolized) or converted through different ‘processing’ pathways comprising a se-
ries of enzyme driven biochemical reactions that are all interconnected to form a 
complex metabolic network (Figure 3).
24
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3.2. Cellular energy-redox reactions and catabolic/anabolic 
         metabolism
Glycolysis
The pathway of carbohydrate catabolism starts with the breakdown of six-carbon 
sugars via glycolysis (Figure 3). This pathway is active under aerobic as well as 
anaerobic conditions and utilizes glucose as its main substrate 111. Glucose is im-
ported by the cell via special glucose transporters. Two classes of glucose trans-
porters exist: the Na+-dependent glucose co-transporters (SGLT family) and the 
facilitative Na+-independent sugar transporters (GLUT family) 115, 116. SGLT utilizes 
the Na+-electrochemical gradient provided by the Na+/K+ ATPase pump to trans-
port glucose into cells against its concentration gradient, while GLUT utilizes the 
diffusion gradient of glucose (and other sugars such as galactose) across plasma 
membranes. In the cytosol, glucose is converted into pyruvate (a three-carbon 
keto-acid) via a series of reactions forming the glycolytic pathway 111. In addi-
tion to pyruvate, the glycolytic breakdown of glucose yields two ATP molecules, 
directly providing chemical energy for the fuelling of cellular reactions, and two 
reduced nicotinamide adenine dinucleotide (NADH) molecules, serving as elec-
tron carriers. Although glycolysis is essential for ATP production, it also provides 
biosynthetic material via intermediates of the pathway, e.g. for nucleotide, amino 
acid, and lipid synthesis. Under anaerobic conditions, most of the formed pyru-
vate is turned into lactate together with the recycling of NADH to its oxidized from, 
NAD+, which can then be reused as co-factor and electron acceptor in the earlier 
glycolytic reactions (Figure 3). Under aerobic conditions, pyruvate is transported 
from the cytosol into the mitochondria via a specific mitochondrial pyruvate car-
rier (MPC1/MPC2 complex) in the inner mitochondrial membrane 117, 118. Here, it is 
oxidized to a metabolically active two-carbon fragment, acetyl-coenzyme A (ace-
tyl-CoA), that undergoes further oxidation in the tricarboxylic acid (TCA) cycle 111. 
Figure 3. Cellular metabolism. Glucose is taken up by the cell through GLUT and catabolized through 
glycolysis (pink arrows). The product of the first step in glycolysis (glucose-6-phosphate) may also enter 
the pentose phosphate pathway (PPP; orange arrows) to produce NADPH. Intermediates from the PPP 
may re-enter the glycolytic pathway to be further broken down. Other hexose sugars, like galactose, 
also enter the glycolytic pathway (purple arrows). However, the breakdown of galactose via glycoly-
sis doesn’t yield any net ATP. Therefore, the cell is forced to rely exclusively on mitochondrial-derived 
ATP112, 113. The end-product of glycolysis (pyruvate) can either be converted into lactate or be transport-
ed into the mitochondrion where it is converted into acetyl-CoA. Acetyl-CoA enters the TCA-cycle (blue 
arrows) where the electron carriers NADH and FADH
2
 are produced. Electrons from NADH and FADH
2
 
are transferred to the complexes of the electron transport chain (green arrows) and which results in 
the production of ATP. The carbon skeletons of amino acids (e.g. glutamine) may enter the TCA-cycle 
at various points (e.g. as α-Ketoglutarate; yellow arrows) in order to contribute to cellular ATP produc-
tion. Cells may also utilize fatty acid for ATP production through β-oxidation (grey arrows) 114.
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The TCA-cycle and OXPHOS
In the TCA-cycle all catabolic pathways merge into one path for oxidative metabo-
lism. Simple carbon compounds from carbohydrate, protein, and lipid breakdown 
enter the TCA-cycle and are oxidized to CO2. Under exceptional circumstances also 
reversal of the reaction sequence (with α-ketoglutarate converted to citrate) is pos-
sible 119. This is important for lipid synthesis and proliferation of cancer cells under 
hypoxia and may also be relevant for macrophage survival and function. In the for-
ward mode, in four consecutive oxidative reactions of the TCA-cycle, reduced elec-
tron carriers are generated, producing three NADH and one FADH2 (reduced flavin 
adenine dinucleotide) molecules (Figure 3). Together with the NADH derived from 
glycolysis, which have to be shuttled across the mitochondrial membrane (see 3.3), 
these electron carriers donate electrons to the complexes of the electron trans-
port chain (ETC) situated in the inner mitochondrial membrane. As the electrons 
are transferred from one complex to another, protons are pumped from the matrix 
across the inner mitochondrial membrane into the intermembrane space, thereby 
generating a proton gradient across the inner membrane and establishing an elec-
tric potential. At the last complex of the ETC, the F0F1 complex, complex V or ATP 
synthase, protons flow back to the matrix and the gradient is discharged, releasing 
energy and driving the synthesis of ATP from ADP and Pi. The last electron acceptor 
in the chain is molecular oxygen, thereby producing H20 (Figure 3). This production 
of ATP via the ETC is called oxidative phosphorylation (OXPHOS) 111. 
Amino acid metabolism: Glutaminolysis
The pyruvate-acetyl-CoA reaction is not the only entry point into the TCA-cycle. 
When amino acid availability exceeds the need for protein synthesis, the cell de-
grades the excess nitrogen and metabolizes the carbon skeletons in the TCA- 
cycle 111. Depending on the amino acid, the carbon skeletons may enter the TCA-
cycle either as pyruvate, acetyl-CoA, α-ketoglutarate, succinate, fumurate, or oxalo-
acetate. Thus, proteins - when broken down into amino acids - can contribute sig-
nificantly to the energetic requirements of the cell. Glutamine is the most abundant 
amino acid in blood plasma 120 and is imported by cells via amino acid transporters 
in the plasma membrane 121. In proliferating cells, it contributes to essentially all 
the main metabolic tasks of the cell. It is involved in bioenergetics, defense against 
oxidative stress, and the production of macromolecules 122. The γ-nitrogen of glu-
tamine is used for nucleotide and hexosamine synthesis while its conversion into 
glutamate by glutaminase is essential for the  synthesis of other amino acids and 
glutathione (GSH), as well as its entry into the TCA-cycle via α-ketoglutarate (Figure 
3), and the production of reduced nicotinamide adenine dinucleotide phosphate 
(NADPH) from its oxidized form (NADP+) via the malate-pyruvate conversion by ma-
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lic enzyme 122. Under conditions when glucose is limiting, glutamine metabolism 
through the TCA-cycle may provide an alternative energy-generating pathway 123. In 
addition, cells may use the reductive metabolism of α-ketoglutarate to synthesize 
acetyl-CoA for lipid synthesis, especially during hypoxia or when mitochondrial res-
piration is disturbed 124, 125.
β-oxidation
Lipids that are synthesized intracellularly can either be stored in the form of triac-
ylglycerol (TG) or used, for example, in membrane synthesis. Under conditions of 
high energy demand, TGs are mobilized and hydrolyzed to yield glycerol and three 
fatty acids. Glycerol may serve as gluconeogenic substrate, yielding glucose, or can 
enter glycolysis while FAs are imported into the mitochondria via the carnitine acyl-
transferase-system and catabolized to acetyl-CoA via β-oxidation, releasing reduced 
electron carriers (NADH and FADH2) along the way 
111 (Figure 3). 
The pentose phosphate pathway
As mentioned above, glycolysis may also contribute to biosynthesis (anabolism) of 
various cellular compounds. One essential anabolic pathway that is linked to the 
catabolism of glucose is the pentose phosphate pathway (PPP). The product of the 
first reaction in glycolysis, glucose-6-phosphate (G6P), forms the starting substrate 
of the PPP and is used to provide NADPH for reductive biosynthesis and protection 
against oxidative stress, and ribose-5-phosphate (R5P) for nucleotide and nucleic 
acid synthesis 111 (Figure 3). The PPP comprises an oxidative and a nonoxidative 
branch. The first three reactions of the pathway forms the oxidative branch and in 
two of these NADPH is produced from the reduction of NADP+. In the nonoxidative 
branch, some ribulose-5-phosphate (Ru5P) from the oxidative phase is converted 
into R5P. However, if the cell doesn’t require large quantities of R5P for nucleotide 
synthesis, Ru5P may have other fates (see Figure 3). If the primary need of the cell 
is reducing molecules, fructose phosphates formed towards the end of the pathway 
are reconverted to G6P for reoxidation in the oxidative phase. Ru5P may also be 
used for energy production by being reconverted to glycolysis through the forma-
tion of fructose-6-phosphate (F6P) and glyceraldehyde-3-phosphate (G3P) thereby 
providing pyruvate to enter the TCA-cycle 111.
3.3. Pyridine nucleotide co-factors and redox couples: NAD(P)  
         and NAD(P)H
Mitochondrial ATP production via OXPHOS involves the transfer of electrons be-
tween complexes I to IV of the ETC with molecular oxygen as the final acceptor. As 
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explained in 3.2 above, these electrons are derived from dehydrogenase reactions of 
glycolysis and the TCA-cycle, transferred to NAD+, and carried to the mitochondria as 
NADH. In addition to their role in cellular energy production, the two redox couples 
NAD+/NADH and NADP+/NADPH buffer the redox state of the cell by accepting and 
donating electrons during oxidation and reduction reactions, respectively. NAD+ can 
be synthesized de novo from the essential amino acid tryptophan, although most of 
the cellular NAD+ in mammalian cells comes from salvage pathways using the NAD+ 
precursors nicotinic acid (NA), nicotinamide (NAM), or nicotinamide riboside (NR) 
as starting substrates 126 (Figure 4). Tryptophan is first converted into N-formylkyn-
urenine either by indolamine 2,3-dioxygenase (IDO) or tryptophan 2,3-dioxygenase 
(TDO), which is then converted into α-amino-β-carboxymuconate-ε-semialdehyde 
(ACMS) in four separate reaction steps. ACMS can undergo spontaneous cycliza-
tion to form quinolinic acid which is transformed into nicotinic acid mononucleotide 
(NAMN) by quinolinate phosphoribosyltransferase (QPRT). Subsequently, NAMN is 
converted into nicotinic acid adenine dinucleotide (NAAD) by NAM mononucleotide 
adenylyltransferase (NMNAT), which is finally converted into NAD+ by glutamine-de-
pendent NAD synthase (NADS). Salvage synthesis from NA starts with the formation 
of NAMN by nicotinic acid phosphoribosyltransferase (NAPRT) which then enters 
the de novo pathway. The other two salvage pathways involve conversion of NAM 
and NR to nicotinamide mononucleotide (NMN) by nicotinamide phosphoribosyl-
transferase (NAMPT) and nicotinamide riboside kinase (NRK), respectively. NMN is 
then finally converted into NAD+ by NMNAT126. NAD+ is the precursor for the other 
three pyridine nucleotides, NADH, NADP+, and NADPH.  Its reduced form, NADH, 
is produced in reactions catalyzed by dehydrogenases while NADP+ is synthesized 
through the phosphorylation of NAD+ by NAD kinase (NADK). NADP+ is subsequently 
and very quickly reduced to NADPH 127 via the PPP, via malic enzyme catalyzed reac-
tions, or by the mitochondrial energy-linked transhydrogenase (or complex VI of the 
ETC). Thus, cellular NADP(H) (i.e. NADP+ and NADPH) occurs mostly as NADPH, while 
cellular NAD(H) (i.e. NAD+ and NADH) occurs mainly in the oxidized form, i.e. NAD+.
Within the cell, NAD(H) and NADP(H) are heavily compartmentalized and not 
able to freely move across membranes. De novo as well as salvage NAD+ synthesis 
occurs mainly in the cytosol. However, mitochondria may have the ability to synthe-
size and maintain their own NAD through NMNAT3 and NMN derived from the cy-
tosol 128. The transfer of reducing equivalents across the mitochondrial membrane, 
therefore, involves specific redox shuttles: the 2-oxoglutarate/isocitrate redox shut-
tle in the case of NADP(H), and the malate-aspartate and α-glycerophosphate shut-
tles for NAD(H) 126. Furthermore, recent literature also suggest separate NAD(P)(H) 
pools for other organelles such as the Golgi-complex and the endoplasmic reticu-
lum 129.
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NADP(H) plays a major role as co-enzyme in cellular electron transfer reactions. 
During reductive anabolic reactions, such as fatty acid and steroid biosynthesis, 
NADPH is the electron donor. It also contributes to DNA synthesis since it is in-
volved in the reduction of ribonucleotides to deoxyribonucleotides by ribonucleo-
tide reductase. Detoxification of xenobiotics by cytochrome P-450 enzymes in the 
liver depends on continuous re-reduction by NADPH-dependent cytochrome P450 
reductases in order to regenerate these enzymes. Another important function of 
NADPH is the regeneration of anti-oxidant systems, for example, the regenera-
Figure 4. De novo and salvage synthesis pathways of NAD+ in mammalian cells.  NAD+ can be synthe-
sized de novo from the essential amino acid tryptophan, although most of the cellular NAD+ in mam-
malian cells comes from salvage pathways using the NAD+ precursors nicotinic acid (NA), nicotinamide 
(NAM), or nicotinamide riboside (NR) as starting substrates. Salvage synthesis from NA starts with 
the formation of NAMN by nicotinic acid phosphoribosyltransferase (NAPRT) which then enters the de 
novo pathway. The other two salvage pathways involve conversion of NAM and NR to nicotinamide 
mononucleotide (NMN) by nicotinamide phosphoribosyltransferase (NAMPT) and nicotinamide ribo-
side kinase(NRK), respectively. NMN is then finally converted into NAD+ by NMNAT 126. 
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tion of GSH from GSSG through the action of glutathione reductase 130. Last but 
not least, NADPH is involved in the production of ROS and the regulation of pH via 
NADPH oxidases, which has first been identified in phagocytes but is known to be 
also present in other cells 130, 131.
Since its discovery as cofactor and electron carrier in cellular energy metabolism, 
NAD+’s cellular functions have been expanded to include roles in gene regulation, 
Ca2+-homeostasis, cell signaling, and immunological reactions 132. In these settings, 
NAD+ is no longer a redox molecule that can be recycled via transfer of electrons, 
but acts as substrate for certain enzymes that are able to physically cleave NAD+. 
Among these NAD+-consuming enzymes are sirtuins, poly-ADP-ribose-polymerases 
(PARP), and CD38, which have been shown to regulate cytokine secretion, DNA re-
pair, gene expression, and Ca2+-mobilization 126, 132, 133. Regulation and maintenance 
of cellular NAD levels are, therefore, of utmost importance for (immune) cell viabili-
ty and function. In this regard, NAMPT-mediated NAD+-synthesis, the main pathway 
for NAD+-regeneration, has been shown to be essential in T-lymphocytes 134, as well 
as monocytes and macrophages 135-137, thereby directly linking cellular metabolism 
and the immune response.
3.4. Intracellular ATP storage and transfer: the creatine kinase/ 
        phosphocreatine energy circuit
The ATP produced from glycolysis or OXPHOS can have two fates: it either has to 
be transported to those regions in the cell where it is hydrolyzed, or it should be 
stored until the cell requires extra energy. In order to achieve this, cells (especially 
those with a high energy demand) are equipped with a special energy storage and 
transport system: the creatine kinase/phosphocreatine (CK/PCr) energy circuit 138. 
The circuit comprises a chain of reversible reactions, catalyzed by creatine kinase 
(CK), through which a high energy phosphoryl group is transferred between ATP and 
creatine (Cr) or ADP and phosphocreatine (PCr): 
PCr2- + MgADP- + H+ ↔  MgATP2- + Cr
Creatine is either synthesized endogenously or derived from dietary products, such 
as fish and meat. Biosynthesis of creatine involves the formation of guanidinoac-
etate (GAA) in the kidney, which is transported through the blood and methylated 
to form creatine in the liver 139. Creatine is then released into the blood for uptake 
by cells with a high energy demand via the specific creatine transporter 140. Intra-
cellularly, it is converted to metabolically inert PCr by CK to such an extent that 
two thirds of the total Cr pool is phosphorylated. In this way, the cell can store 
up to ten times the amount of energy in the ATP-pool. If cells with a high energy 
demand would simply maintain a high cellular [ATP] instead of building up a PCr 
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energy store, the accumulation of ADP + Pi and liberation of H
+ upon ATP hydrolysis 
would largely inhibit ATPases 141. 
Creatine kinase has a number of tissue- and cell-specific isoforms with defined 
subcellular locations 138. Cytosolic CK isoforms include ubiquitous brain-type CK (CK-
B) and sarcomeric muscle-type CK (CK-M) which form homo- or heterodimers and 
may be present as soluble enzyme (CK-c), or be specifically associated with ATP-con-
suming processes (CK-a), such as myofibrillar acto-myosin ATPases 142, or be coupled 
to glycolysis (CK-g; 143). Presently, it is not known how the intracellular localization 
of these different CK’s are determined. One possibility could be differential post-
translational modification of the enzyme. CK-g is coupled to glycolytic enzymes that 
are either involved in ATP-generation (e.g. pyruvate kinase), or with phosphofructo-
kinase (PFK), the main regulatory glycolytic enzyme 143, 144. In this way, they prevent 
negative feedback inhibition of PFK by immediate removal of ATP, and at the same 
time replete the PCr pool. Mitochondrial CK (mtCK) isoforms also include a ubiqui-
tous and a sarcomeric enzyme. MtCK is a homo-octamer and functionally coupled 
to OXPHOS either via the adenine nucleotide translocator (ANT) alone which cata-
lyzes the antiport of ATP vs ADP across the inner mitochondrial membrane, or via 
ANT and voltage-dependent ion channel (VDAC) which is situated in the outer mito-
chondrial membrane and facilitates the export of ATP into the cytosol 145. Thus, ATP 
synthesized in the mitochondrial matrix by F0F1- ATPase is transported across the 
inner membrane via ANT in exchange for ADP and exported into the cytosol directly 
via VDAC or after being converted into PCr. 
The CK/PCr circuit, therefore, connects sites of ATP production (glycolysis or 
OXPHOS) with subcellular sites of ATP utilization (ATPases) without the need for 
ATP or ADP to diffuse back and forth 141 (Figure 5). This is of great advantage to the 
cell since the diffusion rates of ATP and especially ADP is much lower than that of 
Cr and PCr 146. In addition, the CK/PCr system provides an immediately available 
temporal energy buffer and regulates metabolism through the net liberation of Pi 
between ATPase- and CK-reactions, resulting in the stabilization of cellular [ATP] at 
approximately 3-5 mM 141. 
Macrophages contain primarily the CK-B isoform, the expression of which is 
upregulated during monocyte differentiation into macrophages together with their 
ability to import creatine via the transmembrane creatine transporter 147. Creatine 
kinase is activated in macrophages after LPS treatment 148, 149 but whether CK is 
differentially expressed in M1 and M2 macrophages is not known. Since macro-
phages cannot synthesize creatine themselves, the size of the intracellular PCr 
pool is directly proportional to the creatine concentration of the culture medium in 
vitro 150. During phagocytosis, cellular ATP remains fairly stable while [PCr] decreas-
es by 40-50%, indicating that the energy consumed during phagocytosis is largely 
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replenished by CK via PCr 151. Moreover, the early stages of complement-opsonized 
particle adhesion and internalization are characterized by the local accumulation 
of CK-B at the phagocytic cup, where it is also involved in the recruitment of actin 
molecules 152. The CK/PCr system, therefore, plays a significant role when immedi-
ate ATP-supply is required in macrophages. 
3.5. Metabolism and macrophage polarization state
Carbohydrate metabolism
Recent literature has revealed that macrophage differentiation and polarization 
strongly influences macrophage metabolism 153. Also the reciprocal relationship, i.e. 
that metabolism determines differentiation state may be true 154.  When combined, 
these observations imply that macrophage metabolic state may be just as hetero-
Figure 5. The CK/PCr system for intracellular ATP transfer and temporal and spatial energy buffering. 
Creatine is transported across the cell membrane via the creatine transporter (CRT).  Cytosolic CK (CK-
c) regulates intracellular PCr/Cr and ATP/ADP ratios. CK coupled to glycolytic enzymes (CK-g) accepts 
ATP produced by glycolysis, while ATP from oxidative phosphorylation (OXPHOS) is accepted by mito-
chondrial CK (mtCK), which - in turn - is coupled to the adenine nucleotide translocator (ANT). CK may 
also be associated with specific sites of ATP consumption (CK-a), for example ATP-gated ion pumps. 
The CK/PCr circuit, therefore, connects sites of ATP production (glycolysis or OXPHOS) with subcellular 
sites of ATP utilization (ATPases) without the need for ATP or ADP to diffuse back and forth. (Adapted 
from Wallimann et al. 141)
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geneous and complex as their polarization phenotype. During the early studies on 
macrophage metabolism, this was not (fully) acknowledged and general conclusions 
were drawn from experiments performed on macrophages with different origins 
and activation/polarization status. A significant number of studies have been per-
formed using thioglycollate elicited mouse peritoneal macrophages (TEPMs) which 
appear - at least partially - polarized towards a M2 phenotype 155, 156. These TEPMs 
consume three times more oxygen than resident peritoneal macrophages 157. None-
theless, carbohydrate metabolism in all macrophages is fundamentally glycolytic 158. 
Monocytes acquire a glycolytic metabolism as they differentiate into macrophages 
in vitro 159, although a concomitant increase in aerobic metabolism (mitochondrial 
mass and cytochrome oxidase activity) has also been described under aerobic con-
ditions 160, 161. Upon polarization, macrophage metabolism is altered to shape the 
new activation state and to meet the specific requirements for performing effec-
tor functions such as phagocytosis, cytokine secretion, ROS production, and ECM 
synthesis 153. After polarization, the largest amount (95%) of all glucose consumed 
by macrophages remains converted into lactate 158 instead of being oxidized via 
the TCA-cycle and OXPHOS, even under aerobic conditions. In this regard, macro-
phage metabolism closely resembles that of cancer cells where this phenomenon is 
termed the “Warburg phenotype”.
Glucose is imported by macrophages via different GLUT isoforms. The expres-
sion of GLUT isoforms seems to be dependent on species, origin (primary cells or 
cell lines), and differentiation and polarization state. THP-1 cells (human monocytic 
cell line) express GLUT1,3, and 4 and upon differentiation into macrophages up-
regulate GLUT3 and 5 expression 162. In primary human blood monocytes GLUT1 is 
expressed and upregulated during differentiation into macrophages 159, while RAW 
264.7 cells (murine macrophage cell line) mainly express GLUT3 163. Stimulation 
with LPS (driving M1 polarization) causes an upregulation of GLUT isoform expres-
sion, leading to elevated influx of glucose 164, 165. This is accompanied by an increase 
in glycolysis gene expression and glycolytic flux to lactate 154, 158. The molecular basis 
of this upregulation in glycolysis involves a switch in the expression of liver-type 
phosphofructokinase (L-type PFK2) in resting TEPMs to the more active ubiquitous 
PFK2 (uPFK2) in M1 TEPMs 158. This causes a nine times rise in PFK2 activity and five 
times increase in fructose-2,6-bisphosphate levels. In contrast, IL-4/IL-13 stimula-
tion, which drives M2 polarization, causes no alteration in PFK2 expression and has 
only mild metabolic effects. 
The increased rate of gene transcription and synthesis of macromolecules dur-
ing macrophage activation increases the bioenergetic demand but also the need for 
anabolic intermediates. Accordingly, the activity of the pentose phosphate pathway 
(PPP) is increased in LPS-stimulated M1 macrophages and a substantial portion of 
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glucose-derived carbon is routed into the PPP 154. Increased PPP activity switches 
these cells to a reductive mode with elevated levels of reduced glutathione (GSH) 
and NADH. Concomitantly, the oxygen consumption rate and expression of OXPHOS 
genes are downregulated in classically activated macrophages 154, 158. In contrast, 
IL-4 stimulated M2 cells exhibit an upregulation in TCA-cycle genes 158 and mito-
chondrial biogenesis 166 and adapt a more oxidative mode with lower GSH levels 167 
and increased superoxide production 168.  
Lipid metabolism
Although glucose is the main energy producing substrate in macrophages, these 
cells are also able to derive cellular energy from fatty acid (FA) oxidation. They are 
equipped with intracellular triglyceride lipase (TGL) 169, 170 but also produce and se-
crete lipoprotein lipase (LPL) 171-174. These enzymes release FAs through the hydro-
lysis of intracellular triacylglycerol (TG) stores or through the hydrolysis of exog-
enously supplied lipoproteins, respectively.  LPL activity and fatty acid uptake and 
oxidation are inhibited in M1 and upregulated in M2 macrophages 166, 175, 176. TEPMs, 
which are partially M2 polarized, relatedly express a substantial amount of adipose 
TGL (ATGL).  In the absence of ATGL (by double knockout), TEPMs accumulate TG-
rich droplets, reducing the availability of FAs for β-oxidation, and have decreased 
ATP levels even while glucose is sufficiently available 177. Under conditions where 
glucose is limiting, LPL-catalyzed hydrolysis of exogenously supplied lipoproteins 
have been shown to provide energy for (M2 polarized) macrophages during pe-
riods of intense metabolic activity (e.g. phagocytosis) 178. However, the presence 
of FAs does not suppress normal glucose or glutamine utilization when this is suf-
ficiently available 179. Macrophages probably first esterify and convert internalized 
FAs into TGs before hydrolysis by ATGL and transport into the mitochondria for 
β-oxidation 177. The largest fraction of oxidized FAs is incorporated into phospholip-
ids and TAGs both in TEPMs and unstimulated peritoneal macrophages 179, 180. Apart 
from supplying energy, lipid metabolism, therefore, also regulate membrane fluid-
ity which is a determining factor in macrophage adhesion and phagocytosis 153, 181. 
Since the saturation status of fatty acids determines membrane fluidity, saturated 
and unsaturated FAs differentially affect phagocytosis in macrophages: saturated 
FAs, like palmitic acid, inhibit phagocytosis, while unsaturated FAs, like oleic acid, 
stimulate phagocytosis 180, 181. 
Amino acid metabolism
Macrophages, and immune cells in general, consume relatively large amounts of 
glutamine 182. Polarization state does not seem to affect glutamine utilization or 
glutamate production within the first 12 hours of activation 158. However, a minor 
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increase in glutamine consumption has been observed in LPS stimulated mouse 
peritoneal macrophages (resident and Bacillus Calmette–Guerin (BCG) activated) 
later, after 24 and/or 48 hours 183. As mentioned in 3.2 above, glutamine can be 
converted to lactate in a reaction pathway that involves the production of NADPH 
by malic enzyme. Increased NADPH-production may be beneficial to LPS-stimulated 
(M1) macrophages, since NADPH is required for the production of ROS via NADPH 
oxidase (NOX) during the oxidative burst, the production of nitric oxide (NO) by 
inducible nitric oxide synthase (iNOS), and as co-factor in anabolic reactions (e.g. cy-
tokine production, and DNA and RNA synthesis) 184. The production of NO involves 
the conversion of another amino acid, arginine, into citrulline and NO by iNOS. Glu-
tamine itself may also contribute to NO production by being converted into arginine 
first. However, this has only been shown for macrophages cultured in the absence 
of extracellular arginine 183. 
Although arginine, therefore, plays a role in M1 activation, its metabolism 
through arginase 1 is upregulated in mouse M2 macrophages and not in M1 cells 153. 
Alternatively activated (M2) mouse macrophages metabolize L-Arg into ornithine 
and urea thereby contributing to polyamine production for collagen synthesis, cell 
proliferation, and tissue remodeling 185. It is not clear whether arginine metabolism 
is also differentially regulated in human M2 macrophages. 
Another amino acid with a notable role in immunometabolism is tryptophan. 
This essential amino acid is the starting substrate for de novo biosynthesis of NAD+ 
(see 3.3 above). The first enzyme of this pathway, IDO, is downregulated by IL-4 but 
upregulated upon IFNγ or LPS stimulation in monocytes and macrophages 186, 187, 
resulting in increased tryptophan utilization. NAD+ has been implicated in the regu-
lation of inflammatory cytokine production in macrophages and in the modulation 
of immune function 133, 135, 136, 188 in addition to its role as metabolic cofactor. De novo 
NAD+-synthesis from tryptophan may, therefore, have a role in the immune func-
tion of M1 macrophages.  The above examples illustrate that also aspects of amino 
acid metabolism and polarization state of macrophages are clearly - and probably 
reciprocally - coupled.   
3.6. Regulation of macrophage metabolism and polarization
PPAR
The adaptation of macrophage metabolism that accompanies the change in polar-
ization state is determined by a number of regulating molecules that control the 
shift between oxidative and reductive metabolism. Peroxisome proliferator-activat-
ed receptors (PPARs) are the master regulators of lipid metabolism. Of the three 
isoforms, PPARγ and PPARδ play a central role in macrophage polarization, while 
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PPARα’s role is more trivial 189. TEPMs as well as IL-4 activated resident mouse peri-
toneal macrophages and human peripheral blood monocytes have increased PPARγ 
mRNA and protein synthesis 190. PPARγ orchestrates the changes in lipid metabolism 
that accompanies M2 polarization and is required for the acquisition and mainte-
nance of alternative activation 156, 189, 191. In addition to the induction of β-oxidation 
and mitochondrial biogenesis, PPARγ directly regulates the ability of IL-4 to activate 
the arginase I promoter and increases arginase I mRNA levels, and mediates IL-4-in-
duced expression of CD36 which may function as scavenger receptor for oxidized 
low density lipoprotein (LDL) or apoptotic cells 156, 190. PPARδ, on the other hand, 
coordinates the immunologic effector functions of alternative activation which in-
clude suppression of the inflammatory response 189. 
 
HIF-1α and HIF-2α
A second regulatory molecule of macrophage metabolic state is hypoxia-inducible 
factor alpha (HIF-α). Two isoforms of this transcription factor, HIF-1α and HIF-2α, 
are differentially activated in M1 and M2 polarized macrophages and influence me-
tabolism distinctly 155.  HIF-1α mRNA expression is increased during classical activa-
tion by LPS and INFγ, while HIF-2α mRNA expression is significantly repressed 155, 158. 
HIF-1α regulates NO production and glycolytic pathways that promote the effector 
response of M1 macrophages by induction of the iNOS gene and glycolysis-related 
genes 192. Alternative activation by IL-4 and IL-13, on the other hand, has almost no 
effect on HIF-1α mRNA while HIF-2α mRNA is significantly increased 155. This is also 
true for TEPMs. HIF-2α activation is essential for arginase I induction in M2 macro-
phages (even under normoxia) and the suppression of NO synthesis in these cells 
but is not required for the hypoxic induction of HIF-1α  target genes, e.g. GLUT 1 
and LDH-A. A remarkable difference between HIF-1α and HIF-2α activation is that 
HIF-1α increases rapidly in response to classical activators, while HIF-2α responds 
slowly to alternative activators and has a longer half-life, reflecting their respective 
roles in transient, acute phase reactions or in long-term responses of inflammation 
resolution and restoration of homeostasis 155. Further study of this topic in mac-
rophages is surely needed as HIF-1 may also be involved in regulating glutamate 
metabolism and lipid synthesis by controlling the direction (forward/reverse) of the 
TCA-cycle at the α-ketoglutarate dehydrogenase step 119.
c-MYC
Downstream of HIF and upstream of PPARγ, the transcription factor c-MYC regu-
lates macrophage polarization by controlling the induction of 45% of the genes 
associated with alternative activation193. Upon stimulation with IL-4 or other M2-
stimuli, c-MYC expression and translocation to the nucleus is induced, leading to 
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upregulation of the STAT6/ PPARγ signaling axis which is required for alternative 
activation 156, 193. c-MYC is also expressed in TAMs, stimulating their pro-tumoral pro-
gram, and thereby enhancing cancer progression 194. In mouse embryonic fibroblasts 
and cancer cells MYC has been shown to promote glutaminolysis and its inhibition 
by HIF-1α and FOXO proteins negatively regulates mitochondrial biogenesis and O2-
consumption 195-197. In contrast, HIF-2α increases MYC activity 198, thereby positively 
regulating mitochondrial function. Although it has not been directly demonstrated, 
inhibition and activation of MYC by HIF-1α and HIF-2α may have the same meta-
bolic consequences in M1 and M2 macrophages.
KLF4
Krüppel-like factor 4 (KLF4), a member of the KLF subfamily of the zinc finger class 
of DNA-binding transcriptional regulators has also been shown to regulate macro-
phage polarization and the accompanying adaptations in metabolism 199. Its expres-
sion is induced in M2 macrophages where it cooperates with STAT6 to induce a M2-
genetic program. In M1 macrophages KLF4 expression is repressed and KLF4 loss 
induces a M1 phenotype, comprising increased pro-inflammatory gene expression, 
enhanced bactericidal activity, and increased glycolytic flux.
p53 and TAp73
Very recently, the tumor suppressor p53 has been shown to influence macrophage 
polarization state and contribute to tumor suppression non-cell-autonomously 200. 
p53 expression promotes cellular senescence involving stable cell cycle arrest and 
secretion of factors that promote an anti-tumor tissue microenvironment and drive 
the classical activation of macrophages. In contrast, proliferating p53 deficient cells 
secrete factors that promote the alternative activation and hence also tumorigen-
esis. Wild type p53 promotes mitochondrial function and suppresses anaerobic 
metabolism 201. However, p53 is mutated in many different types of cancer 202 and 
therefor also influence cancer cell metabolism. Another member of the p53 family, 
Tap73, has also very recently been identified as a modulator of the macrophage 
phenotype. Absence of TAp73 maintains a M1 phenotype while suppressing M2 
polarization and hence resolution of inflammation 203. 
CARKL
Also quite recently, carbohydrate kinase-like protein (CARKL) has been identified 
as a novel regulatory molecule which orchestrates pro- and anti-inflammatory im-
mune responses in macrophages through metabolic control 154. CARKL catalyzes the 
production of sedoheptulose-7-phosphate (S7P), an intermediate of the pentose 
phosphate pathway (PPP; Figure 3)). Upon LPS treatment, CARKL is rapidly down-
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regulated in mice and humans, in vitro and in vivo. This downregulation occurs 
in synchronization with the induction of IL-6 and TNFα and is required for proper 
classical activation. CARKL-loss promotes the rerouting of glucose from aerobic to 
anaerobic metabolism, similar to LPS-induction. Moreover, CARKL-loss causes a 
marked potentiation of LPS-stimulated TNFα, IL-6, and IL-10 response. Therefore, a 
reduction in CARKL can induce a mild M1-phenotype in macrophages. In contrast, 
CARKL is mildly increased during alternative activation. Similar to IL-4 stimulation, 
overexpression of CARKL blocks the production of a number of LPS-induced cyto-
kines, e.g. TNFα, IL-6, IL-1α, IL-β, and CxCL2, while M2-related molecules are up-
regulated, such as Mrc-1. CARKL, therefore, seems to sensitize macrophages to M2 
polarization. During LPS stimulation, PPP activity is increased and accompanied by 
an increase in NADH and GSH levels. However, when CARKL-overexpressing cells are 
stimulated with LPS, there is a reduction in NADH but not NAD+ levels, increasing 
the NAD+/NADH ratio, as well as a reduction in the GSH/GSSG ratio. CARKL, there-
fore, acts as an important metabolic catalyst for maintaining cellular redox state 
during activation 154. 
4. Coupling between the actin cytoskeleton and cell metabolism
Macrophage polarization is not only recognized by substantial adaptations in meta-
bolic activity, but is also accompanied by distinctive alterations in the arrangement 
of the actin cytoskeleton. The formation of cellular protrusions and podosomes as 
well as the ability to spread are differently affected when macrophages obtain a M1 
or M2 polarization state 90, 204, 205, raising the question whether coupling also exists 
between macrophage metabolism and morphodynamic behavior. 
ATP is involved in, and affects, many different facets of actin dynamics. As out-
lined in more detail above, binding of ATP to actin monomers determines actin fila-
ment properties 9, 206 and influences binding of ABPs, while hydrolysis of this ATP 
by non-muscle myosin ATPase is involved in force generation for contraction 207. In 
addition, ATP binding and hydrolysis on the Arp2/3 complex influence actin filament 
branch formation and stability 4, 6 (see 1.1 above). Furthermore, since GTP levels are 
tightly linked to ATP levels, the normal function of the Rho GTPases that regulate 
actin polymerization is also under the influence of cellular [ATP] 208. When cellular 
ATP is depleted, actin filaments are stabilized by decreasing actin-ATP hydrolysis, 
thereby reducing ATP-consumption 209, 210. This leads to the aggregation of actin fila-
ments that in turn sensitizes the cells to apoptosis 211. 
Several studies have suggested that morphodynamic processes are driven by 
local ATP-supply. For example, when ATP-supply via the adenylate kinase system is 
experimentally targeted to focal contacts in mouse embryonic fibroblasts, motility 
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and spreading is enhanced 212. In addition, glycolytic enzymes (especially GAPDH 
and aldolase) have been shown to associate with the actin cytoskeleton 213-215 and 
to be enriched at sites of dynamic actin remodeling, such as pseudopodia 216, 217 and 
lamellipodia 218, promoting cell motility. 
Apart from supplying ATP, cell metabolism is also an important regulator of cel-
lular pH (via the production of lactate and H+) 219 and redox status (via ROS produc-
tion and supplying reducing molecules such as NADPH). As mentioned in 1.3, actin 
itself, as well as several ABPs involved in actin filament assembly and disassembly 
(for example cofilin), is regulated by these factors.  
Based on the cumulative evidence mentioned in this chapter and a constant 
stream of new findings there is no doubt that the metabolic state of the cell is 
an important regulator of the morphodynamic behavior of the cell.  However, we 
should also realize that this is a relatively new area of interest, and many details on 
the metabo-morphodynamic coupling are still not known.
5. Aim and outline of the thesis
The aim of this thesis was, therefore, to investigate this coupling in more detail, 
focusing on the relationship between actin dynamics and cellular energy metabo-
lism in macrophages. The two macrophage lineages (RAW 264.7 and Maf-DKO) that 
were used during our investigation were first compared with respect to their actin-
based morphology, phagocytic activity, proliferation, and carbohydrate metabolism 
in chapter 2. New insights regarding the mechanism of CK-B-mediated ATP supply at 
subcellular sites of actin polymerization were obtained from the results described 
in chapter 3.  In chapter 4 the importance of glucose for actin-based morphody-
namic processes such as membrane protrusion formation and phagocytosis was 
investigated, and in chapter 5 a regulatory role for NAD+ (the key metabolite in cel-
lular redox regulation) in macrophage morphodynamics was identified. Finally, the 
major findings of chapters 2 to 5 are discussed in a broader context in chapter 6.
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Abstract
For in vitro studies of macrophage function different macrophage lineages with a 
cancerous phenotype, of which RAW 264.7 cells are typical representatives, are 
commonly used.  Recently, a new lineage of macrophages of non-tumorigenic 
origin, Maf-DKO cells, which were isolated from a mouse with a MafB/c-Maf 
deficient hematopoietic system, has become available.  To study which cell type 
resembles primary macrophages most closely we here compared gross features of 
carbohydrate metabolism, proliferative capacity, and morphofunctional properties 
of Maf-DKO and RAW 264.7 macrophages. 
Although RAW 264.7 cells had a significantly higher proliferation rate, Maf-DKO 
cells appeared to be morphodynamically more active, since they formed strikingly 
more surface membrane protrusions and phagocytosed complement opsonized 
particles more efficiently. Carbohydrate catabolism did, however, not overtly differ 
between the two cell lines. We conclude that the Maf-DKO cell line shares many 
characteristics with both primary macrophages and existing macrophage cell lines, 
and could be an ideal intermediate cell model for extending our knowledge on the 
intricate relationships between metabolism, form, and function of macrophages.
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Introduction
Macrophages are vital players in host defense against pathogens and in maintaining 
tissue homeostasis. The name “macrophage” is in fact the collective noun for rather 
heterogeneous populations of highly versatile immune cells that were originally 
classified under the mononuclear phagocyte system (MPS). Use of this classification 
system implies that macrophages are derived from monocytes that develop from 
a common myeloid progenitor cell in the bone marrow 1. Recent work by several 
groups, however, has now also provided evidence for self-renewal of macrophages 
formed from embryonic progenitors independent of hematopoietic stem cells, 
via proliferation of cell populations that are already prenatally established in 
various tissues 2-12. These new findings support older studies that disputed the 
MPS-model already at the time of its introduction and suggest that two subsets of 
tissue macrophages can be distinguished: those of bone marrow-dependent and 
-independent origin 13, 14.
This differential developmental origin, and the fact that macrophages can 
occur in their own tissue environment at multiple different stages of functional 
activation, which allows them to adopt a continuum of phenotypes, makes study 
of macrophages difficult. Therefore, to investigate macrophage function and 
characteristics, mostly in vitro approaches are taken for relatively homogeneous 
populations of macrophages. Primary murine macrophages can be isolated from 
the peritoneal cavity, the lungs, or the bone marrow 15, but after isolation, these 
macrophages, like most mature differentiated cells, are difficult to manipulate and 
can be maintained in culture for only a few days 16. These problems can be overcome 
by the use of immortal clonally-derived macrophage cell lines which are relatively 
easy to obtain, such as the murine J744.A and RAW 264.7 monocyte/macrophage 
cell lines and the human THP-1 cell line, all with a cancerous background. The J744.A 
cell line is a reticulum cell sarcoma, from an ascites tumor that arose in a female 
BALB/c/NIH mouse during plasmacytoma induction, which has the morphologic, 
adherent, and phagocytic properties of macrophages 17. RAW 264.7 cells (most 
commonly used) are macrophage-like cells derived from an Abelson murine 
leukemia virus-induced ascites tumor from a male BAB/14 mouse 18, 19. THP-1 is a 
leukemic cell line with monocytic properties, cultured from the blood of a boy with 
acute monocytic leukemia 20.
Although these macrophage lineages share many properties with primary 
macrophages, one must keep in mind that they have an unusually high proliferative 
capacity and behave like cells with a cancerous “Warburg” phenotype 21-24. 
Therefore, the question arises to what extent does study of the currently available 
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macrophage lines that have been established for use in cell culture reveal the true 
characteristics of primary macrophages in tissues?
In order to shed some light on this issue, we have compared the proliferation 
capacity, morphology, phagocytosis capacity, and metabolism of RAW 264.7 cells 
with that of continuously dividing macrophages isolated from mice with a MafB/
c-Maf deficient hematopoietic system 25. In the presence of M-CSF, these Maf 
double knock-out (Maf-DKO) monocytic cells can differentiate into macrophages 
and be expanded in culture without losing their differentiated phenotype. In 
contrast to RAW 264.7 cells, Maf-DKO cells do not have a cancerous background 
and do not produce tumors when transplanted back into mice. On the contrary, 
these transplanted Maf-DKO cells show homing and functional integration into 
normal macrophage populations of tissues. Maf-DKO cells are positive for specific 
monocyte/macrophage surface markers and have a global gene expression profile, 
morphology, and phagocytic capacity highly similar to wild type cells 25. Therefore, 
these cells resemble primary macrophages more closely than RAW 264.7 cells, with 
features intermediate between transformed and normal cells. 
Here, we report that RAW 264.7 cells have a markedly increased proliferation 
rate compared to Maf-DKO cells and that there are significant differences in 
phagocytosis capacity and (actin cytoskeleton controlled) morphology between 
the two cell lines. Metabolically, both cell lines are highly glycolytic and, although 
we detected some differences in the expression level of certain glycolytic enzymes 
which may be related to their (non-)cancerous background, no major metabolic 
differences were observed. We, therefore, consider Maf-DKO cells as an ideal 
alternative cell line to study macrophage metabolism and function.
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Materials and Methods
Reagents
All reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA), unless stated 
otherwise.
Cell culture
RAW 264.7 cells (kind gift from Dr. Hong-Hee Kim, Department of Cell and Develop-
mental Biology, School of Dentistry, Seoul National University, Korea) 26 were main-
tained in high-glucose DMEM (Gibco, Life Technologies, Paisley, UK) supplemented 
with 10% heat inactivated FBS (PAA laboratories, Pasching, Austria), 1 mM sodium 
pyruvate, and 4 mM GlutaMAX (Gibco, Life Technologies, Paisley, UK), at 37°C in a 
humidified atmosphere with 7.5% CO2. Maf-DKO cells (kind gift from Dr. Michael 
H. Sieweke, Centre d’Immunologie de Marseille-Luminy (CIML), Université Aix-Mar-
seille, France) 25 were maintained in the same way except that medium was supple-
mented with 20% conditioned medium (CM) from macrophage colony stimulating 
factor (M-CSF)-producing L929-cells 27.
Proliferation assay
Cell proliferation was analyzed by sulforhodamine B (SRB) staining of protein con-
tent according to the protocol developed by Skehan et al. 28. To compare prolifera-
tion in the presence and absence of M-CSF, RAW 264.7 and Maf-DKO cells were 
seeded in three 96-well plates (25,000 cells/well) in 100 µl culture medium with 
or without 20% L929-cell CM and incubated at 37°C. After 6 (T0), 21 (T15), and 30 
(T24) hours the plates were washed twice with cold PBS and fixed with 10% trichlo-
roacetic acid (TCA; J.T.Baker, Deventer, Holland) for 1 hour at 4°C. After fixation, 
plates were washed five times with water and stored at -20°C until all plates were 
collected. Cellular protein was stained with 50 µl 0.5% SRB in 1% acetic acid for 20 
minutes after which wells were washed four times with 1% acetic acid. Plates were 
dried at 60°C for 3 hours, protein was dissolved in 150 µl 10 mM Tris-HCl (pH 10.5), 
and the absorbance of each well was measured at 510nm on a BioRad Benchmark 
Plus micro plate reader. Values were corrected for background SRB staining by sub-
tracting the average absorbance value of wells that contained medium only, from 
that of wells with cells. To determine the effect of 2-DG and oligomycin on prolifera-
tion, RAW 264.7 and Maf-DKO cells were seeded in three 96 well plates at a density 
of 7,500 and 25,000 cells/well, respectively. RAW 264.7 cells were incubated for 6 
hours and Maf-DKO cells overnight before wells were washed once with medium 
containing either 10 mM 2-deoxy-D-glucose (2-DG) or 2.5 µM oligomycin and cells 
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were incubated in the same medium for 24, 48 or 72 hours. Cells were then fixed 
and stained as described above.
Scanning electron microscopy
RAW 264.7 and Maf-DKO cells were seeded on 12 mm glass coverslips in 24-well 
plates in medium with or without L929-cell CM and activated with 100 ng/ml LPS 
or left non-activated. Cells were washed once with PBS and fixed with 2% glutare-
aldehyde in 0.1 M sodium cacodylate buffer for 1 hour. After washing cells twice 
with sodium cacodylate buffer, coverslips were stored in the same buffer at 4°C until 
further fixation with 1% OsO4 (osmium tetroxide) for 30 minutes. Coverslips were 
then washed once with water and dehydrated in a graded series of alcohol, critical 
point dried, and mounted for scanning electron microscopy (JEOL SEM6340F Field 
Emission Scanning Electron microscope). Images were acquired at 500x as well as a 
2000x magnification.
Cellular actin staining
RAW 264.7 and Maf-DKO cells were seeded on 12 mm glass coverslips in 24-well 
plates in medium with or without L929-cell CM and activated with 100 ng/ml LPS 
or left non-activated. Cells were washed twice with PBS and fixed in 2% paraformal-
dehyde in 0.2 M sodium phosphate buffer for 30 minutes. After washing twice with 
PBS and twice with PBS containing 20 mM glycine (MP Biomedicals, Illkirch Cedex, 
France; PBS-G) cells were permeabilized with 0.1% saponine/PBS-G for 20 minutes. 
This was followed by actin staining with Alexa 568-labeled phalloidin (1:600 in 0.1% 
saponine/PBS-G) for 1 hour. Cells were successively washed four times for 2-4 min-
utes with 0.1% saponine/PBS-G and once with PBS alone. Coverslips were removed 
from wells, rinsed once in water, air dried, and embedded in MoWiol on microscope 
slides. Images were acquired on a Zeiss LSM510 META confocal laser scanning mi-
croscope using a 63x objective and processed using Fiji imaging software.
Phagocytosis assay
Phagocytic activity was determined as zymosan ingestion capacity essentially as de-
scribed by Kuiper et al. 29. Zymosan particles were dissolved in PBS at 10 mg/ml and 
left to rehydrate for at least one hour. Next, zymosan was sonicated three times for 
5 seconds, spun down, resuspended in carbonate buffer (pH 9.6), sonicated, and 
incubated with 1 µg/ml fluorescein isothiocyanate (FITC) for 1 hour at room tem-
perature, in the dark. After FITC labeling, zymosan was washed three times with 
carbonate buffer and incubated in 1 M Tris-HCl, pH 8.0, for 30 minutes. Zymosan 
was then washed twice with PBS and finally resuspended in PBS. After one more 
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sonication step, FITC-labeled zymosan was divided in aliquots, frozen in liquid nitro-
gen, and stored at -20°C.
For phagocytosis assays without M-CSF, 100,000 RAW 264.7 cells were seeded 
per well in normal culture medium and 200,000 Maf-DKO cells per well in medium 
with 20% L929-cell CM. For assays with M-CSF, both RAW 264.7 and Maf-DKO cells 
were seeded in medium containing L929-cell CM at a density of 75,000 and 200,000 
cells/well, respectively. Where applicable, cells were pre-incubated in medium con-
taining 2.5 µM oligomycin (0 or 24 hours) or 10 mM 2-DG (3 hours) and activated 
overnight with 100 ng/ml LPS. FITC-labeled zymosan particles were complement 
opsonized by incubation in fetal bovine serum for 1 hour at 37°C, washed twice 
with PBS, and finally resuspended in serum-free medium with or without L929-cell 
CM and, where applicable, with or without oligomycin and 2-DG. Cells were washed 
once with serum-free medium and incubated with 1 ml zymosan suspension for 
30 minutes at 37°C. The particle-to-cell ratio was approximately 10:1. Particle en-
gulfment was terminated by washing cells twice with PBS and removing extracel-
lular zymosan by treatment with 500 µl 100 U/ml lyticase for 10 minutes at room 
temperature. Successively, cells were detached with 0.05% trypsin/0.5 mM EDTA 
(Gibco, Life Technologies, Paisley, UK), resuspended in 1 ml medium with serum, 
pelleted, and finally resuspended in 200 µl 1% paraformaldehyde in PBS. Samples 
were analyzed by FACS and phagocytosis efficiency was determined by measuring 
the fluorescence intensity of the FITC positive population as well as the percentage 
of cells in that population. The phagocytic index of each sample was calculated as 
the product of the mean FITC intensity of the positive population times the % of 
FITC positive cells.
Western blot analysis
Protein expression was analyzed by western blot analysis. After washing cells twice 
with cold PBS in 6 cm culture dishes, cell lysates were prepared in lysis buffer (50 
mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2, and 0.5% NP-40; 4°C) and stored at 
-20°C until analysis. Lysates containing ± 10 µg protein were mixed with 5x sample 
buffer (0.25 % Bromophenol Blue, 0.5 M DTT, 50 ml glycerol, 10 %SDS, and 0.25 M 
Tris-HCl pH 6.8), heated at 95°C for 5 minutes, and loaded onto 10 or 12% SDS-PAGE 
gels, depending on the size of the protein of interest. After electrophoretic separa-
tion, proteins were blotted onto PVDF membranes. Membranes were blocked with 
5% (w/v) skimmed milk in PBS-T (HXK1, HXK2, LDH-A, actin) or TBS-T (PKM2) for 1 
hour and labeled overnight with a mouse anti-Tubulin (1:5000; DSHB, University 
of Iowa) and either a goat anti-HXK1 (1:200; Santa Cruz Biotechnology), goat anti-
HXK2 (1:200; Santa Cruz Biotechnology), goat anti-LDH-A (1:5000; Cell Signaling 
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Technology), rabbit anti-PKM2 (1:1000; Cell Signaling Technology), or rabbit anti- 
actin (1:1000; Cytoskeleton Inc.) antibody at 4°C. After washing the membranes 
three times for 5 minutes with PBS-T or TBS-T, they were incubated with IRDye 
secondary antibodies (donkey anti-goat 680, goat anti-rabbit 680, goat anti-rabbit 
800, goat anti-mouse 680, and/or goat anti-mouse 800) for one hour at room tem-
perature. This was followed by 4 wash steps of 5 minutes each in PBS-T or TBS-T, a 
final wash step in PBS, and signal detection on the Odyssey Infrared Imaging System 
(LI-COR Biosciences, Lincoln, NE, USA). Tubulin served as loading control and refer-
ence for calculation of protein expression. 
Glucose and Lactate measurements
Glucose consumption measurements were based on the Amplex Red Glucose/Glu-
cose Oxidase assay kit from Molecular probes (Life Technologies, Eugene, Oregon, 
USA). Glucose, glucose oxidase, and Amplex Red reagent were used from the kit but 
horseradish peroxidase was obtained from Sigma-Aldrich (St. Louis, MO, USA) and 
1x reaction buffer was replaced with 0.05 M Tris-HCl, pH 7.5. Apart from these minor 
changes, the kit protocol was followed as described by the manufacturer. Lactate 
production was measured using the same protocol as for glucose consumption but 
replacing glucose oxidase with lactate oxidase and including a lactate standard se-
ries instead of glucose. Cells were seeded in 12 well tissue culture plates in medium 
containing 20% L929-cell CM and incubated overnight. For glucose measurements, 
medium containing 5 mM glucose was used while lactate production was measured 
for cells grown in 25 mM glucose medium. The next day, wells were rinsed with 
pure DMEM containing no glucose and fresh control medium (containing 10% heat 
inactivated dialyzed FBS, 1 mM sodium pyruvate, and 4 mM GlutaMAX) or medium 
containing 2.5 µM oligomycin was added. After 6 hours, medium was collected and 
supernatants were snap frozen in liquid nitrogen and stored at -20°C until analysis. 
Cytosolic extracts were prepared in lysis buffer (50 mM Tris-HCl pH 7.5, 100 mM 
NaCl, 5 mM MgCl2, and 0.5% NP-40; 4°C) and total protein was determined with the 
Bradford assay. Glucose consumption was calculated by subtracting the amount of 
glucose in the sample from that in medium without cells. Lactate production was 
calculated by subtracting the concentration of any lactate in the medium without 
cells from that of the samples. Glucose and lactate assays were performed in paral-
lel.
LDH-isoenzyme expression
LDH-isoenzymes were separated using the SAS-MX LDH Isoenzyme gel electropho-
resis test from Helena Biosciences Europe, according to the manufacturer’s speci-
fications. Cell lysates were prepared as for western blot and protein concentration 
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was determined with the Bradford assay. Per lane, approximately 2.8 µg protein 
was loaded. 
Oxygen consumption measurements
An Oroboros Oxygraph-2k respirometer was used to measure oxygen consumption 
in RAW 264.7 and Maf-DKO cells according to a standard protocol provided by the 
manufacturer. RAW 264.7 cells were incubated in medium with 20% L929-cell CM 
for at least 24 hours prior to assay. The two cell lines were analyzed in parallel in two 
separate chambers of the respirometer. After air calibration of the medium in the 
chambers and stabilization of the signal, 1 x 106 cells (in 60 µl medium) were inject-
ed into the respective chambers. Basal respiration rate was measured at the point 
where the O2-flux signal stabilized. Oligomycin (2.5 µM) was added to each chamber 
and the leak respiration rate was determined after stabilization of the signal. Next, 
7 µM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, a mitochondrial 
uncoupler) was added to reach maximal oxygen consumption in the cells. Finally, 30 
nM rotenone was added and after stabilization of the system, the residual oxygen 
consumption could be determined. The data was analyzed using the DatLab soft-
ware provided with the instrument.
Statistical analysis
Data was analyzed either with the Student’s t-test or using a two-way ANOVA and 
the Bonferroni post-test (GraphPad software, Inc., Version 4). Values are expressed 
as mean +/-SEM. Values were considered to be significantly different when p values 
were < 0.05.
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Results and Discussion
RAW 264.7 and Maf-DKO proliferation in the presence of M-CSF
MafB/c-Maf deficient (Maf-DKO) monocytes require macrophage colony stimulat-
ing factor (M-CSF or CSF-1) for their in vitro differentiation into macrophages 25. For 
RAW 264.7 cells to achieve this state of differentiation in vitro, continuous presence 
of M-CSF is no prerequisite. In vivo, M-CSF is found in the circulation from where it 
regulates the survival, proliferation, and differentiation of monocytes and macro-
phages 30 after being secreted by various cells including monocytes, macrophages, 
fibroblasts, endothelial cells, and malignant cells 31-35. 
To better compare the potential coupling between metabolic phenotype and 
proliferative capacity of RAW 264.7 and Maf-DKO cells in culture we analyzed first 
the effects of absence or presence of M-CSF (in  conditioned medium from L929 
cells) on cell proliferation. Under standard medium conditions (DMEM supplement-
ed with FBS, pyruvate and GlutaMax but without M-CSF) RAW 264.7 cells had a 
high proliferation rate (Figure 1). In the presence of M-CSF, added as 20% CM, RAW 
264.7 proliferation was further increased. Maf-DKO cells, on the other hand, failed 
to divide without M-CSF but even in the presence of M-CSF Maf-DKO cells had a 
significantly slower growth rate compared to RAW 264.7. The high rate of traverse 
through cell cycle and the independence of RAW 264.7 proliferation on M-CSF most 
likely reflect the malignant background of these cells, while the fact that M-CSF is 
obligatory for Maf-DKO survival and their slow proliferation rate again suggests that 
these cells have retained features that are typical for primary macrophages.
Morphodynamic properties of RAW 264.7 and Maf-DKO cells
Since  M-CSF also induces morphology changes in macrophages 36, we became curi-
ous to see how the morphofunctional properties of RAW 264.7 and Maf DKO depend 
on  M-CSF. Firstly, we used scanning electron microscopy to compare the morphol-
ogy of RAW 264.7 cells that were grown in medium with and without L929-cell CM, 
Figure1. The effect of M-CSF on RAW 264.7 and 
Maf-DKO cells in culture. The SRB assay for total 
cell protein mass was used to follow prolifera-
tion of RAW 264.7 and Maf-DKO cells in the pres-
ence and absence of L929-cell CM (M-CSF). The 
increase in cell mass is plotted as the change in 
optical density at 510nm. Data represent means 
± SEM of three independent experiments per-
formed in triplicate.
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to that of Maf-DKO cells in medium with L929-cell CM. Cells were additionally stim-
ulated overnight with 100 ng/ml LPS before fixation and image acquisition. Strik-
ingly, profound differences were observed in the growth pattern and morphology of 
RAW 264.7 cells in the presence and absence of M-CSF. Without M-CSF, RAW 264.7 
cells grew in a clump-wise fashion and had a rounded shape (Figure 2A,B), while 
the addition of M-CSF induced the formation of cellular protrusions and caused 
the cells to arrange themselves more loosely, similar to Maf-DKO cells (Figure 2E,F). 
Interestingly, Maf-DKO cells displayed a more complex surface morphology com-
pared to RAW 264.7. Maf-DKO cell surfaces were densely decorated with protru-
sive membrane structures, which we henceforth designate as membrane ruffles 
throughout this piece (Figure 2I-L). RAW 264.7 cell surfaces were more ‘bald’, dis-
playing only a few ruffles. LPS induces an inflammatory phenotype in macrophages 
that is accompanied by morphological change 37, 38. Under our culture conditions 
cell spreading was prominently induced by LPS in RAW 264.7 both in the absence 
and presence of M-CSF (Figure 2C,D,G,H), as well as in Maf-DKO cells (Figure 2K,L).
To us, the relative high abundance of ruffle-like structures on Maf-DKO cells 
suggests that these cells have a dynamically more active cortical actin cytoskele-
ton than RAW 264.7 cells that helps them to continuously probe the environment. 
Possibly, under the conditions used, a high percentage of the “cell-dorsal” surface 
protrusions represent the membrane folds that are actively involved in the non-
selective uptake of molecules, nutrients, and antigens from the medium through 
a process called macropinocytosis 39. Our results thus suggest that Maf-DKO cells 
may be much more active in this uptake than RAW 264.7. Indeed, this interpreta-
tion would be consistent with the findings of Aziz et al. 40, who  observed that the 
actin organization of mafB-deficient macrophages is altered and that a number of 
proteins involved in actin polymerization, as well as actin itself, were upregulat-
ed compared to control cells, thereby suggesting a role for MafB in the regulation 
of actin dynamics. Our own findings corroborate this picture, and suggest a dif-
ferential role for actin in Maf-DKO and RAW 264.7 cells.  Firstly, when normalized 
to tubulin expression, we found that Maf-DKO cells expressed considerably more 
actin than RAW 264.7 cells (Figure 3A). Secondly, staining with phalloidin revealed 
that RAW 264.7 and Maf-DKO cells have a noticeably different morphology of the 
actin cytoskeleton (Figure 3B,C). In RAW 264.7 cells, prominent actin-rich filopodial 
structures could be distinguished, while Maf-DKO cells displayed a more ‘cloudy’ 
actin staining. This ‘cloudy’ staining could be the result of the dense organization 
of membrane sheets and ruffles on the surface of Maf-DKO cells, making it difficult 
to distinguish separate structures. In the presence of LPS, Maf-DKO cells also devel-
oped actin rich filopodia, but these structures were still more prominent in RAW 
264.7 cells (Figure 3D,E).
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To assess in a quantitative way how these actin-related features could differen-
tially affect the morphofunctional characteristics of the two cell lines, we decided 
to measure phagocytosis efficiency of complement opsonized zymosan (COZ) in the 
presence and absence of LPS and M-CSF. RAW 264.7 phagocytosis was low in the ab-
sence of LPS and M-CSF (-LPS; Figure 4). In the presence of LPS, the ability to engulf 
COZ was markedly improved, while the addition of M-CSF reduced the RAW 264.7 
phagocytosis efficiency. Aziz et al. 25 reported that, compared to primary wild type 
macrophages, the phagocytic activity of Maf-DKO cells is not altered.  We found here 
that, compared to RAW 264.7 cells, they exhibited a significantly greater phagocy-
tosis efficiency, even in the absence of LPS or M-CSF (Figure 4). Pre-stimulation with 
LPS did not affect COZ engulfment by Maf-DKO cells, while M-CSF increased the 
phagocytosis efficiency significantly. The two cell lines, therefore, clearly have a dif-
ferential dependency on M-CSF for phagocytosis. Most literature studies report on 
a stimulatory effect of M-CSF on phagocytosis 30, 41-43 in agreement with our observa-
tion for the Maf-DKO cells, although an inhibitory effect of M-CSF on phagocytosis 
of serum opsonized yeast cells in resident peritoneal macrophages is mentioned 
in one study 36. Currently it is unclear how M-CSF can have such differential effects 
on phagocytosis in different macrophage cells. Although truly opposing effects are 
Figure 3. Actin cytoskeletal morphology and actin expression in RAW 264.7 and Maf-DKO cells. West-
ern blot quantification of actin expression in RAW 264.7 and Maf-DKO cells relative to tubulin (A). 
Data represent ratios of actin and tubulin band intensities of one blot. B-E, Cells were seeded on glass 
coverslips and stimulated overnight with LPS (100 ng/ml) or left unstimulated. After fixation, cells were 
stained with Alexa568-labled phaloidin and imaged on a Zeiss LSM510 META confocal laser scanning 
microscope.
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difficult to explain, it is possible that activity of the receptor for M-CSF (CSF-1R) 
or downstream pathways in M-CSF-induced signaling are differentially controlled 
in macrophages of different origin. Our observation that RAW 264.7 cells required 
LPS induction to obtain reasonable phagocytosis activity, while Maf-DKO cells were 
far more efficient in phagocytosis of COZ particles even in the absence of any ad-
ditional external stimulus strengthen this possibility. Another explanation may be 
that the difference is not in signaling pathways but that (as we show in Figure 2A,E) 
Maf-DKO cells are structurally better equipped to capture phagocytic targets than 
RAW 264.7 cells, because their  surface is permanently more abundantly decorated 
with membrane sheets and ruffles, structures that have been shown to be involved 
in the capturing of complement opsonized particles 44. Upon stimulation with LPS, 
membrane ruffle formation is induced (Figure 2C,D), along with the activation of 
the complement receptor 45, explaining why phagocytosis is improved with LPS. 
Glycolytic and mitochondrial metabolism
For macrophages, alike many other cell types, an inverse reciprocal relationship be-
tween proliferation capacity and morphological and functional specialization upon 
polarization has been demonstrated 46. Furthermore, proliferative and morpho-
functional characteristics are also coupled to specific metabolic adaptations 23, 47. 
The increased proliferation rate of tumor cells, like RAW 264.7, is usually accom-
panied by a shift in metabolism to aerobic glycolysis. Macrophages are, however, 
perhaps special cells in that even in the untransformed state they appear highly 
glycolytic 48, 49. In order to determine and compare the extent to which RAW 264.7 
and Maf-DKO cells depend on glycolysis or mitochondrial oxidative phosphorylation 
(OXPHOS), we assessed proliferation in the presence and absence of the glycolysis 
inhibitor 2-deoxy-D-glucose (2-DG) and the OXPHOS inhibitor oligomycin. In both 
Figure 4. Phagocytosis of COZ in RAW 264.7 and Maf-DKO cells in the presence and absence of M-
CSF, LPS, or metabolic inhibitors. Phagocytic index of RAW 264.7 and Maf-DKO cells was determined 
with or without LPS (±LPS) and with or without L929-cell CM (± M-CSF). All bars were normalized to 
the RAW 264.7+LPS bar. Data represent means ± SEM of three independent experiments performed in 
triplo. (*p < 0.05, **p < 0.01, ***p < 0.001, Two-way ANOVA and Bonferroni posttest)
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cell lines glucose metabolism via glycolysis appeared to be the primary pathway 
to fuel proliferation. In the presence of 2-DG, proliferation ceased within 24 hours 
(Figure 5A,B). In contrast, in the presence of oligomycin, both cell lines continued 
to proliferate for at least 72 hours, although their growth rate was significantly re-
duced (Figure 5A,B). These results confirm that RAW 264.7 and Maf-DKO cells – in 
accordance with their monocyte-macrophage character - are both highly glycolytic 
but that mitochondrial OXPHOS capacity must be intact, and is used, to attain maxi-
mal growth rates.
To study and compare RAW 264.7 and Maf-DKO metabolism more closely, we 
next measured glucose consumption and lactate production, compared the expres-
sion of certain glycolytic enzymes, and determined mitochondrial respiration. Glu-
cose consumption and lactate production were measured relative to the amount 
of protein per well. No significant differences were found in the amount of glucose 
consumed (Figure 6A) and, although Maf-DKO cells tended to produce less lactate 
(Figure 6B), both cell lines showed a high glycolytic flux to lactate, with RAW 264.7 
cells converting 75% and Maf-DKO cells converting 70% of all glucose to lactate 
(ratio control bars, Figure 6A,B). This percentage is lower than what was reported 
for quiescent peritoneal macrophages in an earlier study by Rodríguez-Prados et 
al. 50 where these cells converted 95% of all glucose to lactate. In the same study 
RAW 264.7 were shown to have a glucose-lactate-conversion of 80%, but to have an 
increased glycolytic flux rate (i.e. consume and produce more glucose and lactate, 
respectively). Maf-DKO cells, therefore, seem to have a glycolytic flux and flux rate 
more comparable to RAW 264.7 cells than to quiescent peritoneal macrophages 
under the culture conditions that we used in our analyses. In both cell lines glucose 
Figure 5. Proliferation of RAW 264.7 and Maf-DKO cells in the presence of glycolysis inhibitor 2-DG 
and OXPHOS inhibitor oligomycin. RAW 264.7 (A) and Maf-DKO (B) cells were incubated in control 
medium or medium containing 10mM 2-DG or 2.5 µM oligomycin for 24, 48, or 72 hours, after which 
protein content was determined. Data represent means ± SEM of three independent experiments per-
formed in triplicate. (**p < 0.01, ***p < 0.001, Two-way ANOVA and Bonferroni posttest)
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Figure 6. RAW 264.7 and Maf-DKO cells are highly glycolytic. Glucose consumption (A) and lactate 
production (B) in RAW 264.7 and Maf-DKO cells in the presence and absence of the OXPHOS inhibitor 
oligomycin. (C) Expression levels of four metabolic enzymes that were noticeably different between 
the two cell lines. Protein expression (relative to tubulin) was calculated from the band intensities of 
three different blots and normalized to the expression in RAW 264.7. D, Lactate dehydrogenase iso-
enzyme expression in RAW 264.7 and Maf-DKO cells. E, Mitochondrial respiration measured as the 
basal oxygen consumption (Basal), the leak respiration (Leak), maximal oxygen consumption (Max), 
and residual oxygen consumption (Res). Data in (C) represent band intensities of HXK I, HXK II, LDH-A, 
and PKM2 of one blot, relative to tubulin. Data in A and B represent means ± SEM of three independent 
experiments performed in triplicate, and in E means ± SEM of four experiments performed with RAW 
264.7 and Maf-DKO cells in parallel.
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consumption and lactate production was increased when mitochondrial OXPHOS 
was inhibited with oligomycin, although the differences were not statistically sig-
nificant.
Glycolytic enzymes are often differentially regulated in cancer cells 51. When the 
expression levels of some glycolytic enzymes were compared on western blot, we 
did not observe any overt differences. We did, however, notice that the expression 
levels of hexokinase (HXK) II, lactate dehydrogenase A (LDH-A), and pyruvate kinase 
M2 (PKM2) tended to be higher in RAW 264.7 cells, while the opposite was true 
for HXK I (Figure 6C). This profile would correspond with the changes in glycolytic 
enzyme expression that is normally associated with cancer cells. Hexokinase II is 
upregulated in cancer cells to maintain an increased rate of glucose consumption 
and sustain a high glycolytic rate 52-55. Whether glucose is used for ATP production 
(via breakdown to pyruvate and conversion to lactic acid) or used for the synthesis 
of anabolic material is determined by PKM2, a splice isoform of PKM 56. PKM2 cata-
lyzes the conversion of phosphoenolpyruvate to pyruvate and is the preferred form 
that is expressed in all types of proliferating cells, including cancer cells. Contrary 
to first believe, a recent study has demonstrated that increased PKM2 expression 
is not associated with increased proliferation in these cells. Proliferation appeared 
rather favored by downregulation/inactivation of total PKM activity 57, creating con-
ditions wherein glycolysis intermediates can be used for nucleotide, amino acid, or 
fatty acid anabolism rather than the production of ATP. Proliferating cells, therefore, 
probably prefer the low PKM activity of isoform M2 to further cell growth. The 
conversion of pyruvate to lactate is catalyzed by LDH.  Alike in the human system, 
in cancer cells of mice the expression of this enzyme is up-regulated and its subunit 
composition is changed, leading to increased lactate production 58, 59. Lactate dehy-
drogenase may exist in five different isoforms (LDH1-5) that differ from one another 
with regard to the ratio of the A and B subunits in the tetramer. We performed a 
LDH zymogram analysis to compare the isoenzyme distribution in our macrophage 
lines. To verify the gel’s capacity to separate LDH1-LDH5 isoforms of mouse and 
human origin, a lysate of the human glioma cell line U87 (which expresses all five 
isoforms) was run in parallel as a control (according to Eyben et al. 60). We found 
that Maf-DKO cells, in contrast to RAW 264.7 cells, express low amounts of LDH-B 
that enables the production of LDH3 and LDH4. Still, LDH5 is by far most dominantly 
expressed in both cell types (Figure 6D). The LDH isoenzymes have different Km val-
ues for pyruvate and lactate and therefore the speed at which pyruvate and lactate 
are interconverted may differ. The LDH isoenzyme pattern may, therefore, play an 
important role during rapid changes in cellular energy metabolism, when the gly-
colytic rate, and thus the production of pyruvate, is markedly altered 61. However, 
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under steady state conditions the physiological significance of a differential LDH 
isoenzyme pattern is still not well understood. 
When pyruvate is not converted to lactate it is transported across the 
mitochondrial membrane and catabolized via the TCA-cycle and used to produce 
ATP via OXPHOS. In order to compare the mitochondrial activity of RAW 264.7 
and Maf-DKO cells, we measured oxygen consumption in absence and presence of 
certain OXPHOS inhibitors in order to determine basal O2-consumption as well as the 
amount of oxygen that is consumed without producing ATP (leak), the respiration 
capacity (maximal respiration rate), and the amount of oxygen consumption by 
systems other than the electron transport chain (residual oxygen consumption), for 
example NADPH oxidases 62. Both cell lines exhibited a relatively low O2-consumption 
(~20 pmol.s-1.10-6 cells compared to ~100 pmol.s-1.10-6 cells for mouse embryonic 
fibroblasts 63; Figure 6E). Indeed, if only a minor fraction of glucose-derived pyruvate 
enters the TCA cycle and ultimately serves to fuel OXPHOS, this may explain why 
treatment with oligomycin did not significantly alter the glycolytic flux (Figure 6A,B). 
Of note, no differences were detected in basal oxygen consumption between RAW 
264.7 and Maf-DKO, neither did the cell lines differ in leak, maximal, or residual O2-
consumption (Figure 6E).
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Summarizing conclusions
We have compared gross features of carbohydrate metabolism, proliferative capacity 
and morphofunctional properties of Maf-DKO and RAW 264.7 macrophages, 
two macrophage cell lines that have an entirely different origin and history of 
development. The two cell lines exhibited vastly different proliferation rates, with 
the RAW 264.7 lineage having a markedly shorter doubling time, consistent with 
its tumorigenic origin. Maf-DKO cells, on the other hand, were morphodynamically 
more active, displaying a strikingly more complex cell surface morphology and 
significantly greater phagocytosis efficiency. Apart from subtle differences in the 
expression level of some glycolytic enzymes, RAW 264.7 and Maf-DKO cells share 
many metabolic characteristics, despite the conspicuous differences in the speed 
at which they traverse through cell cycle.  This apparent dichotomy may be best 
explained by assuming that, although the global rate of glycolysis is similar for 
both cell lineages, there is differential use for this pathway, either mainly as supply 
pathway for ATP to deliver fuel for morphodynamic activity in Maf-DKO cells, or for 
the production of precursors of building blocks (nucleotides, proteins, lipids) for 
generation of cell biomass, in RAW 264.7 cells. More cell biological study is certainly 
necessary on the different processes that can be preferentially served by glycolysis 
in macrophages, to better understand the complex reality of macrophage biology, 
and specifically the coupling between metabolism, proliferation, and activity in 
phagocytosis, membrane ruffling and other changes in these highly plastic cell 
types. Based on our findings we consider Maf-DKO cells, that also exhibit many 
of the other typical properties of primary wild type macrophages 25, as well suited 
intermediate models for such studies.
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Abstract
Subcellular partitioning of creatine kinase contributes to the formation of patterns 
in intracellular ATP distribution and the fuelling of cellular processes with a high and 
sudden energy demand.  We have previously shown that brain-type creatine kinase 
(CK-B) accumulates at the phagocytic cup in macrophages where it is involved in 
the compartmentalized generation of ATP for actin remodeling. Here, we report 
that CK-B catalytic activity helps in the formation of protrusive ruffle structures 
which are actin-dependent and abundant on the surface of both unstimulated 
and LPS-activated macrophages.  Recruitment of CK-B to these structures occurred 
transiently and inhibition of the enzyme’s catalytic activity with cyclocreatine led to 
a general smoothening of surface morphology as visualized by scanning electron 
microscopy. Comparison of the dynamics of distribution of YFP-tagged CK-mutants 
and isoforms by live imaging revealed that amino acid residues in the C-terminal 
segment (aa positions 323-330) that forms one of the protein’s two mobile loops 
determine its partitioning over inner regions of the cytosol and nearby sites where 
membrane protrusions occur during induction of phagocytic cup formation. 
Whereas wt CK-B, muscle-type CK (CK-M), and a catalytically dead CK-B-E232Q 
mutant with intact loop region were normally recruited from the cytosolic pool, 
no dynamic transition to the phagocytic cup area was seen for the CK-homologue 
arginine kinase and a CK-B-D326A mutant protein.  Bioinformatics analysis helped 
us to predict that conformational flexibility of the C-terminal loop, independent 
from conformational changes induced by substrate binding or catalytic activity, is 
likely involved in exposing the enzyme for binding at or near the sites of membrane 
protrusion formation. 
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Introduction
The creatine kinase-phosphocreatine (CK-PCr) phosphagen system 1 serves to store 
chemical energy in the form of high-energy phosphoryl groups and to connect 
subcellular sites of ATP utilization with sites of glycolytic or mitochondrial ATP 
production without the need for ATP and ADP to diffuse back and forth 2. To fulfill 
this energy-transport role, transfer reactions are involved in which the reversible 
exchange of a high energy phosphoryl group between phosphocreatine and ATP 
is catalyzed by different creatine kinases (CKs) 3, 4. In vertebrates, this CK-PCr 
system is farthest evolved and comprises a set of multimeric enzyme isoforms 
that are expressed in a tissue- and cell-specific manner and are subcellularly 
compartmentalized.  Four different genes encode the CK subunits that form the 
different homo- or heteromeric proteins. Functional cytosolic isoforms BB-, BM- 
and MM-CKs are found as dimeric proteins predominantly in brain and many 
other tissues, in heart, and in skeletal muscle, respectively. Mitochondrial isoforms 
UbCKmit (or Mia-CK) and ScCKmit (or Mib-CK) occur as dimeric and octameric proteins 
and are ubiquitously expressed, or found only in skeletal muscle cells, respectively 5. 
Many ATP-dependent systems, for example, the Na2+/K+-ATPase 6,  ATP-gated K+ 
channel 7,  Ca2+-ATPase 8 and actin-myosin ATPase for muscle contraction 9-11 rely 
on this phosphagen-mediated ATP-supply.   Lack of CK isoforms in vivo, however, is 
not associated with complete loss of viability and function because of redundancy 
in the brain, heart and muscle systems for ATP supply and because of structural 
adaptation and physiological compensation 12. 
We ourselves have shown that actin-based cell motility in non-muscle cells 
like astrocytes, macrophages and osteoclasts is also fuelled by CK-mediated ATP 
transfer 13, 14.  In astrocytes, brain-type creatine kinase (CK-B) is most prevalent.  It 
transiently accumulates in membrane ruffles and ablation of its activity reduces 
spreading and migration performance. Also in macrophages, which accumulate PCr 
at a molar level that is three- to five-fold higher than that of ATP 15, CK-B is the most 
abundant isoform 3. Its expression increases upon differentiation of monocytes into 
macrophages. Upon further differentiation of this monocytic lineage into osteoclasts, 
expression is even further upregulated 16. During phagocytosis in peritoneal 
macrophages, obtained as either resident or thioglycollate-elicited cells, 40-50% of 
the PCr pool is depleted while global ATP levels remain stable 17. Moreover, CK-B is 
activated in macrophages after LPS treatment 18, 19, indicating that reversible CrP to 
creatine (Cr) conversion may play an essential part in the physiological regulation 
of macrophage end function.  In accordance with prevailing ideas based on these 
observations, we have identified a role for CK-B in morphodynamics in and around 
the phagocytic cup during CR3-mediated phagocytosis in macrophages, where the 
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enzyme was found to accumulate and be involved in local actin recruitment and 
polymerization/depolymerization dynamics.  Depletion or pharmacological and 
genetic blockade of CK activity specifically affected the early stages of phagocytosis, 
i.e. actin-dependent adhesion of the particle, as well as steps in the internalization 
process 14. This suggests a role for CK-B in the formation and/or functioning of the 
particle capturing machinery, which comprises filopodia and membrane ruffles for 
probing the cell’s environment and capturing phagocytic targets 20-23. Apart from 
having a role in phagocytosis, formation of actin-rich protrusive structures may 
also be involved in macropinocytosis, another highly active endocytic process in 
macrophages 24.  CK’s significance therein and in various other membrane protrusive 
events remains to be examined.  
Here, we address the question on how CK-B is recruited to the subcellular sites 
where actin-dependent membrane protrusions are formed in macrophage cell lines. 
We report on study of the morphological effects of pharmacological inhibition of 
CK-B with cyclocreatine and the partitioning behavior of EYFP-tagged wt and mutant 
homologs. These analyses suggest that the C-terminal flexible loop is crucial for CK-
B’s recruitment to subcellular regions of the cell where phagocytic cups are formed 
during ingestion of complement opsonized zymosan (COZ) particles.  By analogy, we 
think that the accumulation of CK-B to spontaneously formed membrane ruffles is 
controlled similarly.
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Material and Methods
Reagents
All reagents were obtained from Sigma (St. Louis, MO, USA), unless stated other-
wise.
Cell culture
RAW 264.7 cells (kind gift from Dr. Hong-Hee Kim, Department of Cell and Devel-
opmental Biology, School of Dentistry, Seoul National University, Korea) 16 were 
maintained in high-glucose DMEM (Gibco, Life Technologies, Paisley, UK) supple-
mented with 10% heat inactivated FBS (PAA laboratories, Pasching, Austria), 1 mM 
sodium pyruvate, and 4 mM GlutaMAX (Gibco, Life Technologies, Paisley, UK), at 
37°C in a humidified atmosphere with 7.5% CO2. Maf-DKO cells (kind gift from Dr. 
Michael H. Sieweke, Centre d’Immunologie de Marseille-Luminy (CIML), Université 
Aix-Marseille, France) 25 were maintained in the same way except that medium was 
supplemented with 20% conditioned medium from L929-cells containing macro-
phage colony stimulating factor (M-CSF).
DNA constructs and transfection 
The EYFP-CK-B expression vector (pEYFP-CK-B) was constructed as previously de-
scribed 14. To generate plasmids EYFP-CK-B-D326A and -E232Q that encode tagged-
mutant CK-Bs, we excised EcoRI-XhoI or EcoRI-SalI DNA inserts with the entire CK-ORF 
from either pSG8-puroCK-B-D326A or pSG8puroCK-B-E232Q (H.Pluk, unpublished) 
and reintroduced these segments into EcoRI-XhoI or EcoRI-SalI opened pEYFP-C2 
(Clontech) vectors, respectively. EGFP-CK-M was subcloned from pCMVsport-EGFP-
CK-M 26 into pSG8-puro 27 by EcoRI – XhoI digestion. Arginine kinase (AK) cDNA was 
amplified by PCR from a pOT2 vector containing DNA from Drosophila melanogas-
ter EST clone GH11670 (DGRC, Bloomington, IN) 28. The 5’ PCR primer contained the 
translation start codon and an EcoRI restriction site (5’-CACGAATTCATGGTTGATGC-
CGCTGTT-3’), and the 3’ PCR primer contained a silent mutation at S355 (GCC→GAC) 
and a BamHI restriction site (5’-GATGGATCCTTACAGACTCTTCTCGAG CTTGATC-3’). 
The primers were designed using GeneRunner v3.05. The resulting PCR product 
with AK ORF was cloned into the pEYFP-C2 vector by EcoRI – BamHI digestion. The 
protein encoding segments of pEYFP-AK and pSG8puro-GFP-CK-M plasmid DNAs 
were verified by DNA sequencing analysis using as forward primer 5’-CGATCA-
CATGGTCCTGCTGG-3’ and reverse primers 5’-GTTTCAGGTTCAGGGGGAGG-3’ and 
5’-GGACAAACCACAACTAGAATG-3’ (Eurogentec), respectively.
Transfection of RAW 264.7 cells was performed with linearized plasmid DNA 
using Lipofectamine LTX and Plus (Invitrogen, Life Technologies, Paisley, UK). Brief-
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ly, opti-MEM (250 µl; Invitrogen, Life Technologies, Paisley, UK) was mixed with 2 
µg DNA, 2.5 µl plus reagent and 5 µl LTX, according to the manufacturer’s proto-
col. Prior to use pEYFP, pEYFP-CK-B and pEYFP-AK were linearized with MluI and 
pSG8puro-GFP-CK-M was linearized with NdeI. To obtain stably transformed cell 
lines, transfected RAW 264.7 cells were placed under constant drug-selection for 
two weeks using either puromycin (5 µg/ml) or G418 (500 µg/ml).  After this se-
lection, the fraction of fluorescently positive cells in the population was further 
enriched by FACS sorting. 
Western Blot analysis
Protein expression was analyzed by western blot analysis. After washing cells twice 
with cold PBS in 6 cm culture dishes, cell lysates were prepared in lysis buffer (50 
mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MgCl2, and 0.5% NP-40; 4°C) and stored at 
-20°C until analysis. Lysates containing ± 10 µg protein were mixed with 5x sample 
buffer (0.25 % bromophenolblue, 0.5 M DTT, 50 ml glycerol, 10 %SDS, and 0.25 M 
Tris-HCl pH 6.8), heated at 95°C for 5 minutes, and loaded onto 12% SDS-PAGE gels. 
After electrophoretic separation, proteins were blotted onto PVDF membranes. 
Membranes were blocked with 5% (w/v) skimmed milk in PBS-T for 1 hour and 
labeled overnight with monoclonal anti-Tubulin (1:5000; DSHB, University of Iowa) 
and monoclonal anti-CK-B (1:5000; 21E10 29) antibodies at 4°C. After washing the 
membranes three times for 5 minutes with PBS-T, they were incubated with a goat 
anti-mouse IRDye 800 secondary antibody for one hour at room temperature. This 
was followed by 4 wash steps of 5 minutes each in PBS-T, a final wash step in PBS, 
and signal detection on the Odyssey Infrared Imaging System (LI-COR Biosciences, 
Lincoln, NE, USA). Tubulin served as loading control and reference for calculation of 
protein expression.
Scanning electron microscopy
For morphological examination, RAW 264.7 (60,000) and Maf-DKO (120,000) cells 
were seeded on 12 mm glass coverslips in 24-well plates and stimulated overnight 
with 100 ng/ml LPS or left unstimulated. Prior to fixation, medium was replaced 
with fresh medium containing 0, 5, 10, or 50 mM cyclocreatine. After 3 hours, cells 
were washed once with PBS and fixed with 2% glutaraldehyde in 0.1 M sodium 
cacodylate buffer for 1 hour. After washing cells twice with sodium cacodylate buf-
fer, coverslips were stored in this buffer at 4°C until further fixation with 1% OsO4 
(osmium tetroxide) for 30 minutes. Coverslips were then washed once with water 
and dehydrated in a graded series of alcohol washes. Finally, coverslips were critical 
point dried and mounted for scanning electron microscopy on a JEOL SEM6340F 
Field Emission Scanning Electron microscope.
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Immunofluorescence and actin staining 
To examine the actin cytoskeletal morphology and assess the presence of CK-B in 
membrane protrusions, 60,000 RAW 264.7 and/or 120,000 Maf-DKO cells were 
seeded on glass coverslips in 24 well tissue culture plates and stimulated overnight 
with 100 ng/ml LPS or left unstimulated. Where applicable, cells were treated with 
0, 5, 10, or 50 mM cyclocreatine for three hours, prior to fixation. Cells were fixed 
in 1% paraformaldehyde (PFA) by adding an equal volume of 2% PFA in 0.2 M phos-
phate buffer (PB) to cells. Fixative was replaced with fresh 1% PFA/0.2 M PB after 
15 minutes, and cells were incubated for an additional 15 minutes. Coverslips were 
washed twice with PBS and twice with PBS containing 20 mM glycine (MP Biomedi-
cals, Illkirch Cedex, France; PBS-G) before permeabilization with 0.1% saponine/
PBS-G for 20 minutes. Cells were then incubated with primary antibody (anti-CK-B 
(21E10), 1:2000 29) in 0.1% saponine/PBS-G  for one hour at room temperature. 
After four wash steps of 2-4 minutes each with 0.1% saponine/PBS-G, cells were 
incubated with goat anti-mouse Alexa 488-tagged secondary antibody (1:500) and/
or Alexa 568-labeled phalloidin (1:600 in 0.1% saponine/PBS-G) for 1 hour. Cells 
were successively washed four times for 2-4 minutes with 0.1% saponine/PBS-G 
and once with PBS alone. Coverslips were removed from wells, rinsed once in water, 
air dried, and imbedded in MoWiol on microscope slides. Images of cells stained for 
CK-B were acquired on an Olympus FV1000 or a Zeiss LSM510 META confocal laser 
scanning microscope. Alternatively, z-scans consisting of 20 x 0.5 µm sections and 
the pinhole adjusted to one airy unit were recorded and merged to one single im-
age (maximal projection) using Fiji imaging software.   
Quantification of imaging results 
To quantify the number of dorsal surface protrusions, SEM images were used. A 
region of interest with an area of 20-130 µm2 was drawn on the cell body of single 
cells using Fiji imaging software. All protrusive structures (mainly comprising small 
and large membrane ruffles and not filopodia) within this region were counted and 
the number of surface protrusions per square micron was calculated. Per condition, 
11-35 cells from five different fields were analyzed. 
For quantification of filopodia extending laterally from the cell body, lines were 
drawn to delineate contour segments of cells in areas where no contacts with 
neighboring cells were seen. The number of filopodia extending from each contour 
segment was determined.  16-34 line segments, with a total contour length corre-
sponding to the circumference of 10-35 cells, were analyzed per condition.
The percentage of cells with ruffled or actin rich leading edges were determined 
from SEM and immunofluorescence images, respectively. Per field analyzed, the 
total number of cells was counted as well as the number of cells that displayed 
80
these structures and the percentage was calculated. Per condition, five SEM fields 
containing a total of 8-22 cells and 7 fluorescence microscopy fields containing a 
total of 37-59 cells were analyzed.
Phagocytosis assay 
Phagocytic efficiency of complement opsonized zymosan (COZ) was determined 
as described previously 14. RAW 264.7 (75,000) and Maf-DKO cells  (200,000) were 
seeded in 12 well tissue culture plates in medium containing 20% L929 conditioned 
medium and stimulated overnight with 100 ng/ml LPS. Prior to assay, cells were 
incubated in medium containing 0, 5, 10, or 50 mM cyclocreatine (2-Imino-1-im-
idazolidineacetic acid) for three hours. FITC-labeled zymosan particles were opso-
nized by incubation in FBS for 1 hour at 37°C, washed twice with PBS, and finally 
resuspended in serum-free medium containing 0, 5, 10, or 50 mM cyclocreatine. 
Cells were washed once with DMEM and incubated with 1 ml COZ suspension for 30 
minutes at 37°C. The particle-to-cell ratio was approximately 10:1. Particle engulf-
ment was terminated after washing cells twice with PBS and removing extracellular 
COZ by treatment with 500 µl 100 U/ml lyticase for 10 minutes at room tempera-
ture. Successively, cells were detached with 0.05% trypsin/0.5 mM EDTA (Gibco, Life 
Technologies, Paisley, UK), resuspended in 1 ml medium with serum, pelleted, and 
finally resuspended in 200 µl 1% paraformaldehyde in PBS. Samples were analyzed 
by FACS (BD FACSCalibur) and phagocytosis efficiency was determined by measur-
ing the percentage of FITC positive cells and the fluorescence intensity in these 
cells. The phagocytic index of each sample was calculated as the product of the 
mean FITC intensity of the positive population times the % of FITC positive cells.
Live imaging
Unlabeled zymosan was opsonized as described for the phagocytosis assay above. 
Phagocytosis of COZ was recorded live on a Zeiss LSM510 META confocal laser scan-
ning microscope equipped with a temperature and CO2 controllable incubation 
chamber and lens heater. RAW 264.7 cells expressing different fluorescently labeled 
CK-B constructs or homologues were seeded in WillCo dishes (120,000 cells/dish) 
and activated either with LPS (100 ng/ml, overnight) or PMA (phorbol 12-myristate 
13-acetate; 200 µM, 15 minutes). Before cells were imaged, medium was replaced 
with phenolred-free DMEM (Gibco, Life Technologies, Paisley, UK) supplemented 
with 1 mM sodium pyruvate, and 4 mM GlutaMAX. Dishes were mounted on the 
microscope and cells were allowed to equilibrate (5-10 minutes) before COZ was 
added. After the addition of COZ, image acquisition was started using a Plan Apo-
chromatic 63x, 1.4 NA oil immersion DIC lens (Carl Zeiss GmbH, Jena, Germany). The 
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pinhole was adjusted to obtain optical slices of 3 µm and images were taken every 
3 seconds.
To determine the increase in fluorescence at the cup, one single frame showing 
maximal accumulation was selected from each movie by hand by scanning through 
line plots of al images in the stack using Fiji imaging software. Regions of interest 
(ROIs) were then drawn around the phagocytic cup and at a region in the cytosol 
next to the nucleus and the mean fluorescence intensity in these ROIs were mea-
sured, also using Fiji imaging software. The increase in fluorescence intensity (fold 
change) was calculated from the ratio of fluorescence intensities at the cup and in 
the cytosol.
Bioinformatics analysis
Amino acid sequences of CK-B (mouse; NCBI: NP_067248), CK-M (mouse; NCBI: 
NP_031736), and AK (isoform D, Drosophila melanogaster; NCBI: NP_523988) were 
compared using CLUSTEL 2.0.8 multiple sequence alignment 30. Possible post trans-
lational modification differences were identified by using prediction software for 
phosphorylation (NetPhos 2.0 31) and sumoylation (SUMOsp2.0 32). Possible PKC 
phosphorylation sites were predicted using MetaPredPS, 2007, University of Min-
nesota. 
In order to study the differences between CK-B, CK-M, and AK in their open and 
closed conformations we built homology models. To generate the models we used 
an automatic script in the WHAT IF & YASARA Twinset 33, 34 with standard param-
eters. The following PDB-files were chosen as templates: CK-B closed form: human 
brain type CK, PDB: 3B6R 35, sequence identity 97%; CK-B open form: bovine retinal 
CK, PDB: 1g0w 36, sequence identity 98%; CK-M closed form: rabbit muscle CK, PDB: 
1u6r 37, sequence identity 98%; CK-M open form: rabbit muscle CK, PDB: 2crk 38, 
sequence identity 98%; AK closed form: white schrimp AK, PDB: 4bg4 39, sequence 
identity 82%; AK open form: white schrimp AK, PDB: 4bhl 39, sequence identity 82%. 
The models were visualized and studied using the WHAT IF & YASARA Twinset. 
Differences in surface accessible residues were assessed by analyzing the CK-B, 
CK-M, and AK models in ASAview 40. Residues were considered accessible when the 
relative accessibility was higher than 0.25.
Statistical analysis
Data was analyzed either using an unpaired t-test or one-way ANOVA and Bonfer-
roni’s multiple comparison test (GraphPad software, Inc., Version 4). All values are 
expressed as mean +/-SEM. Values were considered to be significantly different 
when p values were < 0.05.
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Results and discussion
Cyclocreatine inhibits formation of actin-rich membrane ruffles in macrophages
Stimulation with PMA or LPS induces the activaction and polarization of macro-
phages with formation of membrane ruffles and the accumulation of Mac-1 (αMβ2 
integrin/CR3) in these structures 23, 41, 42. Ruffling behavior enhances phagocytosis of 
complement opsonized particles and is also involved in mediating reversible cell-
substratum interactions during cell spreading and movement. Since CK-B has a role 
in both the binding and internalization of complement opsonized zymosan (COZ) 
during phagocytosis 14 and also in facilitating cell mobility 13, we wondered whether 
inhibition of CK-B would also affect membrane ruffle formation proper. To resolve 
this issue, knowing that different macrophage populations in vivo comprise pheno-
typically heterogeneous pools of cells 43, 44, we decided to include two distinct types 
of macrophage lineages, RAW 264.7 and MafB/c-Maf deficient (Maf-DKO) cells, in 
our analysis.  RAW 264.7 and MafB/c-Maf deficient cells are macrophages of dif-
ferent origin 25, 45 and morphological appearance. To modulate CK activity in these 
cells we chose for acute pharmacological inhibition with cyclocreatine to avoid the 
adaptation and compensation that can occur as a long-term effect in the metabolic 
energy network, upon permanent genetic ablation 12, 26. Survey with scanning elec-
tron microscopy (SEM) revealed, as shown in Figure 1 and 2, that Maf-DKO cells 
displayed a far more complex surface morphology than RAW 264.7 cells under basal 
conditions. Whereas the surface of Maf-DKO cells was totally covered by protrusive 
membrane structures (mainly comprising membrane ruffles of variable size), RAW 
264.7 cells displayed only a few such structures (Figure 1A,I and 2A,I). Furthermore, 
RAW 264.7 cells had multiple long filopodia extending from the cell body, while 
Maf-DKO cells had less and also shorter filopodia (Figure 1A,K and 2A,K). Upon LPS 
stimulation the morphology of the two cell lines changed differentially. RAW 264.7 
cells underwent a radial spreading while Maf-DKO cells obtained an elongated mor-
phology with two long, thin cellular processes extending from the cell body (Figure 
1B and 2B).  Strikingly, despite these morphological differences cyclocreatine treat-
ment caused both types of macrophages to display fewer dorsal ruffle structures, 
resulting in a much smoother appearance (Figure 1A-J and 2A-J). Disappearance 
of ruffles was already visible upon inhibition with 5 mM cyclocreatine and became 
even more evident with increasing inhibitor concentrations. Interestingly, the cells 
preserved their ability to produce lateral filopodia to a large extent (Figure 1K,L and 
2K,L), suggesting that CK-B is not directly involved in filopodia formation of macro-
phages. 
To determine whether differential distortion of actin cytoskeletal remodeling 
could explain the inhibitor effects on surface ruffle formation we analyzed the ap-
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pearance of the F-actin structures in Maf-DKO and RAW 264.7 cells in the presence 
and absence of LPS and different cyclocreatine concentrations. Phalloidin staining 
revealed that most Maf-DKO cells have a distinct, actin rich leading edge (Figure 
3A,B), whereas RAW 264.7 cells lack this polarity (not shown). Comparing the phal-
loidin images with our SEM results revealed that these actin-rich leading edges 
were decorated with multiple membrane ruffles (inserts Figure 2A,B). Strikingly, 
in the presence of 5 mM cyclocreatine the actin staining at these edges became 
more faint (Figure 3C,D) and with increasing cyclocreatine concentration cells lost 
Figure 1. Cyclocreatine af-
fects the surface morphology 
of RAW 264.7 cells. A-H, Cells 
were seeded and stimulated 
overnight with LPS or left un-
stimulated. The next day, cells 
were incubated in medium 
containing 0, 5, 10, or 50 mM 
cyclocreatine for 3 hours, fixed, 
and prepared for SEM (bar = 
10 µm). The number of surface 
protrusions (I,J) and filopodia 
(K,L) was counted after 3 hour 
with 0, 5, 10 or 50 mM cyclo-
creatine. Cells treated with 
cyclocreatine formed signifi-
cantly less surface protrusions. 
Bars represent means ± SEM. 
Per condition, 11-35 (I,J) or 16-
34 line segments (K,L) from 5 
different fields were analyzed. 
(*p < 0.05, **p < 0.01, ***p < 
0.001; Unpaired t-test)
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Figure 2. Cyclocreatine affects the surface morphology of Maf-DKO cells. A-H, Cells were seeded 
and stimulated overnight with LPS or left unstimulated. The next day, cells were incubated in medium 
containing 0, 5, 10, or 50 mM cyclocreatine for 3 hours, fixed, and prepared for SEM. Inserts in the right 
hand upper corner in A, B, C and D are magnifications of the cell tips in the dashed boxes. Note the loss 
of membrane ruffles on these cell tips in Maf-DKO cells already upon 5 mM cyclocreatine treatment, 
(bar = 10 µm). The number of surface protrusions (I,J) and filopodia (K,L), or the number of ruffled 
leading edges (M,N) was counted after 3 hour incubation with 0, 5, 10 or 50 mM cyclocreatine. Bars 
represent means ± SEM. Per condition, 11-35 (I,J) or 8-22 (M,N) cells, or 16-34 line segments (K,L) from 
5 different fields were analyzed. (*p < 0.05, **p < 0.01, ***p < 0.001; Unpaired t-test)
3 
∙ C
-t
er
m
in
al
 fl
ex
ib
le
 lo
op
 d
et
er
m
in
es
 c
el
lu
la
r 
lo
ca
liz
ati
on
 o
f C
K-
B
85
Figure 3. Inhibition of CK-B reduces actin-rich membrane ruffles in macrophages. A-H, Maf-DKO 
cells were seeded and stimulated overnight with LPS or left unstimulated. The next day, cells were 
incubated in medium containing 0, 5, 10, or 50 mM cyclocreatine for 3 hours after which they were 
fixed in paraformaldehyde and stained with Alexa568-labelled phalloidin. Z-scans were made on a 
Zeiss LSM510 META confocal laser scanning microscope and merged to one single image (maximal 
projection) using Fiji imaging software. Inserts in the right hand lower corner in A, B, C and D are 
magnifications of the cell tips in the dashed boxes. Note the loss of actin staining on these cell tips after 
5 mM cyclocreatine treatment and the loss of polarity after 10 and 50 mM cyclocreatine treatment. 
(Bar = 10 µm).  I,J, Quantification of actin-rich leading edges. Cells treated with cyclocreatine formed 
significantly less actin-rich leading edges in a concentration-dependent manner. (*p < 0.05, **p < 0.01, 
***p < 0.001; Unpaired t-test)
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polarity so that no leading edges were recognizable anymore (Figure 3E-H). Corre-
spondingly, our SEM images showed that membrane ruffles were absent from cell 
tips after inhibition with cyclocreatine (inserts Figure 2C,D).  Quantification of the 
number of ruffled leading edges and the percentage of cells with actin-rich leading 
edges confirmed that cyclocreatine inhibited the formation of these structures (Fig-
ure 2M,N and 3I,J). Together, these observations suggest that CK-B is involved in the 
formation of some, but perhaps not all, types of actin-dependent membrane pro-
trusions that form the particle capturing or adhesion machinery of macrophages. 
This apparently differential CK-B dependence could be associated with the stability/
turnover rate of the structures. Filopodia serve to attach the cell to the substratum 
and are therefore less dynamic than membrane ruffles that continuously form and 
fold back on the cell surface. The more static nature of filopodia may render them 
less dependent on acute and local CK-B-mediated ATP-supply. In line with this, con-
focal microscopy also did not reveal specific accumulation of EYFP-CK-B in filopodia 
of RAW 264.7 cells (unpublished results). Clearly, our analyses permit only tenta-
tive conclusions as they are based on the interpretation of still images as a kind of 
endpoint measurement.  In order to distinguish between the local or global role of 
CK-B and know more about the possible mechanism(s) involved in linking its activ-
ity to formation of different types of protrusions, additional experiments, with live 
recording of the formation or disappearance of these structures under different 
metabolic conditions, ultimately will be necessary.
COZ phagocytosis is compromised in LPS stimulated RAW 264.7 and Maf-DKO cells 
after CK-B inhibition with cyclocreatine
Here we decided to concentrate first on the biological significance of ruffling be-
havior. In order to see whether loss of membrane ruffling activity by blockade of 
CK-B phosphoryl exchange capacity was indeed also accompanied by a reduction in 
complement opsonized particle uptake in both cell lines, we monitored the capacity 
of RAW 264.7 and Maf-DKO cells to phagocytose COZ. Pharmacological inhibition of 
CK-B with cyclocreatine significantly reduced phagocytosis of COZ in LPS-stimulated 
RAW 264.7 and Maf-DKO cells (Figure 4). Interestingly, Maf-DKO cells which pre-
sented the more complex surface morphology also showed the highest efficiency 
in phagocytosis. Another conspicuous observation was that an approximately ten 
times higher concentration of cyclocreatine was needed in these cells to reach the 
same degree of inhibition as in RAW 264.7 cells.  As Western blot analysis revealed 
no overtly deviant expression level for CK-B in Maf-DKO cells (Figure 5), we can-
not explain these quantitative differences by simple correlation to differences in 
enzyme activity level between the two types of macrophages. Qualitatively, our 
data support the idea that ruffle activity and phagocytosis efficiency are coupled, 
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and that CK-B activity mediates the binding and uptake of complement opsonized 
particles via control over dynamic formation of protrusive membrane structures 
in macrophages.  Indeed, a model in which the surface density of structures is a 
determining factor in the macrophage’s capacity to adhere to and capture foreign 
particles also explains our earlier observation that CK-B is in control of the initiating 
steps in phagocytosis 14. 
CK-B localizes to membrane ruffles on macrophage cell tips
Earlier, we have demonstrated that CK-B localizes to membrane ruffles in astrocytes 13 
and is actually also present in the phagocytic cup area during particle ingestion in 
macrophages 14. Organellar or intracellular compartmentation and local recruitment 
by association to cellular structures is important for control of CK’s phosphoryl ex-
change capacity 46, and hence the distribution of ATP availability. Here we used im-
Figure 4. Inhibition of CK-B by cyclocre-
atine inhibits phagocytosis of COZ in 
RAW 264.7 and Maf-DKO macrophages. 
Cells were seeded and stimulated over-
night with LPS. Prior to the assay, cells 
were treated with 0, 5, 10, or 50 mM cy-
clocreatine for 3 hours. FITC-labeled COZ 
was added in serum-free medium and 
cells were incubated for 30 minutes at 
37°C. After washing, cells were detached 
and fixed for FACS. The phagocytic index 
was calculated as described in materials 
and methods. Bars represent means ± 
SEM of three experiments performed in 
triplicate. (*p = 0.05, **p = 0.01, ***p = 
0.001; Unpaired t-test).
Figure 5. CK-B expression in RAW 264.7 
and Maf-DKO cells. Bars represent the 
average band intensities ± SD of two 
blots. Expression was calculated relative 
to tubulin. 
88
munostaining with specific CK-B antibodies because we wished to know whether 
the association of CK-B with ruffles in macrophages had a permanent or temporal 
character. Since CK-B localization in the vicinity of sites of membrane ruffle forma-
tion could best be visualized in the leading edges of macrophages, and these struc-
tures occur relatively abundant on Maf-DKO cells, we included only these cells in 
our assay. The imaging results in Figure 6 show that CK-B appears to accumulate 
in some but not all the ruffling tips of Maf-DKO cells, suggesting that recruitment 
is temporal and that CK-B is not permanently associated with ruffling structures as 
was also found to be the case in phagocytic cups 14. Furthermore, although both 
CK-B and actin localized to these regions, the two proteins did not show complete 
colocalization in all cells. Also this phenomenon is as observed for phagocytic cups 
Figure 6. CK-B localizes to membrane ruffles in Maf-DKO macrophages. Cells were seeded on glass 
coverslips and stimulated overnight with LPS or left unstimulated. After fixation in paraformaldehyde, 
cells were stained for CK-B using an antibody against mouse CK-B (A,C), and actin using Alexa568-
labelled phalloidin (B, D). Images were taken on an Olympus FV1000 confocal laser scanning 
microscope. Arrows indicate cell tips containing CK-B
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and may be a result of differences in recruitment dynamics between the two pro-
teins 14.  Together, our observations point to a short-term, transient, and local need 
for CK-B in membrane ruffle-regions wherein the actin cytoskeleton is highly dy-
namic. Unfortunately, the staining method used on fixed cells only reveals protein 
presence and did not allow us to correlate actin (de)polymerization activity with 
CK-B activity within different time windows of ruffle formation. 
The C-terminal flexible loop of CK-B is essential for its subcellular localization to dy-
namic actin-based protrusions
If CK-B recruitment helps to control actin-based morphological processes that steer 
macrophage function, what could be the principles behind its “mobilization”? In 
view of the dynamic character of ruffle structures and phagocytic cups, it is not 
likely that recruitment of CK-B shares commonalities with the mechanism of asso-
ciation of CK-M to the sarcomeric M-band in muscle cells, which involves a perma-
nent binding to myosin via adapter protein MyBPC1 47.  Although there is a strong 
overall evolutionary relationship between the M- and  B-type CK isoforms, exactly 
the lysine residues involved in this process are not conserved in CK-B 48, 49. Also, di-
rect preferential physical association with actin was ruled out by our group through 
pull-down and FRAP assays, and yeast-2-hybrid studies did not reveal any other 
possible binding partners 14.  Possibly, since CK-B is prone to undergo post-transla-
tional modifications including phosphorylation 50, 51, oxidation 52, methylation 53, and 
ubiquitination 54, temporal  and reversible covalent changes in the CK-B structure 
itself may direct its non-permanent binding characteristics. Besides, non-covalent 
binding of substrate may also determine the enzyme’s associative properties, as has 
been shown for CK-M 55. 
In order to identify features in  CK-B’s conformation  that determine partition-
ing behavior of the enzyme, we turned to existing literature and selected different 
known CK-B mutants for further tests of recruitment behavior. As a first candidate, 
we chose the non-conservative CK-B-D326A mutant, which exhibits some residual 
activity 56 but may have abnormal conformational structure 57, 58. This mutant was 
studied alongside the catalytically inactive E232Q mutant, in which overall protein 
structure is conserved but substrate binding is reduced 56, 59. Comparison of the cel-
lular distribution of these two CK-B-mutants with that of wild type CK-B protein, 
was performed via confocal microcopy imaging of RAW 264.7 cells expressing EYFP- 
tagged wt CK-B,  EYFP-tagged mutants CK-B-E232Q or CK-B-D326A, or free EYFP. 
In resting cells EYFP-CK-B-E232Q was present throughout the cytosol but excluded 
from the nucleus, with a slight perinuclear accumulation very similar to EYFP-CK-B 
(Figure 7 A,B), while EYFP-CK-B-D326A was dispersed throughout the cytoplasm like 
free EYFP (Figure 7C,D). Most forms of membrane protrusion formation are sponta-
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Figure 7. The D326-residue of CK-B is essential for subcellular localization. RAW 264.7 cells expressing 
EYFP-CK-B (A), EYFP-CK-B-E232Q (B), EYFP-CK-B-D326A (C), or EYFP (D) were seeded on glass cover-
slips, incubated overnight, and fixed the next day. Images were taken on a Zeiss LSM510 meta confo-
cal laser scanning microscope. Recruitment of the different fluorescently labeled CK-B mutants during 
phagocytosis of COZ was investigated by live imaging on a Zeiss LSM510 meta confocal laser scan-
ning microscope equipped with a temperature-regulated lens and stage enclosed in a chamber with 
continuous CO2-supply. Cells were seeded in WillCo dishes and stimulated overnight with LPS. Before 
imaging, medium was replaced with phenol red- and serum-free medium. COZ was added and phago-
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neous processes, which occur seemingly randomly in space and time and currently 
cannot be easily manipulated or controlled experimentally.  Hence, recruitment of 
CK-B to such sites of local actin polymerization is difficult to follow by dynamic imag-
ing. To monitor the actual mobilization and translocation dynamics of the different 
mutant CK-Bs by live-cell microscopy we therefore focused on events in LPS-stimu-
lated RAW 264.7 cells that occur during phagocytic cup formation, where the start 
and site of protrusion formation is COZ particle-induced and experimentally better 
controllable 14. Here, RAW 264.7 cells were selected since the individual membrane 
protrusions actively involved in particle uptake could be better distinguished than 
in Maf-DKO cells. For recording of dynamics of EYFP-CK-B variants, the fold increase 
in fluorescence intensity at the cup was determined by measuring the mean fluo-
rescence intensity in the cup region and in an area in the cell body with comparable 
thickness (e.g. the perinuclear region; dashed lines Figure 7E). EYFP-CK-B showed 
a fold increase of 1.32 ± 0.25 which was in agreement with our previous results 
in PMA-stimulated macrophages 14. The E232Q mutant was recruited to the same 
extend (1.21 ± 0.27 fold increase), while the D326A mutant and EYFP did not show 
any significant localization to the phagocytic cup (1.02 ± 0.11 and 0.91 ± 0.11 fold in-
crease, respectively; Figure 7F and H-K). To ratify our findings, the behavior of these 
two CK-B mutants was also assessed in macrophages stimulated with PMA.  Also 
here, EYFP-CK-B-E232Q accumulated at the cup to a similar extent as EYFP-CK-B, 
while the fluorescence intensity at the cup was significantly lower in EYFP-CK-B-
D326A cells (Figure 7G). These results suggest that the C-terminal flexible loop, i.e. 
the segment harboring the D326A mutation, plays a cardinal role in CK-B recruit-
ment during phagocytosis.
To further investigate a potential involvement of this loop in the subcellular lo-
calization of CK-B, we additionally assessed the recruitment behavior of two other 
phosphagen kinases (GFP-CK-M and EYFP-AK) that are related to CK-B but differ 
from one another with regard to this domain. CK-M exhibits high sequence similar-
ity (76%) to CK-B with both the negatively charged cluster (residues 230-234) which 
is critical for enzyme activity 59, and the flexible loop region (residues 60-70 and 
323-330) that closes over the active site during catalysis, conserved. Since CK-M is 
cytic uptake events were recorded live. Single frames showing maximal fluorescence intensity at the 
cup were selected and the mean grey value of a region at the cup and in the cell body was measured 
(E). The cup-to-body-ratio was plotted as the fold increase in fluorescence intensity at the cup (F). 
Recruitment of the different CK-B mutants as well as CK-M and AK was assessed in RAW 264.7 cells 
stimulated with PMA for 15 minutes (G). Movies were analyzed as described in E and F. Symbols in F 
and G represent single events (1 per cell; 20-45 per cell line) recorded on at least 2 different days in at 
least 4 separate dishes, and horizontal lines indicate the means of all events. (*p = 0.05, **p = 0.01, 
***p = 0.001; one-way ANOVA and Bonferroni’s multiple comparison test). H-K, Examples of single 
frames selected for analysis showing recruitment of EYFP-CK-B and EYFP-CK-B-E232Q but minimal or 
no recruitment of EYFP-CK-B-D326A and EYFP to the phagocytic cup (arrows)
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an isoform of CK-B, it catalyzes the same reaction. AK (arginine kinase), on the other 
hand, is more distantly related (44% sequence identity) and has retained the nega-
tively charged cluster but not the flexible loop region. AK can bind phosphocreatine, 
but shows no creatine kinase activity 60. Our live imaging results revealed that GFP-
CK-M could be recruited to the phagocytic cup to the same extent as EYFP-CK-B, 
but that EYFP-AK did not accumulate at the cup (Figure 7G). Interestingly, GFP-CK-M 
exhibited the same cellular distribution as EYFP-CK-B and –E232Q, while EYFP-AK 
remained again dispersed throughout the cytoplasm (not shown). The finding that 
CK-M and CK-B displayed similar “cup recruitment” behavior is particularly interest-
ing, because Hornemann et al. 49 have shown that CK-B and CK-M have a different 
tendency for association to the M-band in muscle fibers.  As already mentioned 
above, findings regarding this differential behavior by them and others 47 can be 
explained by the fact that CK-B lacks the essential lysine residues that enable as-
sociation of CK-M via the adapter protein MyBPC1.  Conversely, to explain our own 
findings by analogous reasoning we would like to suggest that the residues that are 
involved in the CK recruitment to the phagocytic cup must be conserved between 
CK-B and CK-M. Therefore, we tend to believe that the Asp326 residue in the con-
formational mobile loop region spanned by amino acid residues 323-333, which is 
involved in the substrate-induced conformational change of the enzyme, also (co)
determines the subcellular distribution of CK-B.  In contrast, substrate binding and 
catalytic activity, which are both determined by the negatively charged cluster 59 
and expected to be compromised in the E232Q mutant, do not seem to control 
localization of the enzyme.
CK-B’s C-terminal flexible loop contains multiple surface accessible residues that 
may be involved in enzyme recruitment
In an attempt to independently pinpoint residues in the CK molecule that may have 
a crucial role in determining enzyme conformation and/or recruitment behavior, 
we performed a bio-informatics comparison between the three natural phospha-
gen kinases studied above. When amino acid sequences were compared (Figure 
8A), the likelihood of possible posttranslational modification differed for several 
residues between CK-B, CK-M, and AK.  Amongst a number of lysine residues that 
could be modified, only Lys381 was predicted to be sumoylated in both CK-B and 
CK-M but not in AK. CK contains multiple threonine residues in the active site that 
are autophosphorylated, thereby modifying the enzyme kinetics 61. However, these 
residues were not predicted to be differently phosphorylated in CK and AK by our 
bioinformatics analysis. Of the different phosphorylation sites that were predicted, 
we specifically found three possible PKC phosphorylation sites (Ser129, Thr133, and 
Ser136) in CK-M and CK-B that were either not predicted or not conserved in AK. 
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Phosphorylation of these residues by PKC has been shown to regulate the activity of 
CK-B 50, 51. The LPS and PMA used to activate the cells for CR3-mediated phagocyto-
sis in our phagocytosis experiments are both potent activators of PKC 62, 63. However, 
whether phosphorylation of these residues by PKC is involved in determining the 
localization of the enzyme remains to be proven. The same applies for predicted 
differences in other phosphorylation, methylation, or sumoylation sites. Mutational 
studies of the residues involved may provide new insights. Simple changes in the 
charge distribution may determine binding specificity, as has been shown for CK-M 49. 
Concomitantly, such changes may also affect subcellular localization, as has been 
suggested by Yeung et al. 64 for proteins functioning at the cell membrane. Yet an-
other possibility is that protein localization is determined by a combination of fac-
tors or post translational modifications that influence the overall structure of the 
enzyme.
Since amino acid residues that could play a role in the recruitment of CK would 
be expected to be accessible for interaction with accessory or modifying proteins, 
we constructed 3D models of the open and closed states of CK-B, CK-M, and AK and 
assessed the surface availability of amino acid residues in all six models using ASA-
view online software 40. Although the differences that were found between CK and 
AK were spread across the whole molecule (not shown) and not localized to one 
specific region, we made one observation of interest. In CK, the hydrophobic Ala328 
and Val330 are respectively replaced by a hydrophilic Glu317 and Glu319 in AK (Figure 
8B). These amino acids are situated within the C-terminal flexible loop (containing 
CK Asp326 or AK Glu314) which extends into the solvent in the open conformation and 
closes over the active site upon substrate binding (Figure 8C). Val330 and Ala328 are 
both surface accessible in the open and in the closed conformation of CK (Figure 
8D). Together with these two residues, Cantwell et al. 56 identified two other amino 
acids within eight residues of the CK Asp326 or AK Glu314 that had different side-chain 
properties between the two enzymes, namely the non-polar Gly323 and Val325 in CK 
which is replaced by charged Arg312 and His315 in AK. Our surface accessibility assess-
ment revealed that Gly323 is also accessible in both the open and closed conforma-
tion, with a relative accessibility >0.5 (Figure 8D). The second residue (Val325) is only 
accessible (>0.5) in the open conformation. This valine residue forms a hydrophobic 
specificity pocket that accommodates the methyl group distinctive of Cr 57, 65, 66, ex-
plaining why it isn’t accessible in the closed state anymore. The Asp326 residue itself 
was also found to have a relative surface accessibility in both the open and the 
closed conformation, but since it is predicted to interact with His66 in the N-terminal 
flexible loop upon closure, it is not expected to associate simultaneously with bind-
ing partners to facilitate recruitment. 
How important is maintenance of enzyme transition state, i.e. closure of the mo-
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bile loops comprising residues 60-70 and 323-333 over the nucleotide and creatine 
binding sites, for maintenance of associative properties and regional recruitment 
of CK-B? On the basis of the emerging conformational models and the finding that 
phagocytic cup accumulation was not impaired for the E232Q mutant (although it is 
generally accepted that this mutant is unable to bind substrate!), we consider it un-
likely that changes in transition state structure, as such, determine CK-B’s ability for 
recruitment and association with other proteins. We may therefore better concen-
trate on the study of the role of individual residues rather than on the general con-
formational properties of the flexible loop structure.  As explained above, among 
the loop residues that flank the Asp326 position, have high surface accessibility in 
both the open and the closed state, and show no engagement in interactions with 
other residues in the protein, the role of Gly323, Ala328, and Val330 is perhaps most 
intriguing as these are the residues that are not found in other phosphagen kinases 
like AK (which itself is not recruited!). For the hydrophilic Asp326 residue itself, we 
predict that its substitution for a hydrophobic Ala in the D326A mutant may have 
modified the conformation of the entire small loop segment, thereby changing the 
accessibility of adjacent residues and reducing interaction possibilities with binding 
partners.  
Finally, analysis of amino acid positions in the C-terminal flexible loop of the 
ligand-free subunit in the human dimeric CK-B and a structural comparison with 
AK (see Figures 8B, E), revealed the possibility that residues in one loop could be 
occupied for binding between identical enzyme subunits, while residues in the loop 
of the other subunit remain available for other types of associations. We must thus 
even leave open the possibility that homodimer formation is an important interme-
Figure 8. Sequence and structural comparison of CK and AK. A, The amino acid sequences of mouse 
CK-B and CK-M, and Drosophila melanogaster AK were compared. The highly conserved negative cluster 
is shaded grey and the C-terminal flexible loop region is in pink. Indicated in green are residues in AK 
that differ from the same position in CK-B and CK-M. Residues that were predicted to be differently post 
translationally modified are also indicated: lysine residues (methylation, ubiquitination, or sumoylation) 
are shaded blue, phosphorylation sites are shaded purple, and PKC phosphorylation sites are shaded 
yellow. B, CK-B and AK structures were compared by superimposing the two molecules in the closed 
conformation. The ribbon presentation of AK is depicted in grey and CK-B in blue. Note the difference 
between surface accessible residues within the C-terminal flexible loops: Arg312, Glu317 and Glu319 
(colored in red) in AK are replaced by Gly323, Ala328 and Val330 (colored in yellow) in CK-B. C, A model 
was constructed depicting CK-B in the open and the closed conformation. The two flexible loops are 
colored blue in the open conformation and red in the closed conformation. The ATP- Mg2+ and creatine 
substrates are colored yellow. D, The surface accessibility of CK and AK residues was assessed. Residues 
in the C-terminal flexible loop region that had a relative accessibility of > 0.5 are shaded dark blue and 
those with a relative accessibility of > 0.25 and < 0.5 are shaded light blue. E, The ribbon representation 
of the crystal structure of dimeric human CK-B (PDB: 3B6R 35) is presented. Individual subunits are 
shown in yellow and blue. The left panel shows a bottom view of the dimer, while the right panel shows 
a top view. The N- and C-terminal flexible loops are colored red and magenta in the yellow (ligand-free) 
and blue (TSAC) subunit, respectively. 
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diary step in the partitioning dynamics of the enzyme in macrophages.  Differences 
between the amino acid sequences of flexible loops in members of the phospha-
gen kinase family could thereby explain differences in partitioning behavior, such as 
those between dimeric CK-B of mammals and monomeric AK of other species that 
we report here. 
Concluding remarks:  Combined, our experimental findings and bioinformatics pre-
dictions support a role for CK-B’s conformational mobile C-terminal loop in the spa-
tio-temporal recruitment of enzyme activity to sites where dynamic, actin-depen-
dent, membrane protrusions form in macrophages. Mobilization of CK-B activity 
appears to support membrane ruffling activity, and therewith macrophage immune 
functions. For better understanding of the coupling between CK-B’s structure, in-
tracellular enzyme compartmentalization dynamics, and the biological significance 
thereof, we now need first an assessment of the consequences of conservative 
vs. non-conservative substitutions for any of the relevant amino acid positions in 
the flexible C-terminal loop. This requires experiments that are clearly outside the 
scope of this study and should be reserved for follow-up studies. 
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Abstract
Macrophages constantly undergo morphological changes when quiescently 
surveying the tissue milieu for signs of microbial infection or damage, or after 
activation when they are phagocytosing cellular debris or foreign material. These 
morphofunctional alterations require active actin cytoskeleton remodeling and 
metabolic adaptation. 
Here we analyzed RAW 264.7 and Maf-DKO macrophages as models to study 
whether there is a specific association between aspects of carbohydrate metabolism 
and actin-based processes in LPS-stimulated macrophages. We demonstrate 
that the capacity to undergo LPS-induced cell shape changes and to phagocytose 
complement-opsonized zymosan (COZ) particles does not depend on oxidative 
phosphorylation activity but is fueled by glycolysis. Different macrophage activities 
like spreading, formation of cell protrusions, as well as phagocytosis of COZ, were 
thereby strongly reliant on the presence of low levels of extracellular glucose. 
Since global ATP production was not affected by rewiring of glucose catabolism 
and inhibition of glycolysis by 2-deoxy-D-glucose and glucose deprivation had 
differential effects, our observations suggest a non-metabolic role for glucose in actin 
cytoskeletal remodeling in macrophages, e.g. via posttranslational modification of 
receptors or signaling molecules, or other effects on the machinery that drives actin 
cytoskeletal changes. Our findings impute a decisive role for the nutrient state of 
the tissue microenvironment in macrophage morphodynamics.
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Introduction
Macrophages are present in all tissues where they provide a first line of defense 
against pathogens and help to maintain steady-state tissue homeostasis by 
eliminating foreign matter and apoptotic cells via phagocytosis 1, 2. To exert these 
functions they migrate and constantly survey their immediate environment for 
signs of tissue damage or presence of invading organisms 1. During surveillance, 
danger signals are detected through Toll-like receptors (TLRs), intracellular pattern 
recognition receptors (PRRs) and interleukin(IL)-receptors 2. When macrophages 
encounter stimuli like inflammatory cytokines (IFN-g, TNF, or IL-4), foreign material 
(e.g. lipopolysaccharide; LPS), or immunoglobulin G (IgG) immune complexes, tissue-
resident macrophages become activated to undergo a phenotypic change towards 
a classically activated M1 or alternatively activated  (suppressive) M2 polarization 
state 1, 3, 4, which is accompanied by metabolic adaptation. Because M1 and M2 
phenotypes represent extremes in a continuum of phenotypes that macrophages 
can adopt, we still have no clear picture of the (possibly reciprocal) relationship 
between their metabolic profile and activation state. The prevailing idea is that, 
in the resting state, macrophages utilize glucose at a high rate and convert 95% of 
it to lactate 5. Upon polarization towards a M1 phenotype (e.g. after stimulation 
with LPS) glucose import via GLUT, as well as the glycolytic flux, is even further 
upregulated 5-7. M2 macrophages, on the other hand, do not undergo such extensive 
metabolic change but have a metabolic profile comparable to that of unstimulated 
cells, with higher TCA-cycle and oxidative activity 5, 8. Recently, Haschemi et al. 7 
have shown that carbohydrate kinase-like protein (CARKL) orchestrates macrophage 
activation through metabolic control. CARKL overexpression drove cells towards an 
oxidative state and sensitized macrophages towards a M2 polarization state, while 
CARKL-loss promoted a rerouting of glucose from aerobic to anaerobic metabolism 
and induced a mild M1 phenotype. Conversely, Tannahill et al. 9 have demonstrated 
that LPS stimulation of macrophages causes an increase in the intracellular TCA-
cycle intermediate succinate, which stabilizes M1-associated HIF-1α and thereby 
regulates the expression of the pro-inflammatory cytokine IL-1β.
Besides overall metabolic versatility, macrophages also exhibit a wide range of 
morphodynamic activities, needed to exert their tasks in tissue surveillance and 
host defense. To control these activities before and after polarization, macrophages 
continuously form actin-rich membrane protrusions and extend filopodia from 
their cell surface 10, 11. Changes in the organization of the actin cytoskeleton thereby 
enable the cell to dynamically adapt its morphology to suit its particular function 
and differentiation state. For example, LPS induces polymerization of cytoskeletal 
actin filaments, cell spreading, and the formation of filopodia, lamellipodia, and 
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membrane ruffles in monocytes and macrophages 12, 13. Likewise, IL-4, which is 
released during tissue injury, causes the rearrangement of actin-rich podosomes to 
form rosettes in M2 macrophages, enabling degradation of - and migration through - 
dense extracellular matrices 14.
The rearrangements of cytoskeletal actin filaments that steer this behavior 
comprise multiple steps, including the nucleation and elongation of new filaments 
from ATP-bound G-actin monomers, the addition of these monomers to the barbed 
ends of existing filaments, the hydrolysis of actin-bound ATP within the growing 
filament, and the dissociation of ADP-G-actin at the pointed end 15-18. ADP on 
liberated G-actin is substituted with ATP, producing new ATP-G-actin monomers for 
incorporation. The ensemble of activities in this complex process is regulated by more 
than a hundred actin-associated proteins (ABPs), several of which are influenced 
by the availability of ATP. Metabolism, specifically the binding and hydrolysis of 
ATP and ATP-ADP exchange, thereby not only dictates the behavior of the actin 
filaments themselves 19-21, but also controls the activity of regulatory factors like the 
Arp2/3 protein complex 22, 23, or upstream signaling such as the ROCK/Rho-GTPase 
pathway 24. The idea that actin remodeling is a major cellular energy drain is 
corroborated by the observation that actin filaments are stabilized under conditions 
of global ATP-depletion in order to prevent ATP-hydrolysis within the filament and, 
thereby, ATP-consumption 25, 26.
Besides ATP availability 27, 28, intracellular pH and NAD(P)+/NAD(P)H ratio are other 
key metabolic parameters that influence actin network dynamics and cell motility 29, 
either by modifying actin itself 30-32 or by regulating the activity of proteins such as the 
actin depolymerizing factor cofilin, mical, and the actin severing protein gelsolin 33-35. 
In most mammalian cells, production of ATP, NAD+/NADH, and H+ is dominated 
by carbohydrate catabolism via glycolysis and mitochondrial TCA cycle/oxidative 
phosphorylation (OXPHOS) pathways. Importantly, various glycolytic pathway 
enzymes that handle these metabolites/cofactors appear compartmentalized and 
are found associated with the actin cytoskeleton and with actin dependent cellular 
structures, such as pseudopodia, membrane ruffles, and lamellipodia 36-39. Indeed, 
this coupling helps to explain the dependency of cell motility on glycolysis 40, 41. 
Also phagocytosis by macrophages depends on glycolysis 42-44, but not much work 
has been done to study this association in detail. Seeing their vital role in host 
defense and maintenance of tissue homeostasis and their surprising versatility in 
adaptation of functioning in many different tissue environments, we wondered 
whether there is a link between the activation of glucose metabolism and the extent 
of morphodynamic change that macrophages undergo. To apprehend the coupling 
between actin cytoskeletal remodeling and metabolic state we here investigated the 
ability of LPS-stimulated (M1) RAW 264.7 and Maf-DKO macrophages to maintain 
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functional activity under conditions where they were forced to shift between a 
(anaerobic) glycolytic or oxidative metabolism.  RAW 264.7 and Maf-DKO cell lines 
were chosen because they are in vitro manipulable models that have retained 
marked plasticity to stimulus-directed polarized activation,  but lack the phenotypic 
heterogeneity that is characteristic for primary macrophages 45, 46.  We report on 
a stringent dependency of morphodynamics of LPS-stimulated macrophages upon 
sufficient glucose supply.
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Materials and Methods
Reagents
All reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA), unless stated 
otherwise.
Cell culture
RAW 264.7 cells (kind gift from Dr. Hong-Hee Kim, Department of Cell and Devel-
opmental Biology, School of Dentistry, Seoul National University, Korea) 47 were 
maintained in high-glucose DMEM (Gibco, Life Technologies, Paisley, UK) supple-
mented with 10% heat inactivated FBS (PAA laboratories, Pasching, Austria), 1 mM 
sodium pyruvate, and 4 mMGlutaMAX (Gibco, Life Technologies, Paisley, UK), at 
37°C in a humidified atmosphere with 7.5% CO2. Maf-DKO cells (kind gift from Dr. 
Michael H. Sieweke, Centre d’Immunologie de Marseille-Luminy (CIML), Université 
Aix-Marseille, France) 46 were maintained in the same way except that medium was 
supplemented with 20% conditioned medium from L929-cells containing macro-
phage colony stimulating factor (M-CSF).
DNA constructs and transfection 
Plasmid pEYFP-N1-∆ATG-Lifeact was constructed as follows: Lifeact 48 cDNA, con-
taining human codon sequences flanked by a 5’ BglII and 3’ EcoRI restriction site, 
was commercially synthesized and ligated in a pUC57 plasmid by GenScript USA 
Inc. A forward primer (5’-CT CAG ATC TCC ACC ATG GGC GTG GCC GAC C-3’) was 
designed to introduce a BglII site and a Kozak sequence in front of the Lifeact start 
codon. Use of this primer together with the M13 universal reverse primer enabled 
amplification of the Lifeact encoding insert from pUC57 by PCR. PCR products were 
digested with BglII and EcoRI and ligated into pEYFP-N1-∆ATG plasmid DNA (pEYFP-
N1 from Clontech with ATG on position 679 mutated to GCG).
For transfection, RAW 264.7 cells were seeded in 6 well plates at 300,000 cells/
well and incubated overnight. Plasmid pEYFP-N1-∆ATG-Lifeact DNA (12 µg; linear-
ized with AseI) was diluted in 1 ml serum-free DMEM and incubated for 20 minutes 
at 37°C with 24 µl Targefect-RAW transfection reagent (Targeting Systems, El Ca-
jon, CA, USA). Transfection complexes (250 µl) were added to wells containing 2 ml 
fresh culture medium and incubated for 4 hours at 37°C after which medium was 
refreshed. A stable cell pool was established by culturing cells for two weeks in me-
dium containing 500 µg/ml G418, followed by limited dilution cloning.
Media for metabolic manipulation
For cell culture under glucose free conditions, glucose-free DMEM (Gibco, Life Tech-
4 
∙ G
lu
co
se
 c
on
tr
ol
s 
m
or
ph
od
yn
am
ic
s 
of
 L
PS
-s
ti
m
ul
at
ed
 m
ac
ro
ph
ag
es
107
nologies, Paisley, UK) was supplemented with 10 mM galactose. As control, medium 
supplemented with 25 mM glucose was used. Low glucose medium was prepared 
by supplementing glucose free DMEM with 1 mM glucose and 10 mM galactose 
(gluc/gal). Media were further supplemented with 10% heat inactivated dialyzed 
FBS, 1 mM sodium pyruvate, and 4 mM GlutaMAX. For inhibition of glycolysis, high 
(25 mM) glucose DMEM containing 10 mM 2-deoxy-D-glucose (2-DG), 10% heat 
inactivated FBS, 1 mM sodium pyruvate, and 4 mMGlutaMAX was used. Inhibition 
of OXPHOS was achieved by adding 2.5 µM oligomycin to normal culture medium 
(containing 25 mM glucose). For live imaging, phenol red-free media were prepared 
using DMEM Base powder from Sigma-Aldrich to which sodium bicarbonate, Gluta-
MAX, sodium pyruvate, glucose and/or galactose, 2-DG, or oligomycin were added.
Proliferation assay
For cell proliferation analysis, the protocol developed by Skehan et al. 49 was used. 
RAW 264.7 cells were seeded in four 96-well plates (30,000 cells/well) in 100 µl 
culture medium and incubated for eight hours. At T0, plates were washed once and 
the medium in plates T6, T15, and T24 was replaced with either control, galactose, 
gluc/gal, 2-DG, or oligomycin medium containing 100 ng/ml LPS, while plate T0 was 
fixed for sulforhodamine B (SRB) staining of protein content. After 0, 6, 15, and 24 
hours, cells were washed twice with cold PBS and fixed with 10% trichloroacetic 
acid (TCA; J.T.Baker, Deventer, Holland) for 1 hour at 4°C. After fixation, plates were 
washed five times with water and stored at -20°C until all plates were collected. 
Cellular protein was stained with 50 µl 0.5% SRB in 1% acetic acid for 20 minutes 
after which wells were washed four times with 1% acetic acid. Plates were dried 
at 60°C for 3 hours, protein was dissolved in 150 µl 10 mM Tris-HCl (pH 10.5), and 
the absorbance of each well was measured at 510nm on a BioRad Benchmark Plus 
micro plate reader. Values were corrected for background SRB staining by subtract-
ing the average absorbance value of wells that contained medium only, from that 
of wells with cells.
Apoptosis assay
Apoptosis of RAW 264.7 cells was measured using a biosensor (pSIVA) developed by 
Kim et al. 50 (generous gift from Dr. Ralf Langen, University of Southern California). 
Briefly, cells (20,000/well) were seeded in a BD Falcon 96-well imaging plate and 
incubated overnight. On the day of assay, wells were washed once and medium 
was replaced with phenol red-free control, galactose, 2-DG, or oligomycin medium 
containing 8 ng/µl pSIVA or non-labeled control. The plate was immediately imaged 
for 24 hours, continuously, on a BD Pathway high-content spinning disc confocal 
microscope equipped with a temperature and CO2 controllable incubation cham-
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ber, using a 20x objective and 2x2 montage capture. Three wells were imaged per 
condition and the amount of apoptosis was determined by analyzing the increase in 
GFP-signal. For each well the threshold of the whole GFP-image series was adjusted 
and the total pixel area/frame was determined using Fiji imaging software 51 and 
plotted against time.
ATP assay
Intracellular ATP was determined using the CellTiter-Glo cell viability assay kit from 
Promega. 
500,000 cells (RAW 264.7) were seeded per well of a 6-well plate and incubated in 
control medium, galactose medium or 1mM glucose medium for 4 and 14 hours, 
2-DG medium for 1 and 3 hours, or oligomycin-containing medium for 0.5 or 24 
hours prior to assay. Cells were washed twice with ice cold PBS and then scraped in 
350 µl ice cold 0.6 M perchloric acid (PCA). PCA extracts were centrifuged for 3 min-
utes at 4000 rpm and 4°C to pellet all cellular protein. Supernatants were neutral-
ized with 140-155 µl 2 M KOH/0.2 M KH2PO4, pH 7.5 and diluted 1:10 in water. Per 
well, 100 µl diluted PCA extract was added to 100 µl CellTiter-Glo reagent and the 
luminescence intensity per well was measured on a LUMIstar OPTIMA microplate 
luminometer. The ATP concentration was determined using an ATP standard series. 
For determination of total cellular protein, pellets were dissolved in 250 µl 1 M 
NaOH and heated for 30 minutes at 95°C. Protein concentration was then measured 
in 1:50 diluted NaOH extracts.
Glucose and lactate assays
Glucose consumption measurements were based on the Amplex Red Glucose/Glu-
cose Oxidase assay kit from Molecular probes (Life Technologies, Eugene, Oregon, 
USA). Glucose, glucose oxidase, and Amplex Red reagent were used from the kit 
but horseradish peroxidase was obtained from Sigma-Aldrich and 1x reaction buffer 
was replaced with 0.05 M Tris-HCl, pH 7.5. Otherwise, the kit protocol was followed 
as described by the manufacturer. Lactate production was measured using the 
same protocol as for glucose consumption but replacing glucose oxidase with lac-
tate oxidase and including a lactate standard series instead of glucose. RAW 264.7 
cells were seeded in 12 well tissue culture plates and incubated for 6 or 24 hours in 
either 1 ml control or 1 ml 2.5 µM oligomycin medium. For glucose measurements, 
medium containing 5 mM glucose was used while lactate production was measured 
for cells grown in 25 mM glucose medium. For measurement of glucose consump-
tion or lactate production during the last 6 hours of the 24 hour incubation period, 
medium was refreshed after 18 hours in one of the 24 hour plates. Prior to addition 
of incubation media, wells were always rinsed with pure DMEM containing no glu-
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cose. Medium was collected at the end of the 6 or 24 hour incubation period and 
supernatants were snap frozen in liquid nitrogen and stored at -20°C until analy-
sis. Cytosolic extracts were prepared in lysis buffer (50mMTris-HCl pH 7.5, 100 mM 
NaCl, 5 mM MgCl2, and 0.5% NP-40; 4°C) and total protein was determined with the 
Bradford assay. Glucose consumption was calculated by subtracting the amount of 
glucose in the sample from that in medium without cells. Lactate production was 
calculated by subtracting the concentration of any lactate in the medium without 
cells from that of the samples. Glucose and lactate assays were performed in paral-
lel.
Oxygen consumption measurements
Mitochondrial respiration was assessed by measuring oxygen consumption on an 
Oroboros Oxygraph-2k respirometer according to a standard protocol provided 
by the manufacturer. RAW 264.7 and Maf-DKO cells were analyzed in parallel in 
two separate chambers of the respirometer. After air calibration of medium in the 
chambers and stabilization of the signal, 1 x 106 cells (in 60 µl medium) were inject-
ed into the respective chambers. Basal respiration rate was measured at the point 
where the O2-flux signal stabilized. Oligomycin (2.5 µM) was added to each chamber 
and the leak respiration rate was determined after stabilization of the signal. Next, 
7 µM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, a mitochondrial 
uncoupler) was added to reach maximal oxygen consumption in the cells. Finally, 30 
nM rotenone was added and after stabilization of the system, the residual oxygen 
consumption could be determined. The data were analyzed using the DatLab soft-
ware provided with the instrument.
Cellular actin staining
RAW 264.7 cells on coverslips were pre-incubated in control or 2-DG medium (3 
hours), gluc/gal medium (4 and 24 hours), galactose medium (4 and 24 hours), or 
oligomycin-containing medium (0.5 and 24 hours) and stimulated with 100 ng/ml 
LPS overnight or left unstimulated. Medium was removed and cells were imme-
diately fixed in 2% paraformaldehyde in 0.2 M sodium phosphate buffer for 30 
minutes. Coverslips were washed twice with PBS and twice with PBS containing 20 
mM glycine (MP Biomedicals, Illkirch Cedex, France; PBS-G) before permeabiliza-
tion with 0.1% saponine/PBS-G for 20 minutes. This was followed by actin staining 
with Alexa 568-labeled phalloidin (1:600 in 0.1% saponine/PBS-G) for 1 hour. Cells 
were successively washed four times for 2-4 minutes with 0.1% saponine/PBS-G 
and once with PBS alone. Coverslips were removed from wells, rinsed once in water, 
air dried, and imbedded in MoWiol on microscope slides. Z-scans consisting of 25 x 
0.5 µm sections and the pinhole adjusted to one airy unit were recorded on a Zeiss 
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LSM510 META confocal laser scanning microscope and merged to one single image 
using Fiji imaging software. Coverslips were prepared in duplo and per condition 
twelve different fields were analyzed. 
Scanning electron microscopy
Cells were seeded on 12 mm glass coverslips in 24-well plates and pre-incubated in 
control or galactose medium (4 hours), 2-DG medium (3 hours), oligomycin medium 
(0.5and 24 hours), or gluc/gal medium (4 hours). In addition, cells were stimulated 
with 100 ng/ml LPS or left unstimulated. Cells were washed once with PBS and 
fixed with 2% glutarealdehyde in 0.1 M sodium cacodylate buffer for 1 hour. After 
washing cells twice with sodium cacodylate buffer, coverslips were stored in this 
buffer at 4°C until further fixation with 1% OsO4 (osmium tetroxide) for 30 minutes. 
Coverslips were then washed once with water and dehydrated in a graded series of 
alcohol washes. Finally, coverslips were critical point dried and mounted for scan-
ning electron microscopy on a JEOL SEM6340F Field Emission Scanning Electron 
microscope. Coverslips were prepared in duplo and per condition 8-10 different 
fields were analyzed. 
Quantification of filopodia and cell circumference
For quantification of filopodia, fluorescence microscopy or SEM images of fixed cells 
were analyzed.  Lines were drawn to delineate contour segments of cells in areas 
where no contacts with neighboring cells were seen. The length and number of 
filopodia extending from each contour segment were determined.  For phalloidin 
stained cells, 30-40 different line segments with a total contour length correspond-
ing to the circumference of 20-50 cells, were included per condition. From the SEM 
images 20-26 line segments, with a total contour length corresponding to the cir-
cumference of 10-17 cells, were analyzed per condition.  
To compare circumferences of whole cells, contour lengths of circular lines 
around individual cells were measured.  Per condition, 20-50 cells were analyzed 
from both the fluorescence and electron microscopy image collection.
Spreading assay
RAW 264.7 cells expressing Lifeact-EYFP were stimulated with 100 ng/ml LPS over-
night and simultaneously pre-incubated in control or galactose, 2-DG, oligomycin, 
or gluc/gal medium for 0, 3, 15, or 24 hours before they were harvested by treat-
ment with 1 mM EDTA/PBS (10 min at 37°C). After washing, the cells were sus-
pended in medium with 1% bovine serum albumin. A recovery period of 20 minutes 
at 37°C was allowed before cells were seeded in a fibronectin coated (50 µg/ml for 
2h at 37°C) BD Falcon 96-well imaging plate at 4,000 cells/well in the presence of 
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100 ng/ml LPS. Cell spreading was monitored for three hours by recording the in-
crease in EYFP-pixel area per cell (20 cells/well) on a BD Pathway high-content spin-
ning disc confocal microscope, using a 20x objective and 3x3 montage capture. In 
order to combine the data from three independent experiments (performed in du-
plicate), the time axes had to be synchronized. To achieve this, a Boltzmann simula-
tion curve was produced for each data set between time points 0 and 200 in steps 
of 2 minutes using OriginLab data analysis and graphing software (OriginPro 6.1). 
Data sets were then combined and analyzed for statistical significance by applying 
a repeated measures analysis using PASW statistics 18 SPSS software. Three time 
frames (consisting of 30 data points each) of each curve were compared with the 
corresponding three time frames of the control curve.
Phagocytosis assay
Phagocytic activity was determined as zymosan ingestion capacity essentially as 
described by Kuiper et al. 27. Zymosan particles were dissolved in PBS at 10 mg/ml 
and left to rehydrate for at least one hour. Next, zymosan was sonicated three times 
for 5 seconds, spun down, resuspended in sodium carbonate buffer (pH 9.6), soni-
cated, and incubated with 1 µg/ml fluorescein isothiocyanate (FITC) for 1 hour at 
room temperature, in the dark. After FITC labeling, zymosan was washed three 
times with sodium carbonate buffer and incubated in 1 M Tris HCl, pH 8.0, for 30 
minutes. Zymosan was then washed twice with PBS and finally resuspended in PBS. 
After one more sonication step, FITC-labeled zymosan was divided in aliquots, fro-
zen in liquid nitrogen, and stored at -20°C.
Phagocytosis assays were performed in 12-well plates in which cells were seed-
ed the day before. The number of cells seeded was adjusted for some conditions, 
due to the inhibitory effect on proliferation. To compensate for reduced prolifera-
tion rate, 150,000 and 200,000 RAW 264.7 cells were seeded per well for 14h and 
24h galactose treatment, respectively. For all other conditions 100,000 RAW 264.7 
cells were seeded per well. For assays with Maf-DKO cells, 200,000 cells were seed-
ed per well. Prior to assay, cells were pre-incubated in control or galactose medium 
(0, 4, and 14 hours), 2-DG medium (0, 1, and 3 hours), oligomycin medium (0, 0.5, 3, 
15, and 24 hours), or gluc/gal medium (0, 4, and 14 hours), and activated overnight 
with 100 ng/ml LPS. For assays with Maf-DKO cells in galactose medium, L929-cell 
conditioned medium was omitted to ensure that no glucose was present in the me-
dium. FITC-labeled zymosan particles were opsonized by incubation in fetal bovine 
serum for 1 hour at 37°C, washed twice with PBS, and finally resuspended in serum-
free control, galactose-, 2-DG-, oligomycin-, or gluc/gal-medium. Cells were washed 
once with glucose-free DMEM and incubated with 1 ml zymosan suspension for 30 
minutes at 37°C. The particle-to-cell ratio was approximately 10:1. Particle engulf-
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ment was terminated after washing cells twice with PBS and removing extracel-
lular zymosan by treatment with 500 µl 100 U/ml lyticase for 10 minutes at room 
temperature. Successively, cells were detached with 0.05% trypsin/0.5 mM EDTA 
(Gibco, Life Technologies, Paisley, UK), resuspended in 1 ml medium with serum, 
pelleted, and finally resuspended in 200 µl 1% paraformaldehyde in PBS. Samples 
were analyzed by FACS (BD FACS Calibur) and phagocytosis activity was determined 
by measuring the percentage of FITC positive cells and the fluorescence intensity in 
these cells. The phagocytic index of each sample was then calculated as the product 
of the mean FITC intensity of the positive population times the % of FITC positive 
cells.
For the glucose rescue assay, 100,000 Maf-DKO and 60,000 RAW 264.7 cells 
were seeded per well in 24 well plates in medium containing 20% L929 cell condi-
tioned medium and stimulated with 100ng/ml LPS overnight. Cells were washed 
with glucose-free DMEM and incubated with FITC-COZ in galactose medium for 30 
minutes at 37°C. Then, 1mM glucose or glucose-free DMEM was added and the 
cells were incubated for another 30 minutes. Thereafter, cells were detached and 
prepared for FACS.
Adhesion and Internalization assay
Internalization efficiency was determined essentially as described by Sahlin et 
al. 52. RAW 264.7 cells and zymosan particles were prepared as for the phagocytosis 
assay. Pre-incubation in different media without or with inhibitors was as follows: 
galactose 0 hours; 2-DG, 1 hour; oligomycin, 0 and 24 hours; and gluc/gal, 0 hours. 
After 30 minute incubation with serum opsonized zymosan at 37°C, plates were 
transferred to ice and wells were washed twice with ice cold PBS. Cells were then 
scraped in 1 ml cold medium, divided in two equal portions, transferred to micro-
centrifuge tubes, and spun down. Cells in one portion were resuspended in 0.05 % 
trypan blue in potassium dihydrogen citrate/saline, pH4.4 to quench all extracel-
lular FITC-COZ, and cells in the other portion were taken up in the same buffer but 
without trypan blue. Samples were analyzed by FACS.
Statistical analysis
Data were analyzed either with the Student’s t-test, one-sample t-test for relative 
values, or using a two-way ANOVA and the Bonferroni post-test (GraphPad soft-
ware, Inc., Version 4). All values are expressed as mean +/-SEM. Values were con-
sidered to be significantly different when p values were < 0.05.
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Results
The effect of glycolysis and OXPHOS inhibition on RAW 264.7 cell proliferation and 
viability
Tissue-resident macrophages, dependent on the niche that is occupied within the 
body, may become exposed to dramatically different nutrient conditions, includ-
ing variation in oxygen and carbohydrate supply. Their functional plasticity relies 
thereby largely on the capacity to adapt and switch between carbohydrate metabo-
lism via glycolysis or mitochondrial TCA cycle and OXPHOS reactions.  For study of 
different aspects of this coupling we chose to focus on the well-established mac-
rophage model, RAW 264.7 45, and used another macrophage model, Maf-DKO 
cells 46, for comparison of the key findings. In order to find a range of conditions 
wherein the metabolic state of RAW 264.7 macrophages can be manipulated with-
out compromising cell proliferation and viability, we monitored cells for a period of 
at least 24 hours in the presence of the complex V OXPHOS inhibitor oligomycin, the 
competitive glycolysis inhibitor 2-deoxy-D-glucose (2-DG), or in the absence of glu-
cose. Cell proliferation was determined as the increase in total protein mass both 
in the absence and presence of LPS. Since the effect of metabolic inhibitors on cell 
proliferation appeared independent of this stimulation, we chose to present only 
results obtained in the presence of LPS (Figure 1A-C). Cell viability was monitored 
using the the pSIVA apoptosis biosensor with switchable fluorescence states (Figure 
1D).  When pSIVA binds to annexin V that is exposed on the surface of early apop-
totic cells its fluorescence can be detected at an emission wavelength between 500 
and 550 nm. In the absence of apoptotic cells, pSIVA remains unbound and is non-
fluorescent and non-detectable, therefore, an increase in the pSIVA fluorescence 
signal (plotted as pSIVA pixel area on the y-axis in Figure 1D) correlates with an 
increase in the amount of apoptotic cells. 
Incubation with 2.5 µM oligomycin caused a 60-70% inhibition of OXPHOS activ-
ity (measured as the decrease in O2-consumption, Figure S1) and a marked reduc-
tion in proliferation rate (Figure 1A) without inducing excessive apoptosis (Figure 
1D). Inhibition of glycolysis with 10 mM 2-DG induced apoptosis at an early time 
point (i.e. after 3-4 hours) in a relatively small % of cells in the population and, 
under this condition, proliferation ceased (Figure 1B and 1D). Upon substitution of 
glucose with 10 mM galactose (glucose deprivation) apoptotic cells began to appear 
after about 10 hours (Figure 1D), in a pool of cells with already significantly reduced 
proliferation capacity (Figure 1C). These results imply that the proliferation of RAW 
264.7 cells is dependent on both glycolysis and mitochondrial activity, but that vi-
ability is better preserved by glycolysis alone than by mitochondrial TCA/OXPHOS 
activity alone.
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ATP metabolism during metabolic inhibition of RAW 264.7 cells
Since macrophages produce cellular ATP mainly via glycolysis 53, 54, inhibition of this 
pathway or limitation of its starting substrate glucose may have a significant impact 
on cellular energy homeostasis if there is no adequate compensation by mitochon-
drial ATP production. To study whether macrophages are versatile enough to ac-
commodate changes in ATP supply pathways, we first followed [ATP] in RAW 264.7 
Figure 1. Proliferation and viability of 
RAW 264.7 cells under different met-
abolic conditions. Proliferation was 
monitored for 24 hours in the presence 
of LPS and expressed as the increase in 
total cellular protein in either control 
medium (25 mM glucose) or medium 
containing 2.5 µM oligomycin and 25 
mM glucose (A), 10 mM 2-DG and 25 
mM glucose(B), or 10 mM galactose 
and no glucose(C). Cell viability was also 
assessed for 24 hours under the same 
medium conditions in the presence of 
pSIVA apoptosis biosensor 50 (D). The ap-
pearance of the fluorescent pSIVA signal 
was recorded in real time and the total 
pixel area per frame was measured us-
ing Fiji Imaging software. An increase in 
the pSIVA pixel area correlates linearly 
with increase in the amount of apoptot-
ic cells. Data in A-C represent means ± 
SEM of three independent experiments 
performed in triplicate and in D the av-
erages of one experiment performed in 
triplicate. (*p < 0.05, **p < 0.01, ***p < 
0.001, unpaired t-test)
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cells during early stages and modes of inhibition, under conditions where cells were 
still fully viable (1 hour oligomycin and 2-DG, 4 hours galactose). Comparison was 
drawn to [ATP] found at later stages of inhibition when either apoptosis was initiat-
ed (3 hours 2-DG and 14 hours galactose) or proliferation was significantly reduced 
(24 hours oligomycin). Compared to control cells, short term oligomycin treatment 
(1h) did not affect ATP level (Figure 2A). Upon prolonged incubation in presence of 
oligomycin (24h) we even did not observe the 50% drop in ATP level that occurred 
in RAW 264.7 cells, presumably as a result of medium depletion. We currently ex-
Figure 2. ATP levels under dif-
ferent metabolic conditions and 
the effect of OXPHOS inhibition 
on glycolytic flux. RAW 264.7 
cells were incubated for the in-
dicated time intervals with con-
trol (25 mM glucose) medium, 
or medium containing 2.5 µM 
oligomycin and 25 mM glucose 
(A,D,E), 10 mM 2-DG and 25 mM 
glucose (B), or 10 mM galactose 
and no glucose (C). Intracellular 
ATP concentrations and total cel-
lular protein were measured in 
PCA cell extracts (A,B,C). Glucose 
consumption (D) and lactate 
production (E) were measured 
in medium supernatants during 
the first 6 hours (0-6h), the last 
6 hours (18-24h), as well as the 
whole 24 hours (0-24h) of treat-
ment. Data represent means ± 
SEM of three experiments per-
formed in triplicate. (*p < 0.05, 
unpaired t-test)
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plain this observation by assuming that continuous presence of oligomycin forces 
rewiring of (mitochondrial) metabolism and that this protects against this deple-
tion. More study is needed to obtain the evidence to support this explanation. In 
the presence of 2-DG, cells managed to maintain ATP levels beyond the 3 hours be-
fore apoptosis was induced (Figure 2B). Also in the presence of galactose, i.e. under 
conditions of glucose deprivation, no marked decrease in cellular ATP was observed 
until 14 hours, compared to control cells (Figure 2C).
Under conditions where carbohydrate catabolism had to be rewired, i.e. under 
oligomycin treatment, we observed a trend towards higher glucose consumption 
by treated compared to control cells, although the difference was not statistically 
significant (Figure 2D). Oligomycin treatment did not, however, increase the flux of 
glucose to lactate (Figure 2E). Normally, already about 95% of all glucose consumed 
is converted into lactate and only a very small fraction of pyruvate is imported into 
the mitochondria in macrophages 5. This explains why inhibition of OXPHOS cannot 
cause a significant increase in the turnover of pyruvate to lactate and why no signifi-
cant increase in lactate production was observed.
Deviant actin cytoskeleton and cell surface morphology of M1 macrophages in the 
absence of glucose
Polarization of macrophages towards a M1 phenotype with LPS is accompanied 
by an increase in glucose uptake and an accelerated conversion to lactate, while 
the rate of OXPHOS is reduced 5, 6. Concomitantly, LPS induces extensive remodel-
ing of the actin cytoskeleton of macrophages. In vivo, the collective changes in cell 
morphology and the formation of specific membrane structures, like filopodia and 
membrane ruffles on the surface of macrophages 12, 13 form the morphodynamic 
adjustments that help macrophages in adhering to the tissue matrix and in prob-
ing and capturing phagocytic targets. In order to determine whether the metabolic 
changes in LPS-stimulated macrophages have any true morphofunctional signifi-
cance, we metabolically challenged RAW 264.7 cells, using conditions under which 
cells remained fully viable. First, we assessed the surface morphology and appear-
Figure 3. Actin cytoskeletal structural changes induced by inhibition of glycolysis or mitochondrial 
OXPHOS. RAW 264.7 cells were seeded on glass coverslips, incubated in control medium or medium 
containing 2.5 µM oligomycin and 25 mM glucose (A-F), 10 mM 2-DG and 25 mM glucose (G-J), 10 
mM galactose and no glucose (M-P), or 1 mM glucose and 10 mM galactose (Q-T) for the indicated 
time periods and stimulated overnight with LPS or left unstimulated. After fixation in 2% PFA, cellular 
actin was stained with phalloidin-Alexa568 and cells were imaged on a Zeiss LSM510 meta confocal 
laser scanning microscope. The number of filopodia extending radially from the cell surface (expressed 
as # filopodia per μM contour length; see M&M) was determined for control cells and cells treated for 
24 hours with oligomycin, in the presence and absence of LPS (K). The average cell circumference was 
determined for cells in control medium or medium containing 10 mM galactose, or 1 mM glucose and 
10 mM galactose (L). (*p < 0.05, **p < 0.01, ***p < 0.001, unpaired t-test)
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ance of actin-based membrane protrusions, by scanning electron microscopy (SEM) 
and fluorescence microscopy of (phalloidin-stained) RAW 264.7 cells before and 
after LPS-stimulation. Oligomycin treated cells preserved the ability to spread upon 
LPS-stimulation and appeared to have more filopodia than control cells (Figure 3A-F 
and Figure 4A-F). These thorn-like protrusions became clearly visible after 6 hours 
(not shown) and were observed on both LPS stimulated and unstimulated cells. 
Quantification of the number of filopodia extending radially from the cell body af-
ter 24 hours, confirmed that oligomycin induced filopodia formation in RAW 264.7 
cells (Figure 3K and 4K) although the extent of oligomycin effects (on cells with and 
without LPS) as determined by fluorescence and SEM microscopy varied.  Partly this 
variation may be due to differential effects of the fixation-staining, and also to the 
semi-quantitative nature of protrusion recognition and scoring in the image analy-
ses, for the light- and electron microscopy assays. Importantly, removing glucose 
from the culture medium markedly affected cell morphology. Although the actin cy-
toskeletal morphology of unstimulated galactose treated cells did not deviate much 
from control cells after 4 hours, LPS stimulated galactose treated cells had markedly 
different actin cytoskeletal morphology (Figure 3L-P). Instead of expanding their 
surface area and forming distinct protrusions, galactose cells stayed rounded and 
had a smaller cell circumference than control cells (Figure 3L; see also SEM results 
Figure 4L-P). When galactose-containing medium was supplemented with 1 mM 
glucose, the LPS-induced modifications of the cytoskeleton and surface morphology 
were similar to those seen in control cells (Figure 3L,Q-T and Figure 4L,Q-T). In con-
trast, inhibition of glycolysis with 2-DG did not alter the actin cytoskeleton or the 
cell morphology in either LPS- or unstimulated cells (Figure 3G-J and Figure 4G-J). In 
combination, our observations suggest that the presence or uptake of glucose, but 
not necessarily its use in metabolic breakdown, is involved in LPS-induced morpho-
dynamic transitions in RAW 264.7 macrophages.
LPS-induced macrophage spreading depends on constant glucose supply
Next, to further investigate the role of glucose in LPS-induced protrusive actin dy-
namics and obtain a more quantitative measure of the effect of the different meta-
Figure 4. Effect of glucose deprivation and glycolysis or OXPHOS inhibition on morphology of RAW 
264.7 cells. Cells were seeded on glass coverslips, incubated in control medium or medium containing 
2.5 µM oligomycin and 25 mM glucose (A-F), 10 mM 2-DG and 25 mM glucose (G-J), 10 mM galactose 
and no glucose (M-P), or 1 mM glucose and 10 mM galactosel (Q-T) for the indicated time periods and 
stimulated overnight with LPS or left unstimulated. Coverslips were fixed and subjected to scanning 
electron microscopy. The number of filopodia extending radially from the cell surface was determined 
for control cells and cells treated for 24 hours with oligomycin, in the presence and absence of LPS (K). 
The average cell circumference was determined for cells in control medium or medium containing 10 
mM galactose, or 1 mM glucose and 10 mM galactose (L). (***p < 0.001, unpaired t-test). (Bar = 10 
µm)
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bolic conditions on global macrophage morphodynamics, we analyzed the spread-
ing ability of RAW 264.7 cells on fibronectin-coated glass. During cell spreading, 
the increase in cell size is determined by global reorganization of the cellular actin 
cytoskeleton 55.  Inhibition of OXPHOS with oligomycin had no significant effect (Fig-
ure 5A), whereas 2-DG treatment caused slight retardation of spreading (Figure 5B). 
In contrast, removal of glucose from the medium and replacement with galactose 
dramatically inhibited surface expansion. Even without pre-incubation (0h), cells 
spread less efficient in the absence of glucose. With pre-incubation in glucose-free 
medium, spreading was further inhibited and already significantly impaired after 3 
hours of pre-treatment (Figure 5C). Typically, in the presence of 1 mM glucose cells 
largely retained the ability to expand their surface area (Figure 5D). Altogether, our 
findings are in keeping with the morphological observations and indicate that the 
availability of glucose is indispensable for LPS-induced spreading of macrophages.
Phagocytosis of complement-opsonized zymosan by LPS-stimulated macrophages is 
fueled by glycolysis and requires the presence of extracellular glucose
We finally examined whether metabolic conditions (with differential nutrient sup-
ply or inhibitor conditions as above) also affect phagocytosis, the main actin-de-
pendent function of macrophages 27. Formation of the phagocytic cup is driven by 
local polymerization of actin filaments, associated with membrane alterations and 
regionally confined topological alterations at the cell surface. Unlike cell spreading, 
particle uptake via phagocytosis, therefore, is localized and determined by mecha-
nistic events that occur within the small area of contact between cell and particle. 
Acute inhibition (0h pre-incubation) of OXPHOS initially led to a reduction in in-
ternalization efficiency as well as the overall phagocytic index of RAW 264.7 cells 
(Figure 6A,B), however, after three hours, phagocytosis efficiency was restored and 
with longer oligomycin treatment (24h) phagocytic index and the particle internal-
ization capacity was even higher than in control cells. In the presence of ample 
glucose (25 mM), competitive inhibition of glycolysis by 2-DG only inhibited phago-
cytosis significantly after pre-incubation (Figure 6C). 2-DG did not have an acute 
effect, but after 1 hour of 2-DG pre-incubation phagocytosis was markedly down 
(p = 0.055). This effect became even more pronounced with prolonged (3h) pre-
treatment, a period wherein cell viability was still not affected (Figure 1D). The ef-
ficiency of particle internalization was, however, not compromised (Figure 6D) by 
addition of 2-DG. Phagocytosis in the presence of oligomycin and 2-DG was also 
assessed in a second macrophage cell line (Maf-DKO cells). In these cells, oligomycin 
treatment had no effect at all, while 2-DG inhibited Maf-DKO phagocytosis to the 
same extend as in RAW 264.7 cells (Figure S2A,B).
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Figure 5. LPS-stimulated spreading of RAW 264.7 macrophages is compromised by glucose 
deprivation. RAW 264.7 macrophages expressing Lifeact-EYFP were pre-incubated in control medium 
or medium containing 2.5 µM oligomycin and 25 mM glucose (A), 10 mM 2-DG and 25 mM glucose 
(B), 10 mM galactose and no glucose (C), or 1 mM glucose and 10 mM galactosel (D) medium for the 
indicated time periods. To assess spreading efficiency, cells were detached with EDTA, re-suspended, 
seeded in 96 well plates and allowed to adhere. Cell spreading of EYFP-positive cells was recorded over 
time using a BD Pathway high content microscope. The average pixel area per cell was determined 
at 10 minute intervals. Lines and bars represent means ± SEM of three independent experiments 
performed in triplicate. For every condition, representative images of cells at 0 and 200 minutes are 
presented in the panel on the right
122
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Upon total glucose deprivation (by substitution with galactose), the phagocytic 
index in both RAW 264.7 and Maf-DKO cells dropped immediately below 20% (Fig-
ure 6E and Figure S2C). An even bigger drop was seen in RAW 264.7 cells after 4 
and 14 hours (Figure 6E). It is important to note that at 0 and 4 hours the cells were 
still fully viable. Thus, we conclude that the reduction in phagocytic activity must be 
solely the result of insufficiency in glucose availability and not be a secondary effect 
of functional incapacitation. The low phagocytic index in the absence of glucose 
was accompanied by a reduction in particle internalization efficiency (Figure 6F) as 
well as a reduction in the binding capacity of the cells since the percentage of FITC-
COZ positive cells was also reduced by more than 50% (results not shown). These 
results suggest that glucose availability is essential for both particle binding and 
internalization. Interestingly, and in keeping with this conclusion, supplementation 
of galactose medium with 1 mM glucose enabled the cells to maintain full phagocy-
tosis capacity (Figure 6G,H).
Finally, we wanted to determine whether the inhibitory effect of acute glucose 
deprivation on phagocytosis could be directly rescued by reintroducing glucose. 
RAW 264.7 and Maf-DKO cells were incubated with FITC-COZ in galactose medium 
for 30 minutes after which 1 mM of glucose was added and cells were incubated for 
another 30 minutes. RAW 264.7 phagocytosis capacity was restored to 45% while 
Maf-DKO cells regained 75% of their phagocytosis capacity (Figure 6I). Taken to-
gether, our findings imply that glycolysis is critical for phagocytosis of COZ while 
OXPHOS activity is dispensable. Moreover, our results suggest that macrophages 
require the presence of glucose in order to successfully bind and internalize COZ 
particles.
Figure 6. Macrophages require glucose for phagocytosis of COZ. RAW 264.7 cells were incubated 
for the indicated times with control medium, or medium containing 2.5 µM oligomycin and 25 mM 
glucose (A,B), 10 mM 2-DG and 25 mM glucose (C,D), 10 mM galactose and no glucose (E,F), or 10 
mM galactose and 1 mM glucose (G,H) and stimulated o/n with 100 ng/ml LPS. The phagocytic index 
(A,C,E,G) was determined by incubating cells in the respective media with FITC-labeled complement 
opsonized zymosan (COZ) particles for 30 min, analyzed by FACS and calculated as described in materi-
als and methods. The internalization efficiency (B,D,F&H) was determined by quenching extracellular 
FITC-COZ of one sample fraction with 0.05 % trypan blue in potassium dihydrogen citrate/saline, pH 
4.4. Unquenched fractions were used to determine the total fluorescence per cell (internalized and 
external particles), while quenched fractions were used to measure only the internal fluorescence per 
cell. The effect of reintroducing glucose (+ 1 mM Gluc) in the medium after 30 minutes of phagocytosis 
in glucose-free medium was assessed in both RAW 264.7 and Maf-DKO cells (I). Values in A,C,E,G&I 
represent normalized means ±SEM of three or four independent experiments performed in triplicate 
(*p<0.05, **p<0.01, ***p < 0.001; one-sample t-test (A-H) or two-way ANOVA and Bonferroni posttest 
(I)). Values in B,D,F&H represent means ±SEM of three experiments performed in triplicate. (*p<0.05; 
unpaired t-test)
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Discussion
Increased morphodynamic activity, facilitated by rearrangement of the actin 
cytoskeleton, is a cellular response characteristic to LPS-stimulated macrophages. 
This dynamic actin remodeling is essential to macrophage function and considered 
to be an energy draining process. In endothelial cells, actin-ATP hydrolysis accounts 
for almost a fifth (18%) of total ATP consumption 56 and in platelets and neurons it 
is estimated to be more than 50% 26, 57. Cellular energy metabolism and actin-based 
cell dynamics are, therefore, tightly coupled processes. Against this backdrop LPS 
also induces a shift in macrophage redox metabolism, accompanied by increased 
fluxes through glycolysis as well the pentose phosphate pathway for NADPH 
production 5, 7. Here we asked the question whether these temporal associations also 
involve a functional regulatory coupling between metabolic and morphodynamic 
changes in LPS stimulated macrophages.
Our results show that the contribution of mitochondrial OXPHOS to cellular 
energy production is significantly smaller than that of glycolysis and that 
mitochondrial OXPHOS activity is not essential for fueling of morphodynamic 
processes in macrophages. We found that oxygen consumption in resting RAW 
264.7 and Maf-DKO cells is two to four times lower than, for example, in mouse 
embryonic fibroblasts (Figure S1 and Valsecchi et al. 58). More direct support for the 
dispensability of mitochondrial metabolism comes from the observation that, even 
under conditions where we enforced an almost complete dependency on glycolysis 
by treatment with oligomycin, the ability of RAW 264.7 macrophages to undergo 
LPS-induced actin cytoskeleton remodeling remained intact. Although phagocytosis 
capacity in RAW 264.7 cells was initially inhibited upon acute oligomycin treatment, 
this was restored within three hours and did not occur in Maf-DKO cells at all. 
Our observations are consistent with an earlier study by Kvarstein 59, wherein it 
was shown that OXPHOS inhibition with oligomycin and antimycin only had an 
effect on phagocytosis when used in combination with 2-DG. Another study by 
Cifarelli et al. 43 showed minor inhibition of phagocytosis with sodium azide and 
2-4-dinitrophenol only after 3 hours. Our findings additionally showed that OXPHOS 
has also a negligible role in other aspects of macrophage morphodynamics.
In contrast, glucose metabolism through glycolysis (the dominating metabolic 
route of LPS-stimulated macrophages) was clearly indispensable. Perturbation 
of this pathway was achieved either by using the glycolytic inhibitor 2-DG, or by 
replacing glucose with galactose in the culture medium, thereby forcing the cells to 
synthesize and use mitochondrial ATP instead of ATP obtained from glycolysis 60, 61. 
Although 2-DG treatment did not affect the LPS-induced morphology of RAW 264.7 
cells, it caused a minor inhibition of the spreading ability of these cells. Additionally, 
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inhibition of glycolysis with 2-DG also led to a significant reduction in phagocytosis 
capacity. This has been reported before for leukocytes in general and peritoneal 
macrophages 42, 59, 62. Here, we extend these observations and additionally show 
that phagocytosis of complement opsonized zymosan by both RAW 264.7 and Maf-
DKO cells depends on the presence of glucose in the cultivation medium during the 
time of uptake. We know only of two other papers that have reported on direct 
effects of glucose deprivation. In these studies, phagocytosis of unopsonized P. 
aeruginosa by human and murine peritoneal and alveolar macrophages was shown 
to depend on the presence of glucose in the culture medium 63, 64. However, the 
glucose dependency did not apply to phagocytosis of P. aeruginosa opsonized 
with polyclonal rabbit serum, latex particles, unopsonized zymosan, or RBCs 
opsonized with IgG or IgM and complement. Although we only examined COZ 
phagocytosis and used only two macrophage cell lines here, our findings suggest 
that glucose availability may be important for a wider range of actin-dependent 
processes and monocyte cell types. One rarely discussed process in this context 
is macropinocytosis activity, which also requires a dynamic actin cytoskeleton. 
Macropinocytosis activity of macrophages is AMPK-mediated and induced by low 
glucose conditions 65. In turn, macropinocytosis may contribute to nutrient uptake 
capacity, although glucose import probably occurs mainly through GLUT in LPS-
stimulated macrophages 6. Here we would like to speculate that the differences 
in membrane ruffling (not shown) and recovery of phagocytic activity upon 
reintroduction of glucose (75% vs. 45%) that we observed between Maf-DKO and 
RAW 264.7 cells may have to do with the extend of macropinocytosis activity - and 
metabolic regulation thereof - in these cell lines. It is of note here that phagocytosis 
and macropinocytosis are mechanistically related processes, and - especially in the 
initiation phase - also share many morphological features.   Alteration of the actin 
organization, due to loss of MafB, may also explain the differences between the two 
types of macrophages studied here 66.  
Why is presence of glucose so important for formation of actin rich protrusions 
and spreading and other functional activities of LPS-stimulated macrophages? One 
possible answer is that there is a direct link to local ATP-production, even though 
global ATP levels were not affected under the conditions applied. Commonly, when 
glycolytic ATP-production is disturbed, cells adapt to the use of other substrates 
such as fatty acids and amino acids (especially glutamine) for ATP production. It 
has been shown that thioglycollate elicited mouse peritoneal macrophages (which 
are partially M2-polarized) utilize fatty acids to fuel phagocytosis, especially when 
glucose is limiting. However, in LPS-stimulated macrophages, the mitochondrial 
route for ATP-production from fatty acid oxidation is overtly downregulated 8. This 
suggests that LPS-stimulated macrophages do not have many alternative sources 
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for fast supply of ATP. Moreover, the intracellular distribution of ATP may play a 
role. We and others have shown that adenylate kinase or creatine kinase catalyzed 
phosphotransfer reactions may help in the local ATP supply that is needed for 
remodeling of the cortical areas of cells during phagocytosis and migration 27, 28, 67, 68. 
 Since it is generally accepted that actin-rich membrane structures such as filopodia, 
lamellipodia, ruffles, and maybe also the phagocytic cup, are too thin to contain 
mitochondria, glucose and its breakdown via glycolysis may be the only source for 
local ATP production in these structures in LPS-stimulated macrophages. In other 
cell types, glycolytic enzymes such as aldolase and GAPDH have been shown to be 
compartmentalized in cortical actin structures, such as pseudopodia, invadopodia, 
and lamellipodia, and to associate with the actin cytoskeleton 37, 39, 40, 69, 70. Although 
very little is known about the proteome of the early forming phagocytic cup, proteomic 
studies of the phagosome have also identified a role for GAPDH in phagocytosis 71. A 
role for glucose catabolism via glycolysis in local - not global - ATP homeostasis may 
thus explain our findings. A second metabolic role for glucose could be the supply of 
intermediates in reactions that supply fatty acids and phospholipids for direct local 
incorporation into the cell membrane 72. This process is important for maintaining 
membrane fluidity and for supply of membrane components during formation of 
protrusions or maturation of the phagocytic cup and movement of the phagosome, 
respectively. In addition, LPS-stimulated macrophages secrete inflammatory 
compounds such as IL-1, IL-6, and TNFα. High glycolytic activity may be essential 
for the synthesis and post-translational modifications of these compounds, as has 
been shown for quiescent fibroblasts which maintain high glycolytic activity for the 
synthesis of extracellular matrix proteins 73.
Striking, although considered a gentler way of modulating cell metabolism, 
since glucose is still available, 2-DG treatment induced cell death earlier than 
glucose deprivation in our unstimulated cells, although it had a less severe effect on 
LPS-induced morphodynamics. This raises the possibility that, apart from providing 
fuel and anabolic material, glucose could affect cellular morphodynamics through 
another (non-metabolic) mechanism. Indeed, several studies have revealed a 
direct role for glucose metabolism in posttranslational modification of proteins 
and signaling to the actin cytoskeleton. Although not known for complement 
receptor 3, other macrophage receptors that are involved in phagocytosis and 
adhesion to the extracellular matrix, like CD36, FcγRIII, and CR5a, contain sites 
for N-linked glycosylation 74-76. 2-DG has been shown to interfere with (i.e. poison) 
N-linked glycosylation in tumor cells, a process that could be reversed by exogenous 
addition of mannose 77. It may, therefore, be possible that 2-DG interfered with 
normal macrophage receptor expression and function. Michl et al. 42 suggested 
that 2-DG interferes with reactions that link Fcγ- and C3-receptors with the 
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intracellular contractile apparatus, based on the observation that cellular ATP 
levels were not disturbed after 2-DG treatment and that the inhibitory effect of 
2-DG on phagocytosis was reversed upon addition of mannose or high glucose 
concentrations. Furthermore, in studies on glucose-induced insulin secretion in 
pancreatic islet cells and other insulin-secreting cells, such as INS-1, HIT, and MIN6 
cells, glucose metabolism has been implicated in the activation of the small GTPase 
Cdc42, an upstream regulator of actin remodeling. Nevins and Thurmond 78 showed 
in MIN6 β-cells, that glucose stimulation promotes actin cytoskeletal remodeling 
by causing alterations in the cycling of Cdc42 between its active GTP-bound and 
inactive GDP-bound form. Transient activation involves the carboxylmethylation 
of Cdc42, and occurs rapidly (within 15-30 sec) 79, while deactivation of Cdc42 
involves glycosylation of this small RhoGTPase and correlates with transient 
depolymerization of cortical actin 78. This suggests that glucose regulates the 
cortical actin network through modulation of Cdc42 cycling. Transient activation of 
Cdc42 leads to activation of PAK1 and then Rac1 (another small GTPase involved in 
actin cytoskeletal remodeling) within 15 minutes after glucose exposure 80. Finally, 
Uenishi et al. 81 have recently shown that glucose activates N-WASP via Cdc42 and 
induces its translocation to the cell membrane of insulin-secreting clonal pancreatic 
β-cells (MIN6-K8 β-cells). Moreover, glucose stimulation caused LIMK1-mediated 
phosphorylation and deactivation of cofilin via Cdc42 and PAK1. The timing of these 
effects may explain why acute removal of glucose from the culture medium had a 
markedly inhibitory effect on phagocytosis and also why reintroduction of glucose 
instantaneously restored phagocytosis capacity in our study. Interestingly, LPS 
signaling to the cytoskeleton also involves the Cdc42-PAK1-Rac1-LIMK1-pathway 82. 
LPS stimulation additionally increases glucose uptake and metabolism via PI3K/
Akt which are signaling molecules upstream of Cdc42 and Rac1 83-86. Therefore, by 
incorporating glucose as signaling molecule, the metabolic changes that are induced 
by LPS may serve to reinforce the functional changes that macrophage must undergo 
in order to fulfill their function in host defense and tissue homeostasis.
In summary, our results further establish a pivotal role for glucose and its 
breakdown via glycolysis in the control of morphodynamic activity in LPS-stimulated 
macrophages. Based on findings in other cell systems, we consider it likely that for 
exerting this role, the multitalented properties of glucose as metabolic precursor 
and molecule for use in post-translational modification of cytoskeletal (associated) 
structural proteins, receptors or signaling proteins are being used. More in depth 
investigation is required to further unravel these glucose-related events that control 
the activities of macrophages.
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Supplementary material
Figure S1. Oxygen consumption in RAW 
264.7 and Maf-DKO macrophages. Oxygen 
consumption was measured in suspensions 
of 1 x 106 cells on an Oroboros Oxygraph-
2k respirometer. RAW 264.7 and Maf-DKO 
cells were analyzed in parallel on the same 
day. The basal oxygen consumption was 
measured where after oligomycin, FCCP, 
and rotenone was added successively in 
order to determine the leak respiration, 
maximal respiration (Max), and residual 
oxygen consumption (Res). Columns repre-
sent means ± SEM of four experiments
Figure S2. Macrophages require 
glucose for phagocytosis of COZ. 
RAW 264.7 and Maf-DKO cells 
were incubated for the indicated 
times in control medium, or medi-
um containing 2.5 µM oligomycin 
and 25 mM glucose (A), 10 mM 
2-DG and 25 mM glucose (B), or 
10 mM galactose and no glucose 
(C) and stimulated o/n with 100 
ng/ml LPS. Phagocytosis efficien-
cy was determined by incubating 
cells in the respective media with 
FITC-labeled complement opso-
nized zymosan (COZ) particles for 
30 min and analyzing samples by 
FACS. Values represent normal-
ized means ±SEM of three inde-
pendent experiments performed 
in triplicate. (*p < 0.05, **p < 
0.01, ***p < 0.001; one-sample 
t-test)
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Abstract
Functional morphodynamic behavior of differentiated macrophages is strongly 
controlled by actin cytoskeleton rearrangements, a process in which also metabolic 
cofactors ATP and NAD(H) (i.e. NAD+ and NADH) and NADP(H) (i.e. NADP+ and 
NADPH) play an essential role. Whereas the link to intracellular ATP availability 
has been studied extensively, much less is known about the relationship between 
actin cytoskeleton dynamics and intracellular redox state and NAD+-supply. Here, 
we focus on the role of nicotinamide phosphoribosyltransferase (NAMPT), found 
in extracellular form as a cytokine and growth factor, and in intracellular form as 
one of the key enzymes for the production of NAD+ in macrophages. Inhibition 
of NAD+ salvage synthesis by the NAMPT-specific drug FK866 caused a decrease 
in cytosolic NAD+ levels in RAW 264.7 and Maf-DKO macrophages and led to 
significant downregulation of the glycolytic flux without directly affecting cell 
viability, proliferation, ATP production capacity or mitochondrial respiratory 
activity.  Concomitant with these differential metabolic changes, the capacity for 
phagocytic ingestion of particles and also substrate adhesion of macrophages were 
altered.  Depletion of cytoplasmic NAD+ induced cell-morphological changes and 
impaired early adhesion in phagocytosis of zymosan particles as well as spreading 
performance. Restoration of NAD+ levels by NAD+, NMN, or NADP+ supplementation 
reversed the inhibitory effects of FK866. We conclude that direct coupling to local, 
actin-based, cytoskeletal dynamics is an important aspect of NAD+’s cytosolic role in 
the regulation of morphofunctional characteristics of macrophages.
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Introduction 
Important elements of neutrophil and monocyte/macrophage function in innate 
immunity like cell adhesion, locomotion, phagocytosis and regulation of cell shape are 
determined by their ability to regulate actin cytoskeleton reorganization 1. Multiple 
regulatory principles, established via differentiation programming, play a role in 
this coupling. After extravasation, monocytes migrate into target tissue areas and 
differentiate into macrophages.  In response to environmental cues, macrophages 
become polarized, giving rise to different macrophage subtypes. Although other 
nomenclature has been suggested 2, phenotypically polarized macrophages 
are broadly classified as classically activated M1 and alternatively activated M2 
macrophages 3, 4. In vitro, differentiation toward an inflammatory M1 subtype can be 
induced by lipopolysaccharide (LPS) stimulation, while IL-4 and IL-13 promote the 
alternative activation of macrophages towards a suppressive M2 subtype. In keeping 
with their differential roles in either the initial immune response or the resolution 
phase of inflammation and tissue healing, the typical morphodynamic activities, 
including adhesion to the extracellular matrix, or the capturing, adhesion and 
internalization of cells, debris, or foreign particles via phagocytosis, differ between 
the M1- and M2-polarized macrophages. Recent work has  demonstrated that also 
the mode of migration, amoeboid or mesenchymal, in 2D and 3D environments 
differs 5. However, as pointed out by Cougoule and co-workers 5 it is important to 
realize that distinction between macrophage shape and motility behavior is often 
based on in vitro studies and that in vivo, macrophages may occur in a continuum of 
phenotypes, with less explicit differences between differentiation-induction effects 
on morphofunctional properties. Diversity in macrophage phenotype is thus to a 
large extent the result of variable cues from the tissue microenvironment 6.
One of the most variable environmental cues is nutrient availability which may 
be dramatically reduced in diseased tissue due to local disruption of the normal 
blood flow. Macrophages have been shown to sense changes in nutrient availability 
via sirtuin-1 (SirT1)7 and modulate the inflammatory response accordingly. Here, 
we study with a M1 macrophage model whether the metabolic state also has 
control over one archetypal process in this response, the dynamic remodeling of 
the actin cytoskeleton that follows induction with bacterial products (like LPS) and 
the stimulation of phagocytosis by foreign particles 8, 9. Multiple actin-associated 
proteins have a role in the spatiotemporal aspects of this remodeling. For proper 
regulation of actin polymerization and the activity of accessory proteins the cell 
requires sufficient ATP 10-12, supplied via either glycolysis or mitochondrial oxidative 
phosphorylation (OXPHOS) in a locally demand-controlled manner 13, 14. That tight 
regulation of fuel supply is also important for macrophage function is illustrated by 
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the observation that glucose influx through GLUT1 is enhanced when macrophages 
are exposed to LPS 15, or that glucose consumption via glycolysis is increased 
when macrophages are incubated with zymosan 16. Unfortunately, not much 
more is known about the relative contributions of cytoplasmic and mitochondrial 
energy-redox reactions to specific morpho-physiological functioning of these cells, 
although macrophage activities are thought to be generally more dependent on 
glycolytic metabolism than on oxidative pathways 17-19. In order to produce ATP in 
sufficient quantities and sustain a high flux through glycolysis, glycolytic cells such 
as macrophages 20 need to maintain a delicate NAD+/NADH balance and threshold 
concentration of NAD(H) (i.e. oxidized and reduced form) in the cytoplasm. In order 
to achieve this, NAD+ can be synthesized de novo from tryptophan, although most 
of the cellular NAD+ in mammalian cells comes from salvage pathways using the 
NAD+ precursors nicotinamide (NAM), nicotinic acid (NA), or nicotinamide riboside 
(NR) as starting substrates 21. The first reaction in the conversion of NAM to NAD+ 
is catalyzed by nicotinamide phosphoribosyltransferase (NAMPT) and is the rate 
limiting step in the pathway, yielding nicotinamide mononucleotide (NMN) as 
intermediate product. 
NAMPT, also known as pre-B cell colony-enhancing factor (PBEF) or visfatin, 
is one of the more than hundred gene products that undergo conspicuous 
upregulation upon functional differentiation of macrophages 22, 23. Apart from 
having an intracellular enzymatic function in NAD+ salvage synthesis, NAMPT 
is also secreted into the extracellular environment 24-26. Extracellular NAMPT 
(eNAMPT) appears not to exhibit enzymatic activity but functions as a cytokine 
by inducing pro-inflammatory responses in macrophages and neutrophils, a role 
that is unaffected by treatment with the specific inhibitor FK866 (also known as 
APO866) 27-29. In contrast, inhibition of intracellular NAMPT (iNAMPT) by FK866 
decreases intracellular NAD+ and LPS-stimulated TNF levels in THP-1 cells and 
primary mouse and human monocytes as well as IL-1β and IL-6 levels in mouse 
monocytes 30-32. These observations suggest that a global link exists between NAD+ 
salvage metabolism and the inflammatory response of M1 macrophages. However, 
whether there is coupling to specific aspects of macrophage functioning or a role of 
NAD+/NADH compartmentalization over mitochondrial and cytosolic pools therein, 
has not yet been determined.
We have recently, by genetic and pharmacological modulation of NAMPT-
dependent NAD+ salvage synthesis, provided evidence for a controlling role of 
NAD(H) (predominantly cytosolic NAD(H)) in the motile behavior of malignant 
glioma cells 33. Here we extend this work by extrapolation of these findings to the 
metabolic control over cellular functions in macrophages. We report on a specific 
link between cytoplasmic NAD+ homeostasis and aspects of adhesion, spreading and 
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phagocytosis in LPS-stimulated cells from the RAW 264.7 lineage and in continuously 
proliferating MafB/c-Maf deficient (Maf-DKO) macrophages 34. Pharmacological 
inhibition of NAMPT was used as a tool to selectively and differentially modulate 
intracellular NAD+ concentration.
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Materials and methods
Reagents
FK866 was obtained from Enzo Life Sciences (Antwerpen, Belgium). All other re-
agents were obtained from Sigma-Aldrich (St. Louis, MO, USA), unless stated oth-
erwise.
Cell culture
RAW 264.7 cells (gift from Dr. Hong-Hee Kim, Department of Cell and Developmental 
Biology, School of Dentistry, Seoul National University, Korea) 35 were maintained in 
high-glucose DMEM (Gibco, Life Technologies, Paisley, UK) supplemented with 10% 
heat inactivated FBS (PAA laboratories, Pasching, Austria), 1 mM sodium pyruvate, 
and 4 mM GlutaMAX (Gibco, Life Technologies, Paisley, UK), at 37°C in a humidi-
fied atmosphere with 7.5% CO2. Maf-DKO cells (gift from Dr. Michael H. Sieweke, 
Centre d’Immunologie de Marseille-Luminy (CIML), Université Aix-Marseille, 
France) 34 were maintained in the same way except that medium was supplement-
ed with 20% conditioned medium from L929-cells containing macrophage colony 
stimulating factor (M-CSF). 
DNA constructs and transfection
pEYFP-N1-∆ATG-Lifeact was constructed as follows:  Lifeact 36 cDNA, containing hu-
man codon sequences flanked by a 5’ BglII and 3’ EcoRI restriction site, was syn-
thesized by GenScript Corporation and provided in a pUC57 plasmid. The Lifeact-
fragment did not contain a Kozak sequence, therefore, a forward primer (5’-CT CAG 
ATC TCC ACC ATG GGC GTG GCC GAC C-3’) was designed to induce a BglII site and a 
Kozak sequence in front of the Lifeact start codon and used together with the M13 
universal reverse primer to amplify Lifeact from pUC57 by PCR. PCR products were 
digested with BglII and EcoRI and ligated into pEYFP-N1-∆ATG plasmid DNA (pEYFP-
N1 from Clontech with ATG on position 679 mutated to GCG). For transfection, cells 
were seeded in 6 well plates at 300,000 cells/well and incubated overnight. DNA (12 
µg; linearized with AseI) was diluted in 1 ml serum-free DMEM and incubated for 20 
minutes at 37°C with 24 µl Targefect-RAW transfection reagent (Targeting Systems, 
El Cajon, CA, USA). Transfection complexes (250 µl) were added to wells containing 
2 ml fresh culture medium and incubated for 4 hours at 37°C after which medium 
was refreshed. A stable cell population was established by culturing cells for two 
weeks in medium containing 500 µg/ml G418 and cloning by limited dilution.
NAMPT and NAPRT expression
NAMPT and NAPRT expression was analyzed by western blot analysis. Whole cell ly-
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sates were prepared using 5x SDS-sample buffer (10% (w/v) SDS, 25% β-mercapto-
ethanol, 50% glycerol, 0.05% w/v bromophenolblue, and 312.5 mM Tris-Cl, pH 6.8) 
and stored at -20°C until analysis. Before lysates were loaded onto 12% SDS-PAGE 
gels, they were heated at 95°C for 5 minutes. After electrophoretic separation, 
proteins were blotted onto PVDF membranes. Membranes were blocked with 5% 
skimmed milk in PBS-T (NAMPT) or TBS-T (NAPRT) for 1 hour and labeled overnight 
with mouse anti-tubulin (1:5000; DSHB, University of Iowa) and either rabbit anti-
NAMPT (1:2500; Bethyl Laboratories, Montgomery, TX,USA) or anti-NAPRT (1:1000; 
Sigma-Aldrich, St. Louis, MO, USA) antibodies at 4°C. After washing the membranes 
three times for 5 minutes with PBS-T or TBS-T, they were incubated with IRDye sec-
ondary antibodies (goat anti-rabbit 800 and goat anti-mouse 680) for one hour at 
room temperature. This was followed by 4 wash steps of 5 minutes each in PBS-T or 
TBS-T, a final wash step in PBS, and signal detection on the Odyssey Infrared Imag-
ing System (LI-COR Biosciences, Lincoln, NE, USA). Cell lysate from mouse embry-
onic fibroblasts (MEFs) was used as positive control for detection of NAPRT.
NAD(H)/NADP(H) measurements
Intracellular NAD(H)/NADP(H) was measured according to the protocol published 
by Wosikowski et al. 37. Cells (2.0 x 106) were seeded in 25 cm2 tissue culture flasks 
and incubated in either control medium or medium with 10 nM FK866 for 3, 6, 15, 
or 24 hours prior to sample collection. Cells were detached mechanically by scrap-
ing in fresh culture medium and counted. Suspensions of 2.0 x 106 cells were spun 
down and cell pellets were resuspended in 2 ml 0.9% NaCl (Merck, Darmstadt, Ger-
many), split in two and kept on ice. Both fractions were spun down and NaCl was re-
moved. One fraction was used to measure NADH and NADPH levels, and the other 
fraction was used to measure NAD+ and NADP+ levels. For NAD(P)H measurement, 
cell pellets were resuspended in 200 µl 0.02 M NaOH (Merck, Darmstadt, Germany) 
containing 0.5 mM L-cysteine (Merck, Darmstadt, Germany) and incubated at 60°C 
for 10 minutes. The alkaline lysates were then neutralized with 60 µl 0.5 M Gly-Gly 
buffer, pH 7.6, and kept on ice. For NAD(P)+ measurement, cells were lysed in 200 µl 
ice cold 0.5 M perchloric acid (PCA; Fluka) and incubated at 4°C for 15 minutes. The 
acidic lysates were neutralized by initially adding 80 µl 2 M KOH/0.2 M KH2PO4, pH 
7.5, and adjusting the pH by further addition of 1-5 µl buffer until reaching neutral 
pH. Extracts were centrifuged at 13,000 rpm at 4°C for 3 minutes. Supernatants were 
snap frozen in liquid nitrogen and stored at -20°C until analysis. NAD(P)+/NAD(P)
H was measured spectrophotometrically in an enzymatic cycling assay. The NAD+/
NADH content of 10 µl sample was measured in 140 µl reaction mix containing 1.8 
mM 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, 70 µM 1-me-
thoxy-5-methyl-phenzzinium methyl sulfate, 64 mM nicotinamide, 0.32 M ethanol, 
140
64 mM Gl-Gly buffer (pH 7.4), 20 mM succinate (SAFC supply solutions), and 20U 
alcohol dehydrogenase. The NADP+/NADPH content of 10 µl sample was measured 
in 140 µl reaction mix containing 1.8 mM 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyl-tetrazolium bromide, 70 µM 1-methoxy-5-methyl-phenzzinium methyl sulfate, 
5 mM glucose-6-phosphate, 50 mM Tris-HCl (pH 8.0; Invitrogen), 20 mM succinate, 
and 0.45 units glucose-6-phosphate dehydrogenase. After addition of reaction mix-
es, plates were incubated at 37°C for 30-60 minutes and absorbance measured at 
510nm on a BioRad Benchmark Plus micro plate reader. NAD(H) and NADP(H) con-
centrations were calculated from an NAD+ and NADP+ standard curve, respectively. 
Absorbance values were corrected for blank absorbance (without NAD+ or NADP+) 
before concentrations were determined. All samples were corrected for the dilution 
factor. 
 
NAD(P)H autofluorescence measurements
Cellular autofluorescence was determined as a measure of mitochondrial NAD(P)
H-level. Cells were seeded in glass-bottom WillCo dishes and incubated with or 
without 5 nM FK866 for 24 hours. Using the 340 nm filter block, cells were exited 
for 500 ms and autofluorescence was recorded of at least 10 different fields using 
the Olympus IX-71 wide field fluorescence microscope (Olympus Mitico) equipped 
with an EM-CCD camera (Hamamatsu ImagEM). Per field analyzed, the background 
fluorescence as well as the fluorescence of each cell in the field was measured by 
determining the average grey value of two regions of interest in the background of 
the image and of two regions of interest in the cell body.  Per cell, the autofluores-
cence was determined by subtracting the average background fluorescence from 
the average fluorescence inside the cell. Per condition, 80-110 cells were analyzed.
Glucose and lactate assays
Glucose consumption measurements were based on the Amplex Red Glucose/Glu-
cose Oxidase assay kit from Molecular probes (Life Technologies, Eugene, Oregon, 
USA). Glucose, glucose oxidase, and Amplex Red reagent were used from the kit but 
horseradish peroxidase was obtained from Sigma-Aldrich (St. Louis, MO, USA) and 
1x reaction buffer was replaced with 0.05 M Tris-HCl, pH 7.5. Apart from these mi-
nor changes, the kit protocol was followed as described by the manufacturer. Lac-
tate production was measured using the same protocol as for glucose consumption 
but replacing glucose oxidase with lactate oxidase and including a lactate standard 
series instead of glucose. Cells were seeded in 12 well tissue culture plates and in-
cubated for 24 hours in either 1 ml control or 1 ml 5 nM FK866 medium. For glucose 
measurements, medium containing 5 mM glucose was used while lactate produc-
tion was measured for cells grown in 25 mM glucose medium. After 18 hours, me-
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dium was refreshed in some wells for measurement of glucose consumption or lac-
tate production during the last 6 hours of incubation. Prior to addition of incubation 
media, wells were always rinsed with pure DMEM containing no glucose. Medium 
was collected at the end of the 24 hour incubation period and supernatants were 
snap frozen in liquid nitrogen and stored at -20°C until analysis. Cytosolic extracts 
were prepared in lysis 100 buffer ( 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM 
MgCl2, and 0.5% NP-40; 4°C) and total protein was determined with the Bradford 
assay. Glucose consumption was calculated by subtracting the amount of glucose in 
the sample from that in medium without cells. Lactate production was calculated by 
subtracting the concentration of any lactate in the medium without cells from that 
of the samples. Glucose and lactate assays were performed in parallel.
ATP assay
Intracellular ATP was determined using the CellTiter-Glo cell viability assay kit from 
Promega. A total of 500,000 cells were seeded per well of a 6-well plate and treated 
with 5 nM FK866 for 1, 3, or 24 hours prior to assay. Cells were washed twice with 
ice cold PBS and then scraped in 350 µl ice cold 0.6 M perchloric acid (PCA; Fluka). 
PCA extracts were centrifuged for 3 minutes at 4000 rpm and 4°C to pellet all cellu-
lar protein. Supernatants were neutralized with 140-155 µl 2 M KOH/0.2 M KH2PO4, 
pH 7.5 and diluted 1:10 in water. Per well, 100 µl diluted PCA extract was added to 
100 µl CellTiter-Glo reagent and the ATP concentration was determined using an 
ATP standard series. For determination of total cellular protein, pellets were dis-
solved in 250 µl 1 M NaOH and heated for 30 minutes at 95°C. Protein concentra-
tion was then measured in 1:50 diluted NaOH extracts. 
Oxygen consumption measurements
Mitochondrial respiration was assessed by measuring oxygen consumption on an 
Oroboros Oxygraph-2k respirometer according to a standard protocol provided by 
the manufacturer. Control and 24 hour FK866 treated cells were analyzed in paral-
lel in two separate chambers of the respirometer. After air calibration of control or 
FK866 medium in the chambers and stabilization of the signal, 1 x 106 cells (in 60 
µl medium) were injected into the respective chambers. Basal respiration rate was 
measured at the point where the O2-flux signal stabilized. Oligomycin (2.5 µM) was 
added to each chamber and the leak respiration rate was determined after stabiliza-
tion of the signal. Next, 7 µM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone 
(FCCP, a mitochondrial uncoupler) was added to reach maximal oxygen consump-
tion in the cells. Finally, 30 nM rotenone was added and after stabilization of the 
system, the residual oxygen consumption could be determined. The data was ana-
lyzed using the DatLab software provided with the instrument. 
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Proliferation assay
For cell proliferation measurement, the protocol developed by Skehan et al. 38 was 
used. Cells were seeded in four 96-well plates (20,000 cells/well) in 100 µl culture 
medium and incubated overnight. At T0, the medium of plates T6, T15, and T24 
were replaced with medium containing 0, 1, 5, or 10 nM FK866 and plate T0 was 
fixed for sulforhodamine B (SRB) staining of protein content. After 0, 6, 15, and 24 
hours of FK866 treatment, cells were washed twice with cold PBS and fixed in 10% 
trichloroacetic acid (TCA; J.T.Baker, Deventer, Holland) for 1 hour at 4°C. After fixa-
tion, plates were washed five times with water and stored at -20°C until all plates 
were collected. Cellular protein was stained with 50 µl 0.5% SRB in 1% acetic acid 
for 20 minutes after which wells were washed four times with 1% acetic acid. Plates 
were dried at 60°C for 3 hours, protein was dissolved in 150 µl 10 mM Tris-HCl (pH 
10.5), and the absorbance of each well was measured at 510nm on a BioRad Bench-
mark Plus micro plate reader. Values were corrected for background SRB staining 
by subtracting the average absorbance value of wells that contained medium only, 
from that of wells with cells.
In order to monitor proliferation up to 72 hours, cells were seeded at a lower 
density (7,500/well) to avoid any confluency in the cell monolayer and incubated in 
medium with 10 nM FK866 for 24, 48, and 72 hours. Plates were fixed and stained 
as described above.
Apoptosis assay
Apoptosis of cells was measured using a biosensor (pSIVA) developed by Kim et 
al. 39. Briefly, cells (20,000/well) were seeded in a BD Falcon 96-well imaging plate 
and incubated overnight. On the day of assay, cells were washed once with control 
or FK866 containing medium before adding 100 µl of fresh control or FK866 me-
dium containing 8 ng/µl pSIVA or non-labeled control (generous gift from Dr.Ralf 
Langen, University of Southern California). The plate was immediately imaged for 
24 hours, continuously, on a BD Pathway high-content spinning disc confocal micro-
scope, using a 20x objective and 2x2 montage capture. Three wells were imaged per 
condition and the amount of apoptosis was determined by analyzing the increase in 
GFP-signal. For each well the threshold of the whole GFP-image series was adjusted 
and the total pixel area/frame was determined using Fiji imaging software and plot-
ted against time.
Spreading assay
RAW 264.7 cells expressing Lifeact-EYFP were pre-incubated in control or 5 nM 
FK866 medium for 0, 3, 15, or 24 hours before they were harvested by treatment 
with 1 mM EDTA/PBS (10 min at 37°C). After washing, the cells were suspended 
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in medium with 1% BSA. A recovery period of 20 minutes at 37°C was allowed be-
fore cells were seeded in a fibronectin coated (50 µg/ml for 2h at 37°C) BD Falcon 
96-well imaging plate at 4000 cells/well. Cell spreading was monitored for three 
hours by recording the increase in EYFP-pixel area per cell (20 cells/well) on a BD 
Pathway high-content spinning disc confocal microscope, using a 20x objective and 
3x3 montage capture. In order to combine the data from three independent experi-
ments (performed in duplicate), the time axes had to be synchronized. To achieve 
this, a Boltzmann simulation curve was produced for each data set between time 
points 0 and 200 in steps of 2 minutes using OriginLab data analysis and graphing 
software (OriginPro 6.1). Data sets were then combined and analysed for statistical 
significance by applying a repeated measures analysis using PASW statistics 18 SPSS 
software. Three time frames (consisting of 30 data points each) of each FK866 curve 
were compared with the corresponding three time frames of the control curve. 
Scanning electron microscopy
Cells were seeded on 12 mm glass coverslips in 24-well plates and treated with 10 
nM FK866 for 3, 6, 15, or 24 hours. In addition, cells were activated with 100 ng/
ml LPS or left non-activated. Cells were washed once with PBS and fixed with 2% 
glutarealdehyde in 0.1 M sodium cacodylate buffer for 1 hour. After washing cells 
twice with cacodylate buffer, coverslips were stored in the same buffer at 4°C until 
further fixation with 1% OsO4 (osmium tetroxide) for 30 minutes. Coverslips were 
then washed once with water and dehydrated in a graded series of alcohol washes. 
Finally, coverslips were critical point dried and mounted for scanning electron mi-
croscopy (JEOL SEM6340F Field Emission Scanning Electron microscope).
Cellular actin staining
Cells on coverslips were incubated in control or FK866 medium for 24 hours and stim-
ulated with 100 ng/ml LPS overnight or left unstimulated. Cells were washed twice 
with PBS and fixed in 2% paraformaldehyde in 0.2 M sodium phosphate buffer for 
30 minutes. Coverslips were washed twice with PBS and twice with PBS containing 
20 mM glycine (MP Biomedicals, Illkirch Cedex, France; PBS-G) before permeabiliza-
tion with 0.1% saponine/PBS-G for 20 minutes. This was followed by actin staining 
with Alexa 568-labeled phalloidin (1:600 in 0.1% saponine/PBS-G) for 1 hour. Cells 
were successively washed four times for 2-4 minutes with 0.1% saponine/PBS-G 
and once with PBS alone. Coverslips were removed from wells, rinsed once in water, 
air dried, and embedded in MoWiol on microscope slides. Z-scans consisting of 25 
x 0.5 µm sections with the pinhole adjusted to 1 airy unit were recorded on a Zeiss 
LSM510 META confocal laser scanning microscope and merged to one single image 
using Fiji imaging software.
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Phagocytosis assay
Phagocytic activity was determined as zymosan ingestion capacity essentially as de-
scribed by Kuiper et al. 13. Zymosan particles were dissolved in PBS at 10 mg/ml and 
left to rehydrate for at least one hour. Next, zymosan was sonicated three times for 
5 seconds, spun down, resuspended in carbonate buffer (pH 9.6), sonicated, and 
incubated with 1 µg/ml fluorescein isothiocyanate (FITC) for 1 hour at room tem-
perature, in the dark. After FITC labeling, zymosan was washed three times with 
carbonate buffer and incubated in 1 M Tris-HCl, pH 8.0, for 30 minutes. Zymosan 
was then washed twice with PBS and finally resuspended in PBS. After one more 
sonication step, FITC-labeled zymosan was divided in aliquots, frozen in liquid nitro-
gen, and stored at -20°C.
Phagocytosis assays were performed in 12-well plates in which 100,000 cells 
were seeded per well the day before. Cells were incubated in control or FK866 con-
taining medium for 3, 15, or 24 hours prior to assay and activated overnight with 
100 ng/ml LPS. FITC-labeled zymosan particles were complement opsonized by in-
cubation in FBS for 1 hour at 37°C, washed twice with PBS, and finally resuspended 
in serum-free control or FK866 medium. Cells were washed once with serum-free 
medium and incubated with 1 ml zymosan suspension for 30 minutes at 37°C. The 
particle-to-cell ratio was approximately 10:1. Particle engulfment was terminated 
by washing cells twice with PBS and removing extracellular zymosan by treatment 
with 500 µl 100 U/ml lyticase for 10 minutes at room temperature. Successively, 
cells were detached with 0.05% trypsin/0.5 mM EDTA (Gibco, Life Technologies, 
Paisley, UK), resuspended in 1 ml medium with serum, pelleted, and finally resus-
pended in 200 µl 1% paraformaldehyde in PBS. Samples were analyzed by FACS and 
phagocytosis efficiency was determined by measuring the fluorescence intensity of 
the FITC positive population as well as the percentage of cells in that population. 
The phagocytic index of each sample was calculated as the product of the mean 
FITC intensity of the positive population times the % of FITC positive cells. 
To determine the effect of nucleotide supplementation on the phagocytosis ef-
ficiency of control and FK866-treated cells, RAW 264.7 cells were incubated for 24 
hours with 100 µM NAD+, 100 µM NMN or 50 µM NADP+ alone or in combination 
with 5 nM FK866 and phagocytosis efficiency was determined as described above.
Adhesion and Internalization assay
Internalization efficiency was determined essentially as described by Sahlin et al. 40. 
Cells and zymosan particles were prepared as for the phagocytosis assay. After 30 
minute incubation with serum opsonized zymosan at 37°C, plates were transferred 
to ice and wells were washed twice with ice cold PBS. Cells were then scraped in 1 
ml cold medium, divided in two fractions, transferred to microcentrifuge tubes, and 
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spun down. One fraction of each sample was resuspended in 0.05 % trypan blue 
in 13 mM potassium dihydrogen citrate/saline, pH4.4, to quench the fluorescence 
of all extracellular particles, and the other fraction in the same buffer but without 
trypan blue. Samples were analyzed by FACS.
Statistical analysis
Data was analyzed either with the Student’s t-test or one-sample t-test for normal-
ized values. All values are expressed as mean +/-SEM. Values were considered to be 
significantly different when p values were < 0.05. 
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Results
FK866 inhibits cellular NAD+ synthesis
NAMPT mRNA levels in leukocytes are significantly higher than average levels in var-
ious mammalian tissues as determined by quantitative real time PCR 24. However, 
within the lineage differences exist between leukocyte subtypes in that monocytes 
and granulocytes express higher NAMPT mRNA and protein levels than lympho-
cytes. To test if possible variations in mode or capacity of NAD+ synthesis could also 
exist among different macrophage lines, we first determined the relative expression 
levels of NAMPT and NAPRT, essential enzymes for NAD+ synthesis from nicotin-
amide or nicotinic acid, respectively, in RAW 264.7 macrophages and in MafB/c-Maf 
deficient (Maf-DKO) macrophages 34. Despite differences in cell origin 34, 41, 42 and 
proliferative doubling between these macrophage subtypes (Supplementary Figure 
S1A), only NAMPT appeared to be expressed at comparable and detectable level 
(Figure 1A) in both, suggesting that their capacity for NAD+ synthesis is similar and 
primarily determined by the NAMPT reaction step only. Therefore, we considered 
modulation of NAD+ levels by inhibition of NAMPT activity with FK866 a suitable 
strategy for our further studies into metabolic-morphodynamic relationships in 
macrophages.
Since NAD+ can be converted into other pyridine nucleotides, we compared 
not only cellular NAD+ levels but also determined NADH, NADP+, and NADPH lev-
els in the presence and absence of FK866. Strikingly, although most mammalian 
cells contain at least 5-10 fold more total NAD(H) than NADP(H) 33, 43-45, RAW264.7 
macrophages and Maf-DKO macrophages appeared relatively rich in NADP(H). In 
RAW 264.7 cells NAD(H) and NADP(H) levels were about equal (Figure 1B,C,E,F) 
and  in Maf-DKO cells NADP(H) levels were at least one third of that of NAD(H) 
(Figure 1H,I,K,L). Prolonged FK866 treatment affected NAD(H) and NADP(H) differ-
entially, in a time dependent manner. Within 3 hours, total NAD+ levels in RAW 
254.7 cells were already reduced by approximately 60% (p < 0.05; Figure 1B) while 
NADH, NADP+ and NADPH levels remained within the range of the control (Figure 
1C,E,F). After 6 hours of FK866 treatment the levels of NAD+, NADH, and NADPH 
were significantly decreased. While NAD+ and NADH fell back to levels that were 
barely detectable, the cellular NADPH concentration remained at 30- 40% and did 
not decline further with prolonged treatment. FK866-mediated NAD(H)-depletion 
occurred slower in Maf-DKO cells. After 3 hours NAD+ levels were not significantly 
affected and although there was a marked reduction, NAD+ was still not fully deplet-
ed after 6 hours (Figure 1H). A slower proliferation rate of Maf-DKO cells (Supple-
mentary Figure S1A), and/or effects of other metabolic differences, may explain the 
delayed effect of FK866 inhibition in these cells. Nevertheless, upon near complete 
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Figure 1. FK866 treatment causes a time dependent decrease in cellular NAD+/NADH and NADP+/
NADPH content. A, Western blot analysis of NAMPT and NAPRT expression in RAW 264.7 and Maf-
DKO macrophages.Lysate from mouse embryonic fibroblasts (MEF) was used as positive control for 
NAPRT expression. Note that relative high amounts of lysate were used (intense tubulin control sig-
nal) for detection of NAPRT. B,C,E,F, Pyridine nucleotide levels in RAW 264.7 cells incubated for the 
indicated time periods with or without 10 nM FK866. H,I,K,L, Pyridine nucleotide levels in Maf-DKO 
cells incubated for the indicated time periods with or without 5 nM FK866. D,G,J,M, NAD+/NADH and 
NADPH/NADP+ ratios were calculated from the data in A&B, E&F, H&I, and K&L. Data in B-M represent 
means of three experiments performed in triplicate. ND, not detected. (N.S., not significant, *p < 0.05, 
**p < 0.01, ***p < 0.001, unpaired t-test)
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depletion of cellular NAD(H), after 6 hours for RAW 264.7 and 15 hours for Maf-DKO 
cells, also NADP(H) levels were profoundly affected. A significant number of cellular 
reactions depend on the NAD+/NADH or NADP+/NADPH redox potential, rather than 
on the absolute concentration of the oxidized and reduced forms of these pyridine 
nucleotides. We noticed that the NADPH/NADP+ ratio fluctuated somewhat (within 
a two-fold ratio change; Figure 1G,M) during the monitoring period, both with and 
without the FK866 inhibitor, while this seemed less apparent for the NAD+/NADH 
ratio (Figure 1D,J). However, at some time points ( 15h and 24h) in incubations with 
inhibitor the NAD+ and NADH levels became simply too low to accurately calculate 
a ratio. Whether the fluctuations observed are an experimental artifact or a feature 
that is associated with oscillations in cellular redox state, as has been described for 
yeast cells 46, remains to be determined.  
FK866 inhibition of NAMPT reduces glycolytic flux but not intracellular ATP
Since the NAD(P)(H) profiles of the two macrophage cell lines were highly similar 
and FK866 affected the NAD(P)(H) levels to the same extent, we chose to continue 
our study with main focus on the RAW 264.7 cell line and made comparisons with 
the Maf-DKO cell line where appropriate. In order to determine the metabolic effect 
of NAD+-depletion we assessed glycolytic activity and ATP production. Other stud-
ies already demonstrated that macrophages depend strongly on glycolysis for cel-
lular ATP production 20, 47. Instead of complete oxidation via the mitochondrial route 
through the TCA cycle and oxidative phosphorylation (OXPHOS), 80% of the glucose 
molecules that are imported, are ultimately converted into lactate 19. For the RAW 
264.7 lineage we confirmed this picture and found that ~75% of all glucose used is 
converted into lactate, yielding approximately 1.5 moles of lactate per mole glucose 
(ratio of control bars, Figure 2A,B). In glycolysis, NAD+ is converted into NADH by 
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH), producing 1,3-biphospho-
glycerate from glyceraldehyde-3-phosphate.  In concert therewith, the end reaction 
of glycolysis (pyruvate-to-lactic acid conversion by lactate dehydrogenase; LDH), 
helps to restore the cytoplasmic NAD+/NADH balance. Therefore, in view of the 
crucial role of NAD+ availability in maintenance of glycolytic flux, and on the basis 
of our data shown in Figure 1B, we expected a strong effect of FK866 on glycolytic 
activity. Metabolic comparison between RAW 264.7 cells cultured in presence and 
absence of FK866 confirmed this prediction, showing a reduction of 65% and 50% in 
the amount of glucose consumed and lactate produced, respectively (Figure 2A,B). 
Simultaneously, the efficacy of lactate formation increased to 1.8 moles of lactate 
produced per mole of glucose consumed.
In spite of the significant changes in glycolytic activity, we did not observe a 
significant effect on cellular ATP production capacity. Intracellular [ATP] measured 
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at time points 3, 15, and 24h after FK866 addition remained in range of the control 
(around 0.3 µM/µg protein after 3 hours and 0.2 µM/µg protein after 15 and 24 
hours; Figure 2C), whereas NAD+ levels were already significantly reduced at these 
time points (Figure 1B). The 30-40% drop in ATP level that occurred in RAW 264.7 
cells after 15 and 24 hours was observed repeatedly and can be best explained as a 
direct result of medium depletion.
Figure 2. The effect of FK866 on RAW 264.7 metabolism. A,B, Glucose consumption and lactate 
production in the presence and absence of FK866. Cells were incubated in control or FK866 medium 
for a total of 24 hours. Glucose and lactate was measured in medium supernatants collected over the 
last 6 hours (18-24h) of incubation. C, Intracellular ATP levels of RAW 264.7 macrophages treated with 
5 nM FK866 for 3, 15, or 24 hours. D, Mitochondrial NAD(P)H-level. Cellular autofluorescence was 
measured after 24 hour incubation in control medium or medium with 5 nM FK866. E, After 24 hour pre-
incubation with or without FK866, oxygen consumption was measured in suspensions of 1 x 106 cells in 
either FK866 or control medium. Control and FK866 treated cells were analyzed in parallel on the same 
day. The basal oxygen consumption was measured where after oligomycin, FCCP, and rotenone was 
added successively in order to determine the leak respiration, maximal respiration (Max), and residual 
oxygen consumption (Res). Data in A-C represent means ± SEM of three experiments performed in 
triplicate, in D means ± SEM of three experiments, and in E means ± SEM of five experiments. (*p < 
0.05, **p < 0.01; unpaired t-test)
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Inhibition of NAMPT-mediated NAD+ synthesis does not affect mitochondrial respi-
ration
A large fraction of the cell’s content of reduced pyridine nucleotides is compartmen-
talized in the mitochondria.  Cellular NAD(P)H autofluorescence is therefore consid-
ered a reliable measure for assessing the  mitochondrial  NAD(P)H status 48. We 
utilized this parameter to determine whether FK866 mediated inhibition of NAMPT 
affected mitochondrial NAD(P)(H) pools of RAW 264.7 cells. Although the autofluo-
rescence intensity of 24 hour FK866-treated cells was reduced by 38% (Figure 2D), 
it did not mirror the dramatic (60-90%) reduction observed in total cellular NAD(P)H 
after 24 hours (Figure 1C,F).  One possible explanation for this apparent discrepancy 
may be that FK866 hardly affects mitochondrial NAD(P)(H) levels (see also Pittelli et 
al. 49). However, controversy exists around the source of mitochondrial NAD(P)+ 50, 51, 
as the level of this pool appears still to be linked - directly or indirectly - to the level 
of cytosolic NAD(P)+. Therefore, by reducing cytosolic NAD+, NAMPT inhibition may 
ultimately affect the mitochondrial pool, but with differential kinetics.
Another explanation for the roughly one-third shift in autofluorescence signal 
would be that adaptation in mitochondrial OXPHOS occurs, to compensate for the 
loss in glycolytic ATP-production. Thereby a situation would be created wherein an 
increased fraction of total mitochondrial NAD(H) would appear in the (invisible) oxi-
dized form (NAD+). In order to obtain a better view on the consequences for mito-
chondrial respiration capacity, we therefore measured basal oxygen consumption in 
RAW 264.7 cells pre-treated with 5 nM FK866 for 24 hours and also determined the 
leak respiration, maximal respiration, and residual oxygen consumption in the pres-
ence and absence of FK866. The leak respiration gives an indication of the amount 
of oxygen that is consumed without producing ATP. The maximal respiration rate 
is a measure for the respiration capacity, while the residual oxygen consumption 
after addition of rotenone is a measure for oxygen consumption by systems other 
than the electron transport chain, for example NADPH oxidases. Figure 2E shows 
the respiratory values obtained after sequential addition of mitochondrial inhibi-
tors oligomycin, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), and 
rotenone, after measurement of the basal respiration rate. Importantly, we found 
that FK866 did not affect any of these parameters and therefore left mitochondrial 
metabolism virtually untouched. We believe, therefore, that the decrease in auto-
fluorescence must represent a reduction in total cellular NAD(P)H, caused by the 
global FK866-mediated depletion of cytosolic NAD+.
Inhibition of NAD+ salvage synthesis does not affect cell proliferation or viability
Next, we investigated the effects of blockade in NAD+ salvage synthesis on cell 
viability and proliferation capacity. Figure 3A shows the increase in total protein 
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mass as a consequence of growth in RAW 264.7 cell populations, cultivated in ab-
sence or presence of different concentrations of FK866. Within the entire 24 hour 
period of incubation, FK866 at concentrations up to 10 nM had no - or only a very 
minor - effect on the rate of proliferation of RAW 264.7 macrophages.  Due to their 
slower growth rate, proliferation of Maf-DKO cells was monitored for 72 hours and 
also found not to be affected at these concentrations up to 48 hours (Figure 3B). 
Furthermore, use of a polarity-sensitive annexin-based apoptosis biosensor (pSIVA) 
Figure 3. Inhibition of NAD+ salvage synthesis with FK866 does not affect proliferation or viability 
of macrophages. A,B, RAW 264.7 and Maf-KDO proliferation in the presence of different concentra-
tions of FK866, monitored by measuring the increase in protein mass at different intervals over a 24 
or 72 hour period. Data represent means of three independent experiments performed in triplicate. C, 
RAW 264.7 cell viability in the presence of 10 nM FK866. The appearance of the fluorescent apoptosis-
specific pSIVA signal was recorded over time and the total pSIVA pixel area was determined per frame 
using Fiji Imaging software and plotted against time. Lines represent averages from one experiment 
performed in triplicate. (N.S., not significant; unpaired t-test)
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with switchable fluorescence states 39 also did not reveal an increase in the frequen-
cy of RAW 264.7 apoptosis within the 24 hours of FK866 treatment (Figure 3C). In 
contrast, upon cultivation in glucose-free medium, used as a control-condition for 
apoptosis induction, pSIVA signal strength increased strongly, indicating that RAW 
264.7 cells underwent massive apoptosis within 10 hours. Together, these observa-
tions indicate that cell viability and cell growth are not compromised within the test 
period and under the conditions used for inhibition of NAD+ salvage synthesis with 
FK866. 
LPS-stimulated spreading and formation of actin-rich membrane protrusions are in-
hibited in FK866 treated macrophages 
The immune activity of macrophages requires the dynamic remodeling of their cor-
tical actin cytoskeleton, active transport of membrane components, and a diverse 
set of receptor-ligand binding reactions at the cell surface. Together, these are pro-
cesses with a large cellular energy demand 10, 11, 13. Remodeling of the cytoskeleton 
and engagement in adhesion to particles, or binding to other cells or the ECM are 
also under control of other aspects of metabolism, including calcium and redox 
homeostasis 52-56. In order to disclose possible involvement of NAD+ in the morpho-
functional behavior of macrophages we first analyzed whether NAMPT inhibition 
affected cell surface morphology. Scanning electron microscopy (SEM) images of 
resting RAW 264.7 cells after different FK866 incubation periods revealed no differ-
ences compared to control cells (not shown). Next, we analyzed the adhesive ability 
of cells with normal or impaired NAD+ salvage capacity after LPS-stimulation. Inter-
estingly, the ability to undergo spreading and the formation of LPS-induced cellular 
protrusions appeared affected by NAMPT inhibition. Cells treated with FK866 failed 
to spread upon LPS stimulation already after 15 hours (Figure 4A,B) but the effect 
was most prominent after 24 hours (Figure 4C,D). In order to quantify the effect of 
FK866 on cell spreading, we followed the adhesion and spreading of RAW 264.7 
cells expressing Lifeact-EYFP in real time. The cells were stimulated with LPS over-
night and pre-incubated with 5 nM FK866 for 0, 3, 15 and 24 hours after which they 
were seeded in 96 well plates and allowed to adhere. FK866 clearly inhibited the 
spreading ability of the cells in a time dependent manner (Figure 4E). Three hour 
pre-incubation with FK866 only had a minor affect, while spreading was significant-
ly impaired after 15 and 24 hours of NAMPT inhibition. A notable observation was 
that 24 hour FK866-treated cells already covered a smaller cellular pixel area at T0. 
This may indicate that NAMPT inhibition affected the pliability of the cells, causing 
them to maintain a rounded shape after reaching the well bottom instead of un-
dergoing ventral flattening. Alternatively, it may indicate that the formation of cel-
lular adhesion structures has been disturbed. Using TIRF microscopy we attempted 
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to detect differences in the formation of actin-based adhesion structures between 
control and FK866-treated cells but, unfortunately, our results were inconclusive.
To know otherwise whether the organization of the actin cytoskeleton of the 
cells was affected by FK866, cells were again stimulated overnight with LPS and 
treated with FK866 for 3, 6, 15, and 24 hours. After this treatment they were fixed 
and stained with Alexa568-labelled phalloidin. No difference was observed in the 
actin cytoskeleton after 3 and 6 hours of FK866 treatment (not shown). However, 
after 15 hours and especially after 24 hours, the formation of actin-rich membrane 
structures was disrupted in FK866 treated cells. Control cells developed multiple cel-
lular protrusions upon LPS stimulation with a dense and straight appearance, while 
this was less well visible or even absent in the FK866 treated cells (Figure 5A-D). 
Figure 4. LPS-stimu-
lated spreading is in-
hibited during NAMPT 
inhibition in RAW 
264.7 macrophages. 
A-D, RAW 264.7 cells 
were treated with 10 
nM FK866 for 15 or 
24 hours and simul-
taneously stimulated 
overnight with LPS. A 
representative image 
of each condition is 
shown, (Bar = 10 µm). 
E, To quantify spreading 
efficiency, RAW 264.7 
macrophages express-
ing lifeact-EYFP were 
pre-treated with 5 nM 
FK866 for the indicated 
time periods, detached, 
resuspended, seeded 
in 96 well plates and 
allowed to adhere. Ad-
herence and spreading 
of EYFP-positive cells 
were recorded over 
time. The average pixel 
area per cell was de-
termined at every 10 
minute interval. Lines 
represent means ± SEM 
(grey bars) of three ex-
periments performed in 
duplicate
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Phalloidin staining of Maf-DKO cells revealed that the cells themselves as well as 
their actin-rich surface structures have a strikingly different morphology compared 
to RAW 264.7 cells (Supplementary Figure S2A,E). Nevertheless, upon LPS-stimu-
lation, Maf-DKO control cells also developed sharp membrane protrusions which 
were, of note, also inhibited in the presence of FK866 (Supplementary Figure S2A-
H). Blocking of NAD+ salvage synthesis therefore clearly affects LPS-induced mac-
rophage morphology, spreading ability, and the formation of actin-rich membrane 
protrusions. 
Phagocytosis of serum opsonized zymosan is hampered when NAD+ salvage synthe-
sis is inhibited
Finally, we assessed NAD+’s role in phagocytosis, the most typical immune function 
of macrophages which requires special morphodynamic activity. The mechanism 
of phagocytosis shares many similarities with that of adhesive spreading of cells 57. 
Intracellular uptake of FITC-labeled, complement (serum) opsonized zymosan (COZ 
particles) by RAW 264.7 macrophages was impaired after 15 and 24 hour FK866 
treatment (Figure 6A-C). Both the percentage of cells that engaged in phagocytosis 
(Figure 6A) and the mean fluorescence intensity of active cells (Figure 6B) were sig-
nificantly reduced at these two time points. Of note, at 3 hours of incubation with 
FK866 we observed no effect, although the NAD+ level was already significantly low-
ered (Figure 1B). In Maf- DKO cells, phagocytosis of COZ was assessed after 24 hour 
FK866 incubation and also found to be significantly inhibited (Supplementary Figure 
Figure 5. Actin reorganization is al-
tered during NAMPT inhibition in RAW 
264.7 macrophages. Actin organization 
was assessed in wild type cells seeded 
on glass coverslips, treated with FK866 
for 15 or 24 hours, and simultaneously 
stimulated overnight with 100 ng/ml 
LPS. After fixation in 2% PFA, cellular ac-
tin was stained with phalloidin-Alexa568 
and cells were imaged on a Zeiss LSM510 
META confocal laser scanning micro-
scope. (Bar = 10 µm)
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S3), indicating that both these cell lines rely on NAMPT-mediated NAD+ synthesis for 
efficient phagocytosis. In addition, supplying cells with extracellular NAD+, NMN, or 
NADP+ stimulated phagocytosis of COZ and prevented this inhibitory effect of FK866 
(Figure 7). Although it is not exactly clear how NAD+ and NADP+ are taken up by the 
cell, this result further supports our idea that NAD+ is a principal compound in the 
control of phagocytosis efficiency and confirms that FK866 exerts its effect on mor-
phofunctional activity via a reduction in concentration of this pyridine nucleotide.
As the number of actively phagocytosing cells and the number of COZ particles 
engulfed per cell (Figure 6A and B, respectively) do not provide information about 
the internalization efficiency, i.e. the fraction of bound COZ particles that is actually 
engulfed, we decided to perform also an internalization efficiency assay.  Since the 
inhibitory effects of 15 and 24 hour NAMPT inhibition were comparable, we treated 
cells with FK866 for the entire period of 24 hours.  After incubation with COZ, the 
Figure 6. Phagocytosis efficiency is reduced when NAD+ salvage synthesis is inhibited. Cells were 
pretreated with 10 nM FK866 for the indicated times and activated with LPS before they were incu-
bated with FITC-labeled complement opsonized zymosan (COZ) particles for 30 min and analyzed by 
FACS. For each sample the percentage of FITC positive cells (A) and mean fluorescence of FITC positive 
cells (B) were measured. The phagocytic index (C) was calculated as the product of these two param-
eters. The internalization efficiency (D) was determined by quenching the extracellular FITC-COZ of one 
sample fraction with 0.05 % trypan blue in potassium dihydrogen citrate/saline, pH4.4. Unquenched 
fractions were used to determine the total fluorescence per cell (internalized and external particles), 
while quenched fractions were used to measure only the internal fluorescence per cell. Data represent 
means ± SEM of three assays performed in triplicate. Values were normalized to controls in b and c. 
(*p < 0.05; paired t-test)
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extracellular particles were not removed by lyticase, but samples were split and the 
fraction of internalized particles determined from the signal ratio between trypan 
blue quenched (internal) and total unquenched fluorescence (see Materials and 
Methods for details). Figure 6D shows that the ability to internalize particles was 
not compromised in the presence of FK866. The association with the phagocytic 
target is a crucial early step in phagocytosis and is mediated by multiple actin-rich 
membrane structures (filopodia, pseudopodia, and membrane ruffles) that are 
displayed on the cell surface 58-60. Macrophages use these protrusive structures to 
probe the environment and capture targets for phagocytosis. When combined,  the 
findings listed in  Figures 4 and 5, together with the observation that fewer cells en-
gaged in phagocytosis (Figure 6A) and  their internalization ability was not affected 
(Figure 6D), suggest that macrophages treated with FK866 may have lost the ability 
to capture COZ efficiently, perhaps by loss of the ability to form proper membrane 
protrusions and adherence structures. Once contact between cell and particle is 
established, [NAD+] variation apparently has no effect on successful internalization. 
Figure 7. NAD+, NMN, and NADP+ supplementation stimulate phagocytosis and give reversal of 
FK866 effects. Cells were incubated for 24 hours with 100 µM NAD+, 100 µM NMN or 50 µM NADP+ in 
the presence or absence of  5 nM FK866 and activated overnight with LPS before they were incubated 
with FITC-labeled complement opsonized zymosan (COZ) particles for 30 min and analyzed by FACS. 
Values were normalized to the 0 nM FK866 control. Data represent normalized means ± SEM of four (0 
nM FK866) or three (5 nM FK866) experiments performed in duplicate. (N.S., not significant, *p < 0.05, 
**p < 0.01; paired t-test)
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Discussion
Macrophage function involves efficient migration into tissues, adhesion to the 
extracellular matrix, probing or sampling of their extracellular environment 
via filopodia, and - most importantly - phagocytosis of the pathogens and 
foreign particles they encounter. These processes rely on proper regulation of 
polymerization and depolymerization, branching and debranching of the actin 
cytoskeleton and on adequate cellular ATP supply, but the precise metabolic 
requirements and mechanisms involved are not yet fully understood. The NAD+ 
biosynthetic enzyme NAMPT has been implicated in linking NAD+ metabolism and 
the inflammatory cytokine response of monocytes and macrophages and to play a 
regulatory role in cancer cell motility 30-33. Here we have investigated the importance 
of NAMPT dependent NAD+ synthesis for the actin driven processes of adhesion and 
spreading and phagocytosis in macrophages. As a novel finding we report that these 
morphofunctional activities depended heavily on NAD+ availability, even under 
metabolic conditions whereby cell growth and viability and intracellular ATP levels 
appeared not (yet!) affected.  How these metabolic and morphodynamic activities 
are mechanistically controlled remains to be further investigated, but possibilities 
are discussed further below and graphically summarized in Figure 8.
Although the biosynthetic pathways involved in the synthesis of NAD(H) and 
NADP(H) are generally quite well conserved in mammalian cells, their synthetic 
capacity and also the intracellular levels of NAD(H) and NADP(H) may differ 
dramatically between cell types 21, 61. NAD+ can be produced via de novo synthesis 
from tryptophan or via three salvage pathways. It also serves as precursor for the 
other three pyridine nucleotides, NADH, NADP+, and NADPH. Its reduced form, 
NADH, is produced in reactions catalyzed by dehydrogenases (mainly by LDH and 
in the TCA cycle) while NADP+ is synthesized through the phosphorylation of NAD+ 
by NAD kinase (NADK). NADP+ is subsequently and very quickly reduced, so that 
cellular NADP(H) occurs mostly as NADPH 62. In contrast, cellular NAD(H) occurs 
mainly in the oxidized form, i.e. NAD+. Our measurements shown in Figure 1 confirm 
that this general picture also holds for RAW 264.7 and Maf-DKO macrophages. 
However, one striking observation was that RAW 264.7 cells contain remarkably 
high levels of NADP(H) and appear to maintain these levels during FK866 treatment. 
FK866 inhibition caused a marked reduction in NAD+ level already after 3 hours 
of treatment, while NADP(H) levels were not significantly affected. At later time 
points, NAD+ and NADH were totally depleted while 40% of the cellular NADPH still 
remained. That cellular NAD(H) is more sensitive to NAMPT inhibition by FK866 was 
also observed for the Maf-DKO cell line and for U251 glioma cells and activated T 
cells in previous studies 33, 63. Although the mitochondrial NAD(P)(H)-pool was not 
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left completely untouched, it was clearly less sensitive to NAMPT inhibition. More 
importantly, FK866-mediated 
NAMPT inhibition did not noticeably affect mitochondrial respiration. Multiple 
divergent explanations are possible for these combined observations. Firstly, 
mitochondria may not be solely dependent on NAMPT activity to build up a pool 
of NAD+. Some studies show that these organelles do not even contain NAMPT 
themselves, although this is an issue of some controversy 49, 64. According to Nikiforov 
Figure 8. NAMPT-mediated salvage synthesis of NAD+ controls morphofunctional changes of macro-
phages: Synthesis of literature evidence. NAD+ is required to sustain high glycolytic activity in macro-
phages. Metabolism of glucose yields cellular ATP which is loaded onto G-actin monomers by profilin 
before incorporation into an actin filament, or used to activate the Arp2/3 complex. ATP also binds to 
Rho GTPase Rho A, which in turn also stimulates actin polymerization (pink arrows). LPS stimulation 
induces the expression of the NAD+ synthesizing enzyme NAMPT (turquoise arrows). NAMPT-mediat-
ed NAD+ synthesis may regulate actin dynamics by activating Cdc42 (green arrows) or by influencing 
cellular metabolism and, thereby, intracellular pH and cofilin activity (purple arrows). Alternatively, 
NAMPT may control redox regulation of the actin cytoskeleton via mical or NADPH oxidase by regu-
lating NADPH levels (orange arrows). GLUT, glucose transporter; NOX, NADPH oxidase; PPP, pentose 
phosphate pathway; ROS, reactive oxygen species; SSH-1L, slingshot-1L; TLR4, toll-like receptor 4
5 
∙ N
A
M
PT
-m
ed
ia
te
d 
sa
lv
ag
e 
sy
nt
he
si
s 
of
 N
A
D
+  c
on
tr
ol
s 
m
or
ph
of
un
cti
on
al
 c
ha
ng
es
 o
f m
ac
ro
ph
ag
es
159
et al. 50, NMNAT3 is the only enzyme of NAD+ synthesis in mitochondria of human 
cells. This enzyme uses NMN, formed by cleavage of cytosolic NAD+, as substrate 
for intramitochondrial synthesis of NAD+. However, a more recent study by Felici 
et al. 51 contradicts these assertions showing that cytosolic NAD+ maintains the 
mitochondrial NAD+ pool and that neither NMNAT3v1 nor its splice variant FKSG76 
is detectable in human cells. Moreover, upon of transfection of NMNAT3v1, FKSG76 
was the isoform found to be localized to the mitochondria but to be involved in 
NAD+ splicing rather than synthesis.   What remains, is that the mitochondrial 
NAD(P)(H) pool in our macrophage model cells reacts differently, but appears not 
to be completely separated from the cytosolic pool. Therefore, the reduction in 
mitochondrial autofluorescence signal (Figure 2D) can be best explained as an 
effect of a drop in cytosolic NAD+.
The global NAD+ depletion after 24 hours resulted in a reduced glycolytic rate 
but the cells nevertheless managed to maintain cellular ATP production. How 
this is accomplished is currently not completely clear to us. Recently Tan et al. 65, 
showed that FK866 treatment of cancer cells led to an attenuation of glycolysis 
at the GAPDH reaction resulting in a carbon overflow into the pentose phosphate 
pathway, a reduced carbon flow into the TCA cycle, and eventually a reduction 
in cellular ATP. They also showed that the inhibitory effect on the TCA cycle was 
less when glutamine was not limiting in the culture medium. Since our cells 
were cultured in the presence of glutamine and glycolysis was clearly inhibited, 
glutamine consumption may have been upregulated in the presence of FK866. 
Upon glutaminolysis, glutamine is converted into pyruvate and, finally, lactate via 
the formation of TCA-cycle intermediates α-ketoglutarate, succinate, fumarate, and 
malate, yielding NADH and FADH2 for ATP production via OXPHOS. This could also 
explain the minor increase in lactate formation from 1.5 to 1.8 moles of lactate 
per mole of glucose consumed (ratio of bars, Figure 2A,B). We did not observe any 
increase in basal mitochondrial OXPHOS activity (Figure 2E), however, indicating 
that ATP production was not significantly upregulated via this route. Thus, any 
increase in glutaminolysis probably only matched the reduced carbon flow from 
glycolysis into the TCA cycle but did not contribute to ATP homeostasis.
Can we thus rule out limited availability of ATP, due to lack of NAD+, as the cause 
of morphofunctional change in FK866 treated macrophages? Earlier we showed that 
microcompartmentation of ATP-supply plays a role in the control of cell migratory 
activity of cells 66. It remains therefore possible that FK866-mediated NAD+ reduction 
is associated with a local change in ATP supply capacity, which may be not sufficient 
to meet the highly variable and transient demand for cytoskeletal remodeling and 
phagocytosis. Under these conditions global cellular ATP concentrations may not be 
overtly affected. Interestingly, after 3 hours of NAMPT inhibition still no inhibitory 
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effect was observed on either phagocytosis, spreading, or LPS induced morphology 
change, while global NAD+ was already significantly reduced. In addition, the 
accumulated glucose consumption and lactate production over the entire 24 hour 
incubation period was not significantly different for control and FK866 treated 
cells (results not shown). The decrease in glycolytic flux only became substantial 
towards the end of the 24 hour treatment (Figure 2A,B). Thus, if metabolic coupling 
of NAD+ concentration to local or global ATP supply is not the primary mechanism 
that accounts for FK866 effects on macrophage morphodynamics, what other 
mechanisms could be involved? 
Apart from limiting the ATP supply, NAD+-depletion may have other metabolic 
consequences that could (directly or indirectly) interfere with actin dependent 
morphodynamics. For example, the production of lactate in the last step of glycolysis, 
together with release of protons from the conversion of NADH to NAD+, influences 
global intracellular pH (pHi). Locally, the lactate molecules, when transported out 
of the cell by the monocarboxylate transporter (MCT1) together with the H+ 67, 68, 
form a pH gradient across the membrane, which is thought to induce cytoskeletal 
rearrangement via actin-binding proteins gelsolin, cofilin, and talin 69. By inhibiting 
the glycolytic flux to lactate, NAD+-depletion may thus exert direct effects on global 
and local pH homeostasis. In line with this, we have recently shown that both the 
pHi and the pericellular pH (pHe) of FK866 treated and NAMPT knockdown U251 
cells were elevated compared to control cells and that the addition of lactic acid 
to culture media restored the inhibitory effect of FK866 on U251-shNAMPT cell 
migration 33. Whether [NAD+] changes also cause shifts in lactate dehydrogenase 
(LDH) activity in macrophages, and thereby affect the remodeling of the acto-myosin 
cytoskeleton in the micro-environment of phagocytic cup formation remains a topic 
for further study.
Upon stimulation with LPS, macrophages undergo dynamic morphological 
changes and reorganization of their actin cytoskeleton 8, 9. LPS forms a complex 
with LPS binding protein (LBP) present in serum, binds to CD14, and finally to the 
TLR4/MD-2 complex on the macrophage cell membrane 70, 71. LPS signaling via 
TLR4 induces Src family kinase mediated phosphorylation of Pyk2 and paxillin 8, 9, 72 
as well as phosphorylation of the PI3K/AKT pathway 73. These are molecules 
acting upstream of the small GTPases Rho, Rac and Cdc42 which regulate stress 
fiber, lamellipodia and membrane ruffle, and filopodia formation, respectively 74-76. 
As a consequence, LPS stimulation induces cell spreading and the formation of 
protrusive membrane structures. In addition, LPS is responsible for the activation 
of the complement receptor (CR3) that is involved in the recognition of serum 
opsonized particles via Rap1 and RhoA 77, 78. Together, this enhances the phagocytic 
capacity of macrophages. We observed here that NAD+-depletion upon NAMPT 
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inhibition markedly reduced the phagocytic capacity of RAW 264.7 and Maf-DKO 
cells, even though they were still able to internalize particles once these were 
bound. Recently, NAMPT was shown to regulate directionally persistent migration 
of vascular smooth muscle cells (SMCs), mediated by Cdc42 activation 79. Although 
Cdc42 has been implicated in IgG-mediated and not CR3-mediated phagocytosis 80, 
it is also involved in filopodia formation, the assembly of multimolecular focal com- 
plexes 76, and in integrin-mediated adhesion and spreading 81 by regulating actin 
network reorganization via LIMK2-mediated phosphorylation/inactivation of 
cofilin 82. This, in combination with the knowledge that  phagocytosis is an area-
restricted form of cell adhesion and spreading 57, suggests that our findings can 
also be explained by direct NAMPT activity effects on the Cdc42-mediated probing, 
particle capturing, and adhesion activity of macrophages.
Finally, yet another  determinant of proper actin cytoskeletal remodeling is 
cellular redox state 53, 54, in which NAD+/NADH and NADP+/NADPH play an important 
role. In macrophages, cellular NADPH may influence redox regulation of actin 
remodeling in several ways. Professional phagocytes express NADPH oxidases 
(NOX) which use NADPH to transfer an electron to molecular oxygen during the 
respiratory burst. This gives rise to superoxide which can further be converted into 
hydrogen peroxide (H2O2) and other reactive oxygen species (ROS), both intra- and 
extracellularly. Extracellularly and in the phagosomal lumen, these ROS serve a 
microbicidal function, thereby offering protection against pathogens. Intracellularly, 
the ROS is involved in redox signaling, mediating the production of cytokines via 
NFκβ-dependent mechanisms 83 but also regulating the activity of cofilin 84 which 
increases the recycling of actin monomers at the pointed end of actin filaments. At the 
same time, NADPH is also responsible for the regeneration of antioxidant molecules 
such as glutathione (GSH) and thioredoxin (Trx), thereby offering protection against 
oxidative stress, which may affect the redox state of actin itself 85). NADPH may also 
regulate the balance between ROS-mediated activation/deactivation of signaling 
molecules (GTPases) that control the actin cytoskeleton 54. Furthermore, NADPH is 
required for the disassembly of actin filaments by MICAL redox enzymes 86 which 
have been shown to regulate actin dynamics in many cell types 87-90, including 
macrophages 91. Our findings suggest that NADP(H) may even be a principal pyridine 
nucleotide in coupling NAD+-metabolism to actin-based morphodynamics, based 
on the following arguments: i) RAW 264.7 cells have a relatively high level of cellular 
NADPH, ii) NADP(H) levels were relatively spared during the initial phases of FK866 
inhibition and - in association -  morpho-functional changes became only apparent 
at later time points when cellular NADPH reached critical levels, i.e. after 6, 15, or 
24 hours of NAMPT inhibition, and finally, iii) supplementation with NADP+ quite 
effectively rescued phagocytosis  in FK866 treated cells (Figure 7).
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Studies during the last decade have identified FK866 as a promising drug against 
many different cancers. Currently, this compound is being tested in phase two 
clinical trials 92-94. Tumor cells are more sensitive to inhibition of NAD+ synthesis than 
normal cells since they are metabolically highly glycolytic and, therefore, FK866 is 
an effective inhibitor of tumor cell growth. Earlier we have shown in glioma cells 33, 
and here now also in macrophages, that morphodynamic behavior (motility, 
phagocytosis, spreading) is significantly inhibited at moderately effective FK866 
concentrations, during treatment periods wherein proliferation and viability were 
not yet affected. When extrapolating these findings to the in vivo situation, we expect 
that the magnitude of effects of FK866 will be dependent on a tumor-cell’s nutrient 
state and its capacity for NAD+ synthesis via different metabolic pathways (i.e. via de 
novo or salvage pathways, via NAPRT or NAMPT). Treatment with FK866 may thus 
have broad consequences, particularly also for normal glycolytic cells in tumors 
such as macrophages. For example, our findings thus leave open  the possibility that 
FK866 could affect the morphodynamics of tumor associated macrophages (TAMs), 
which have a promoting role in tumor cell migration 95, tumor cell proliferation and 
angiogenesis 96. From a treatment perspective, this could help to further enhance 
FK866’s anti-cancer effect. On the other hand, FK866 treatment could have adverse 
effects and lead to an overall repression of macrophage migratory and phagocytic 
function, with less clearance of apoptotic cells and debris from dying tumors. These 
effects – even in a more broader sense – are also a point of concern for use of 
FK866 as anti-inflammatory drug for the treatment of autoimmune diseases such as 
rheumatoid arthritis, inflammatory bowel disease, or Crohn’s disease. Further study 
in patients and animal models in vivo is, therefore, necessary to fully understand all 
possible consequences of FK866 treatment regimes.
In summary, we report here that FK866 mediated inhibition of NAMPT causes 
NAD+-depletion and down regulation of glycolysis in macrophage model cells. 
Inhibition of NAD+ salvage synthesis did not affect cell viability, proliferative capacity, 
or ATP levels but significantly impaired morphofunctional changes involved in 
phagocytosis and spreading. Future research should elucidate how NAD+ production 
and these processes are exactly linked.
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Supplementary material
Figure S1. RAW 264.7 and Maf-DKO proliferation. A, Proliferation of RAW 264.7 and Maf-DKO cells in 
the presence and absence of L929 cell conditioned medium (M-CSF). B, RAW 264.7 proliferation in the 
presence of FK866 over a period for 72 hours. Proliferation was monitored by measuring the increase 
in protein mass at the indicated time periods. Data represent means of three independent experiments 
performed in triplicate. (*p < 0.05, **p < 0.01; unpaired t-test)
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Figure S2. RAW 264.7 and Maf-DKO morphology and actin structures are affected during NAD+- 
depletion. RAW 264.7 (A-D) and Maf-DKO (E-H) macrophages were seeded on glass coverslips in 
RAW264.7 (without M-CSF) and Maf-DKO (with M-CSF) medium, respectively. Cells were incubated for 
24h in control 5 nM FK866 medium and stimulated o/n with 100 ng/ml LPS or left unstimulated. Cells 
were fixed in 2% PFA, stained with phalloidin-Alexa568, and imaged on a Zeiss LSM510 META confocal 
laser scanning microscope
Figure S3. FK866-mediated NAD+-depletion reduces RAW 264.7 and Maf-DKO phagocytosis effi-
ciency. Cells were seeded in medium containing 20% conditioned medium from L929-cell cultures 
(+M-CSF) and incubated for 24 hours in the presence or absence of 5 nM FK866. Cells were additionally 
stimulated overnight with 100 ng/ml LPS. After 30 minutes incubation with FITC-labelled complement 
opsonized zymosan (COZ) particles, cells were harvested, fixed, and analyzed by FACS. The percentage 
of FITC positive cells were measured as well as the mean fluorescence of this population. The product 
of these two parameters were used to calculated the phagocytic index. Data represent normlaized 
means ± SEM of three experiments performed in duplicate. (*p < 0.05; paired t-test)
166
References
1. Vicente-Manzanares, M. & Sanchez-Madrid, F. Role of the cytoskeleton during leukocyte responses. Nat. Rev. 
Immunol. 4, 110-122 (2004).
2. Mosser, D.M. & Edwards, J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 
958 (2008).
3. Mills, C.D., Kincaid, K., Alt, J.M., Heilman, M.J. & Hill, A.M. M-1/M-2 Macrophages and the Th1/Th2 Paradigm. 
J. Immunol. 164, 6166-6173 (2000).
4. Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795 
(2012).
5. Cougoule, C. et al. Blood leukocytes and macrophages of various phenotypes have distinct abilities to form 
podosomes and to migrate in 3D environments. Eur. J. Cell Biol. 91, 938-949 (2012).
6. Stout, R.D. & Suttles, J. Functional plasticity of macrophages: reversible adaptation to changing microenviron-
ments. J. Leukoc. Biol. 76, 509-513 (2004).
7. Kotas, M.E., Gorecki, M.C. & Gillum, M.P. Sirtuin-1 is a nutrient-dependent modulator of inflammation. Adi-
pocyte 2, 36-35 (2013).
8. Williams, L.M. & Ridley, A.J. Lipopolysaccharide Induces Actin Reorganization and Tyrosine Phosphorylation 
of Pyk2 and Paxillin in Monocytes and Macrophages. J. Immunol. 164, 2028-2036 (2000).
9. Kleveta, G. et al. LPS induces phosphorylation of actin-regulatory proteins leading to actin reassembly and 
macrophage motility. J. Cell. Biochem. 113, 80-92 (2012).
10. Atkinson, S.J., Hosford, M.A. & Molitoris, B.A. Mechanism of Actin Polymerization in Cellular ATP Depletion. 
J. Biol. Chem. 279, 5194-5199 (2004).
11. Huang, T.Y., Minamide, L.S., Bamburg, J.R. & Bokoch, G.M. Chronophin Mediates an ATP-Sensing Mechanism 
for Cofilin Dephosphorylation and Neuronal Cofilin-Actin Rod Formation. Dev. Cell 15, 691-703 (2008).
12. Ingerman, E., Hsiao, J.Y. & Mullins, R.D. Arp2/3 complex ATP hydrolysis promotes lamellipodial actin network 
disassembly but is dispensable for assembly. J. Cell Biol. 200, 619-633 (2013).
13. Kuiper, J.W.P. et al. Creatine Kinase–Mediated ATP Supply Fuels Actin-Based Events in Phagocytosis. PLoS Biol. 
6, e51 (2008).
14. Kuiper, J.W.P. et al. Local ATP Generation by Brain-Type Creatine Kinase (CK-B) Facilitates Cell Motility. PLoS 
ONE 4, e5030 (2009).
15. Fukuzumi, M., Shinomiya, H., Shimizu, Y., Ohishi, K. & Utsumi, S. Endotoxin-induced enhancement of glucose 
influx into murine peritoneal macrophages via GLUT1. Infect. Immun. 64, 108-112 (1996).
16. Albina, J.E. & Mastrofrancesco, B. Modulation of glucose metabolism in macrophages by products of nitric 
oxide synthase. Am. J. Physiol. Cell Physiol. 264, C1594-C1599 (1993).
17. Cifarelli, A., Pepe, G., Paradisi, F. & Piccolo, D. The influence of some metabolic inhibitors on phagocytic activ-
ity of mouse macrophages in vitro. Res. Exp. Med. (Berl). 174, 197-204 (1979).
18. Paradisi, F., D’Onofrio, C., Pepe, G., Cifarelli, A. & Piccolo, D. Phagocytosis and cellular metabolism. Ric. Clin. 
Lab. 9, 47-60 (1979).
19. Rodríguez-Prados, J.-C. et al. Substrate Fate in Activated Macrophages: A Comparison between Innate, Clas-
sic, and Alternative Activation. J. Immunol. 185, 605-614 (2010).
20. Newsholme, P., Curi, R., Gordon, S. & Newsholme, E.A. Metabolism of glucose, glutamine, long-chain fatty 
acids and ketone bodies by murine macrophages. Biochem. J. 239, 121-125 (1986).
21. Houtkooper, R.H., Canto, C., Wanders, R.J. & Auwerx, J. The Secret Life of NAD+: An Old Metabolite Control-
ling New Metabolic Signaling Pathways. Endocr. Rev. 31, 194-223 (2010).
22. Nau, G.J. et al. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. 
U. S. A. 99, 1503-1508 (2002).
23. Iqbal, J. & Zaidi, M. TNF regulates cellular NAD+ metabolism in primary macrophages. Biochem. Biophys. Res. 
Commun. 342, 1312-1318 (2006).
24. Friebe, D. et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase 
(NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 54, 
1200-1211 (2011).
25. Jia, S.H. et al. Pre–B cell colony–enhancing factor inhibits neutrophil apoptosis in experimental inflammation 
and clinical sepsis. J. Clin. Invest. 113, 1318-1327 (2004).
26. Samal, B. et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhanc-
ing factor. Mol. Cell. Biol. 14, 1431-1437 (1994).
27. Li, Y. et al. Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signal-
ing Mechanism. J. Biol. Chem. 283, 34833-34843 (2008).
28. Malam, Z. et al. Pre-B Cell Colony-Enhancing Factor (PBEF/Nampt/Visfatin) Primes Neutrophils for Augment-
ed Respiratory Burst Activity through Partial Assembly of the NADPH Oxidase. J. Immunol. 186, 6474-6484 
5 
∙ N
A
M
PT
-m
ed
ia
te
d 
sa
lv
ag
e 
sy
nt
he
si
s 
of
 N
A
D
+  c
on
tr
ol
s 
m
or
ph
of
un
cti
on
al
 c
ha
ng
es
 o
f m
ac
ro
ph
ag
es
167
(2011).
29. Hara, N., Yamada, K., Shibata, T., Osago, H. & Tsuchiya, M. Nicotinamide Phosphoribosyltransferase/Visfatin 
Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood Plasma. PLoS ONE 6, e22781 (2011).
30. Busso, N. et al. Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Ac-
tivity Identifies a New Inflammatory Pathway Linked to NAD. PLoS ONE 3, e2267 (2008).
31. Van Gool, F. et al. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-depen-
dent manner. Nat. Med. 15, 206-210 (2009).
32. Schilling, E. et al. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory 
responses of human monocytes. Innate Immun. 0, 1-13 (2011).
33. van Horssen, R. et al. Intracellular NAD(H) levels control motility and invasion of glioma cells. Cell. Mol. Life 
Sci., 1-16 (2013).
34. Aziz, A., Soucie, E., Sarrazin, S. & Sieweke, M.H. MafB/c-Maf Deficiency Enables Self-Renewal of Differentiated 
Functional Macrophages. Science 326, 867-871 (2009).
35. Chang, E.-J. et al. Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nat. 
Med. 14, 966-972 (2008).
36. Riedl, J. et al. Lifeact: a versatile marker to visualize F-actin. Nat. Methods 5, 605-607 (2008).
37. Wosikowski, K. et al. WK175, a Novel Antitumor Agent, Decreases the Intracellular Nicotinamide Adenine 
Dinucleotide Concentration and Induces the Apoptotic Cascade in Human Leukemia Cells. Cancer Res. 62, 
1057-1062 (2002).
38. Skehan, P. et al. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. J. Natl. Cancer Inst. 82, 
1107-1112 (1990).
39. Kim, Y.E., Chen, J., Chan, J.R. & Langen, R. Engineering a polarity-sensitive biosensor for time-lapse imaging of 
apoptotic processes and degeneration. Nat. Methods 7, 67-73 (2010).
40. Sahlin, S., Hed, J. & Runfquist, I. Differentiation between attached and ingested immune complexes by a fluo-
rescence quenching cytofluorometric assay. J. Immunol. Methods 60, 115-124 (1983).
41. Raschke, W.C., Baird, S., Ralph, P. & Nakoinz, I. Functional macrophage cell lines transformed by abelson leu-
kemia virus. Cell 15, 261-267 (1978).
42. Raschke, W.C., Ralph, P., Watson, J., Sklar, M. & Coon, H. Oncogenic transformation of murine lymphoid cells 
by in vitro infection with Abelson leukemia virus. J. Natl. Cancer Inst. 54, 1249-1253 (1975).
43. Reiss, P.D., Zuurendonk, P.F. & Veech, R.L. Measurement of tissue purine, pyrimidine, and other nucleotides 
by radial compression high-performance liquid chromatography. Anal. Biochem. 140, 162-171 (1984).
44. Pollak, N., Dölle, C. & Ziegler, M. The power to reduce: pyridine nucleotides – small molecules with a multi-
tude of functions. Biochem. J. 402, 205-218 (2007).
45. Klaidman, L.K., Leung, A.C. & Adams, J.D. High-Performance Liquid Chromatography Analysis of Oxidized and 
Reduced Pyridine Dinucleotides in Specific Brain Regions. Anal. Biochem. 228, 312-317 (1995).
46. Tu, B.P. et al. Cyclic changes in metabolic state during the life of a yeast cell. Proc. Natl. Acad. Sci. U. S. A. 104, 
16886-16891 (2007).
47. Calder, P.C. Fuel utilization by cells of the immune system. Proc. Nutr. Soc. 54, 65-82 (1995).
48. Heikal, A.A. Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anoma-
lies. Biomark. Med. 4, 241-263 (2010).
49. Pittelli, M. et al. Inhibition of Nicotinamide Phosphoribosyltransferase. J. Biol. Chem. 285, 34106-34114 
(2010).
50. Nikiforov, A., Dölle, C., Niere, M. & Ziegler, M. Pathways and Subcellular Compartmentation of NAD Biosyn-
thesis in Human Cells: From entry of  extracellular precursors to mitochondrial NAD generation. J. Biol. Chem. 
286, 21767-21778 (2011).
51. Felici, R., Lapucci, A., Ramazzotti, M. & Chiarugi, A. Insight into Molecular and Functional Properties of 
NMNAT3 Reveals New Hints of NAD Homeostasis within Human Mitochondria. PLoS ONE 8, e76938 (2013).
52. Chiarugi, P. et al. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a 
FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 161, 933-944 (2003).
53. Hurd, T.R., DeGennaro, M. & Lehmann, R. Redox regulation of cell migration and adhesion. Trends Cell Biol. 
22, 107-115 (2012).
54. Nimnual, A.S., Taylor, L.J. & Bar-Sagi, D. Redox-dependent downregulation of Rho by Rac. Nat. Cell Biol. 5, 
236-241 (2003).
55. Tharmalingam, S. et al. Calcium-sensing Receptor Modulates Cell Adhesion and Migration via Integrins. J. Biol. 
Chem. 286, 40922-40933 (2011).
56. Janmey, P.A. Phosphoinositides and Calcium as Regulators of Cellular Actin Assembly and Disassembly. Annu. 
Rev. Physiol. 56, 169-191 (1994).
57. Cougoule, C., Wiedemann, A., Lim, J. & Caron, E. Phagocytosis, an alternative model system for the study of 
cell adhesion. Semin. Cell Dev. Biol. 15, 679-689 (2004).
58. Kress, H. et al. Filopodia act as phagocytic tentacles and pull with discrete steps and a load-dependent veloc-
168
ity. Proc. Natl. Acad. Sci. U. S. A. 104, 11633-11638 (2007).
59. Patel, P.C. & Harrison, R.E. Membrane Ruffles Capture C3bi-opsonized Particles in Activated Macrophages. 
Mol. Biol. Cell 19, 4628-4639 (2008).
60. Flannagan, R.S., Harrison, R.E., Yip, C.M., Jaqaman, K. & Grinstein, S. Dynamic macrophage “probing” is re-
quired for the efficient capture of phagocytic targets. J. Cell Biol. 191, 1205-1218 (2010).
61. Braidy, N. et al. Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats. 
PLoS ONE 6, e19194 (2011).
62. Pollak, N., Niere, M. & Ziegler, M. NAD Kinase Levels Control the NADPH Concentration in Human Cells. J. Biol. 
Chem. 282, 33562-33571 (2007).
63. Bruzzone, S. et al. Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Re-
duces Demyelination and Disability in EAE. PLoS ONE 4, e7897 (2009).
64. Yang, H. et al. Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival. Cell 130, 1095-1107 (2007).
65. Tan, B. et al. Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme 
Essential for NAD+ Biosynthesis, in Human Cancer Cells: Metabolic basis and potential clinical implications. J. 
Biol. Chem. 288, 3500-3511 (2013).
66. van Horssen, R. et al. Modulation of Cell Motility by Spatial Repositioning of Enzymatic ATP/ADP Exchange 
Capacity. J. Biol. Chem. 284, 1620-1627 (2009).
67. Poole, R.C. & Halestrap, A.P. Transport of lactate and other monocarboxylates across mammalian plasma 
membranes. Am. J. Physiol. Cell Physiol. 264, C761-C782 (1993).
68. Hahn, E.L., Halestrap, A.P. & Gamelli, R.L. Expression of the lactate transporter MCT1 in macrophages. Shock 
13, 253-260 (2000).
69. Stock, C. & Schwab, A. Protons make tumor cells move like clockwork. Pfluegers Arch./Eur. J. Physiol. 458, 
981-992-992 (2009).
70. Beutler, B. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 12, 20-26 (2000).
71. Guha, M. & Mackman, N. LPS induction of gene expression in human monocytes. Cell. Signal. 13, 85-94 
(2001).
72. Hazeki, K. et al. Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and 
-independent pathways. Eur. J. Immunol. 33, 740-747 (2003).
73. Weintz, G. et al. The phosphoproteome of toll-like receptor-activated macrophages. Mol. Syst. Biol. 6, 371 
(2010).
74. Ridley, A.J. & Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin 
stress fibers in response to growth factors. Cell 70, 389-399 (1992).
75. Ridley, A.J., Paterson, H.F., Johnston, C.L., Diekmann, D. & Hall, A. The small GTP-binding protein rac regulates 
growth factor-induced membrane ruffling. Cell 70, 401-410 (1992).
76. Nobes, C.D. & Hall, A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes 
associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62 (1995).
77. Caron, E., Self, A.J. & Hall, A. The GTPase Rap1 controls functional activation of macrophage integrin αMβ2 by 
LPS and other inflammatory mediators. Curr. Biol. 10, 974-978 (2000).
78. Kim, J.-G. et al. Ras-related GTPases Rap1 and RhoA Collectively Induce the Phagocytosis of Serum-opsonized 
Zymosan Particles in Macrophages. J. Biol. Chem. 287, 5145-5155 (2012).
79. Yin, H. et al. Intrinsic directionality of migrating vascular smooth muscle cells is regulated by NAD+ biosynthe-
sis. J. Cell Sci. 125, 5770-5780 (2012).
80. Caron, E. & Hall, A. Identification of Two Distinct Mechanisms of Phagocytosis Controlled by Different Rho 
GTPases. Science 282, 1717-1721 (1998).
81. Price, L.S., Leng, J., Schwartz, M.A. & Bokoch, G.M. Activation of Rac and Cdc42 by Integrins Mediates Cell 
Spreading. Mol. Biol. Cell 9, 1863-1871 (1998).
82. Sumi, T., Matsumoto, K., Takai, Y. & Nakamura, T. Cofilin Phosphorylation and Actin Cytoskeletal Dynamics 
Regulated by Rho- and Cdc42-Activated Lim-Kinase 2. J. Cell Biol. 147, 1519-1532 (1999).
83. Forman, H.J. & Torres, M. Reactive Oxygen Species and Cell Signaling: Respiratory Burst in Macrophage Signal-
ing. Am. J. Respir. Crit. Care Med. 166, S4-8 (2002).
84. Kim, J.-S., Huang, T.Y. & Bokoch, G.M. Reactive Oxygen Species Regulate a Slingshot-Cofilin Activation Pathway. 
Mol. Biol. Cell 20, 2650-2660 (2009).
85. Dalle-Donne, I., Rossi, R., Milzani, A., Di Simplicio, P. & Colombo, R. The actin cytoskeleton response to oxi-
dants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic. 
Biol. Med. 31, 1624-1632 (2001).
86. Hung, R.-J., Pak, C.W. & Terman, J.R. Direct Redox Regulation of F-Actin Assembly and Disassembly by Mical. 
Science 334, 1710-1713 (2011).
87. Hung, R.J. et al. Mical links semaphorins to F-actin disassembly. Nature 463, 823-827 (2010).
88. Beuchle, D., Schwarz, H., Langegger, M., Koch, I. & Aberle, H. Drosophila MICAL regulates myofilament orga-
nization and synaptic structure. Mech. Dev. 124, 390-406 (2007).
5 
∙ N
A
M
PT
-m
ed
ia
te
d 
sa
lv
ag
e 
sy
nt
he
si
s 
of
 N
A
D
+  c
on
tr
ol
s 
m
or
ph
of
un
cti
on
al
 c
ha
ng
es
 o
f m
ac
ro
ph
ag
es
169
89. Giridharan, S.S., Rohn, J.L., Naslavsky, N. & Caplan, S. Differential regulation of actin microfilaments by human 
MICAL proteins. J. Cell Sci. 125, 614-624 (2012).
90. Morinaka, A. et al. Thioredoxin mediates oxidation-dependent phosphorylation of CRMP2 and growth cone 
collapse. Sci. Signal. 4, ra26 (2011).
91. Lee, Byung C. et al. MsrB1 and MICALs Regulate Actin Assembly and Macrophage Function via Reversible 
Stereoselective Methionine Oxidation. Mol. Cell 51, 397-404 (2013).
92. Hasmann, M. & Schemainda, I. FK866, a Highly Specific Noncompetitive Inhibitor of Nicotinamide Phospho-
ribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis. Cancer Res. 63, 
7436-7442 (2003).
93. Holen, K., Saltz, L., Hollywood, E., Burk, K. & Hanauske, A.-R. The pharmacokinetics, toxicities, and biologic 
effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Invest. New Drugs 26, 45-51 
(2008).
94. Olesen, U.H., Thougaard, A.V., Jensen, P.B. & Sehested, M. A Preclinical Study on the Rescue of Normal Tissue 
by Nicotinic Acid in High-Dose Treatment with APO866, a Specific Nicotinamide Phosphoribosyltransferase 
Inhibitor. Mol. Cancer Ther. 9, 1609-1617 (2010).
95. Guiet, R. et al. The Process of Macrophage Migration Promotes Matrix Metalloproteinase-Independent Inva-
sion by Tumor Cells. J. Immunol. 187, 3806-3814 (2011).
96. Solinas, G., Germano, G., Mantovani, A. & Allavena, P. Tumor-associated macrophages (TAM) as major players 
of the cancer-related inflammation. J. Leukoc. Biol. 86, 1065-1073 (2009).

General Discussion
6
172
General Discussion
Morphodynamics is the collective term for all cellular processes that alter cell 
morphology through remodeling of the cytoskeletal network of the cell.  Instability 
of microtubules by association and dissociation of tubulin subunits from the 
protofilaments and reorganization of actin filaments by polymerization and 
depolymerization of actin subunits are the basic phenomena that regulate this 
cytoskeletal dynamics.  Strong coupling exists between morphodynamics and cell 
energy metabolism, as the primary determinant of whether microtubules grow or 
shrink is the rate of GTP hydrolysis 1, 2, and F-actin dynamics is strictly coupled to ATP 
hydrolysis and phosphate (Pi) release 
3-5. All the different aspects of morphodynamic 
behavior and coupling thereof to metabolism are much too complex for universal 
coverage in one holistic study. The research described in this thesis was therefore 
uniquely focused on the relationship between carbohydrate-energy metabolism 
and actin-based processes that play a physiological role in one particular cell type, 
macrophages. 
Macrophages are highly morphodynamic cells. In the resting state, they are 
continuously probing the extracellular environment via the formation of actin-
dependent membrane protrusions for the presence of pathogens or signs of injury 6. 
When they perceive signals from their tissue environment they become activated 
and take on a M1 or M2 - or intermediate - polarization state, depending on the type 
of stimulus 7. Macrophage polarization is accompanied by morphodynamic changes 
that are characteristic of the polarization state that is assumed. Lipopolysaccharide 
(LPS-) stimulation drives macrophages towards an inflammatory (M1) phenotype 
which is typified by increased pathogen phagocytosis, filopodia and membrane ruffle 
formation, and radial spreading, while podosome turnover and migration activity 
is reduced 8-11. IL-4/IL-13-mediated activation towards an anti-inflammatory (M2) 
phenotype, on the other hand, is characterized by cellular elongation, formation of 
podosome rosettes, increased migration in dense matrices, but reduced pathogen 
phagocytosis 9, 12, 13. Interestingly, macrophage metabolism is also differentially 
regulated upon polarization 14. M1 macrophage metabolism is driven to a reductive 
mode with increased fluxes through glycolysis and the pentose phosphate pathway 
(PPP), while M2 macrophages enter an oxidative mode signified by an upregulation 
of the TCA-cycle and increased fatty acid oxidation 15, 16. In order to obtain a better 
understanding of the possible relationship between these two aspects, we have 
investigated and compared the morphodynamic capacity of two macrophage 
cell lines under conditions where different aspects of energy metabolism were 
challenged. Experiments were performed mainly in the RAW 264.7 macrophage 
cell line but all key findings were confirmed in Maf-DKO cells, a recently established 
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macrophage cell line that shares characteristics with both RAW 264.7 and primary 
cells.
The main finding described in this thesis is that glucose is involved at different 
levels of control over macrophage morphodynamics via pathways that converge in 
regulation of actin remodeling (Figure 1). Based on a literature survey of possible 
regulatory mechanisms I speculate on a central mechanistic role for cofilin in this 
actin dynamics. 
Glycolysis is the main fuel in macrophages
Most mammalian cells use mainly mitochondrial oxidative phosphorylation for ATP 
production. Since complete oxidation of glucose via this pathway delivers 30 moles 
of ATP per mole of glucose consumed, it is far more efficient than glycolysis alone, 
which produces only a net of 2 moles of ATP per mole of glucose 17.  Proliferating cells 
and cancer cells, however, have a reduced aerobic (mitochondrial) metabolism and 
markedly increased glycolytic rate which favors the production of anabolic material 18. 
Macrophages seem to be exceptional in this regard. Although more and more 
evidence is mounting for self-renewal of macrophages in vivo, their proliferation 
rate does not compare with that of, for example, tumor cells. Still, macrophages 
have high glycolytic activity and significantly low OXPHOS activity (Newsholme et 
al. 19 and chapter 2). Moreover, upon functional activation towards a M1 or 
inflammatory phenotype, glucose consumption is further upregulated, while 
proliferation rate is slowed down (Rodríguez-Prados et al.  15 and chapter 4). This 
means that the high glycolytic rate in macrophages must have another purpose. 
A very recent study by Freemerman et al.  20 has unveiled a role for glucose 
metabolism in reactive oxygen species (ROS-) mediated regulation of macrophage 
polarization state. The results described in chapters 2 and 4 of this thesis assign a 
further role for glucose metabolism in controlling the morphofunctional activities of 
macrophages. Maf-DKO cells exhibited a markedly slower proliferation rate but had 
more actin based surface membrane structures and a higher phagocytosis capacity 
compared to RAW 264.7 cells, while consuming the same amount of glucose. 
Furthermore, the formation of (LPS-induced) membrane protrusions, spreading, 
and phagocytosis by both cell lines was inhibited when glycolysis was disturbed.
OXPHOS activity, on the other hand, does not seem to be essential for these 
processes, since the ability of the cells to form membrane protrusions, expand their 
surface area, and internalize complement opsonized zymosan (COZ) particles was 
not compromised in the presence of the complex V inhibitor oligomycin (chapter 
4).  Interestingly, in both fast growing RAW 264.7 and the slower multiplying Maf-
DKO cells low OXPHOS activity was essential to attain maximal proliferation rates 
(chapter 2). Translated to the in vivo situation this may suggest that, even though 
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cell viability and functionality are not affected, self-renewal of macrophages would 
be compromised under hypoxic conditions, thereby affecting macrophage numbers 
in the affected tissues. Thus, in macrophages, both glycolysis and mitochondrial 
OXPHOS contribute to cellular ATP production to sustain cell viability, but glycolysis 
fuels energy consuming morphofunctional activities, such as phagocytosis.
Transfer of glycolysis-derived ATP to subcellular compartments
Seemingly, our findings and findings of many others thus point to a model in which 
ATP derived from glycolysis and mitochondrial OXPHOS is used as distinct “energy 
currency”, i.e. as fuel with differential value for the promotion of cell-wellbeing 
and growth, and cell-labor. How can we explain this model?  Currently, the best 
explanation is that subcellular compartmentation of energy supply systems is 
involved. During phagocytosis and the formation of different forms of membrane 
protrusions (parts of the phagocytic cup, filopodia, lamellopodia, ruffles) there is 
a need for local actin-driven remodeling of the cell membrane. This remodeling 
is fuelled by ATP production, which is generated on the spot, at the site of where 
activity is needed. This can be achieved by local presence of glycolytic ATP-production 
machinery, as was shown to be the case for fast axonal transport in neurons 21. Like 
in axonal segments of neuronal cells, mitochondria may be completely excluded 
from thin membrane protrusions, such as ruffles and the phagocytic cup, due to the 
dimension of these structures, thereby leaving the local production of ATP up to the 
glycolytic pathway. Another way by which energy could be locally generated is by the 
transfer of ATP from the site of synthesis (via glycolysis or mitochondrial OXPHOS) to 
the area of membrane protrusion via the creatine kinase/phosphocreatine energy 
circuit 22. One cytosolic isoform of creatine kinase, the brain type creatine kinase CK-
B, is the main isoform expressed in macrophages. This enzyme accumulates in the 
phagocytic cup as well as in membrane ruffles (Kuiper et al.   22, 23 and chapter 3) where 
it regulates actin dynamics. Up to now, nothing was known about the mechanism of 
CK-B recruitment to subcellular sites of actin cytoskeletal remodeling. In chapter 3, 
we provide evidence that the C-terminal flexible loop of the CK-molecule containing 
Asp326 is involved in its subcellular displacement. This loop has been associated with 
a conformational change that occurs upon substrate binding to exclude solvent from 
the active site 24, 25. We speculate that changes in the loop region may also influence 
the overall conformation or possibility for subunit interaction in the CK-B dimer, or 
alter the availability of surface accessible residues.  Thereby these changes could 
influence the association of the enzyme with specific binding partners and promote 
alteration of its subcellular localization. 
The ATP supplied by CK-B may not only be essential for the polymerization and 
treadmilling of actin filaments but also be used for actin-myosin contraction, and 
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functioning of actin binding proteins, like the Arp2/3 complex, as well as small GTP-
ases 26-30 (Figure 1, pink arrows). Interestingly, however, not all actin driven processes 
appear equally dependent on CK-B.   For example, FcγR-mediated phagocytosis, 
filipodia formation, as well as LPS-stimulated cell spreading of macrophages seem 
less sensitive to inhibition of CK-B (chapter 3 and Kuiper et al.  22). It is of note 
here that these latter processes are mainly regulated by the GTPases Cdc42 and 
Rac1 33-35, while CR3-mediated phagocytosis and membrane ruffling require Rho A 
activity 36-38. Furthermore, it may be relevant that Rho A is the GTPase most sensitive 
to ATP depletion 29. Cdc42 activity appears not to be affected by low ATP levels, 
while Rac1 (which has also been implicated in membrane ruffle formation 39) is 
mildly sensitive. Rho A regulates actin dynamics by activating ROCK which can then 
either deactivate the actin severing protein cofilin through LIMK1/2 40, 41 (Figure 1, 
pink arrows), or stimulate the actin filament crosslinking activity of myosin II by 
deactivation of MLC phosphatase 42. In addition, Rho A activates mDia which is 
involved in actin remodeling in CR3-mediated phagocytosis 43. CK-B-mediated ATP 
supply may, therefore, be particularly involved in actin-based processes that depend 
on Rho A signaling, and it would be interesting to determine whether Rho A (or its 
upstream signaling molecules) are involved in recruitment of CK-B to subcellular 
sites of actin polymerization and whether the C-terminal flexible loop is facilitating 
(possible) interaction. Also, there may be a relationship between the role of CK 
mediated ATP supply and the turnover dynamics of different surface protrusions 
and the acto-myosin based structures therein. Further study is thus necessary to 
discriminate between a transient and permanent role of CK-B in these locales.
 
Glucose signaling to the actin cytoskeleton
Apart from having a general or local catabolic role, as the principal source for 
energy, in all living cells, glucose also has an anabolic role, as precursor for amino 
acids, fatty acids, and phospholipids. Furthermore, glucose can also be involved in 
the posttranslational modification of proteins. In chapter 4, we provided evidence 
suggesting that glucose may have a non-metabolic role in regulating actin dynamics 
in macrophages, as has been described for insulin secreting cells 44 (Figure 1). 
Glucose stimulation can cause carboxymethylation and O-linked glycosylation of 
Cdc42, leading to its activation and deactivation, respectively 45, 46. Thus, glucose 
modulates Cdc42 cycling between its active and inactive forms. Activated Cdc42 
interacts and activates N-WASP which then translocates to membrane where it is 
involved in nucleation of actin polymerization via the Arp2/3 complex 47. In addition, 
Cdc42 is a potent activator of PAK1 and Rac1 that in turn activates LIMK1, leading to 
phosphorylation and inactivation of cofilin 47-49. Interestingly, this pathway (Cdc42-
PAK1-Rac1-LIMK1) is also activated by LPS, along with upstream PI3K/Akt 50, 51 
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(Figure 1, green, yellow, and blue arrows). Moreover, LPS signaling stimulates glucose 
uptake and metabolism which is known to be mediated by the PI3K/Akt pathway 52-55. 
Glucose consumption and LPS-induced morphodynamics may, therefore, be 
coupled processes in macrophages. However, LPS-signaling may also induce 
morphodynamics via pathways that do not involve glucose. Activation of TLR4-
signaling by LPS leads to recruitment of MyD88 and phosphorylation of the PI3K/
ATK pathway which in turn activates Cdc42 and Rac1 56, 57 (Figure 1, yellow arrows). 
LPS can also induce phosphorylation of Pyk2 and its substrate paxilin in a Src-
family-dependent mechanism through both MyD88-dependent and -independent 
pathways 11, 58 (Figure 1, red arrows). Whether LPS-induced inactivation of cofilin 
utilizes glucose as upstream signaling molecule in macrophages or whether LPS- 
and glucose-induced pathways are activated in parallel remains to be determined. 
Further study is therefore needed of, for example, the effect of O-linked glycosylation 
inhibition by N-Acetylglucosamine-thiazoline (NAG-thiazoline) or GlcNAcstatin 59 
on LPS-induced morphodynamic processes and activation or inactivation of 
downstream signaling molecules such as Rac1, Cdc42, and cofilin. 
Glucose-dependent redox and pH regulation of morphodynamics
Another way in which glucose can exert regulatory effects on actin remodeling 
is by stimulating NADPH oxidase (NOX)-mediated ROS production. NOX is a 
multicomponent enzyme complex that catalyzes the transfer of electrons from 
NADPH (reduced nicotinamide adenine dinucleotide phosphate) to molecular 
oxygen, thereby producing superoxide and other ROS. Cellular NADPH is mainly 
produced via the reduction of NADP+ by G6PDH in the PPP, although a very recent 
report identified folate-dependent NADPH production as a second major source 60. 
Figure 1. Metabolic regulation of morphodynamics in macrophages. LPS complexes with LPS 
binding protein and CD14. This complex binds to and activates TLR4, leading to recruitment of 
MyD88 31, 32. TLR4-signaling leads to phosphorylation of the PI3K/ATK pathway (yellow arrows) and 
induces phosphorylation of Pyk2 and its substrate paxilin in a Src-family-dependent mechanism 
through both MyD88-dependent and -independent pathways (red arrows). This leads to the activation 
of the Rho GTPases Cdc42 and Rac1, although LPS-induced activation of Cdc42 and Rac1 can occur 
independently of MyD88 (green arrows). The activity of Cdc42 may also be directly controlled via 
carboxymethylation or glycosylation by glucose (blue arrows).  Activation of Rac1 and Cdc42 leads to 
the activation/deactivation of actin binding proteins Arp2/3 and cofilin. Metabolism of glucose yields 
cellular ATP which is transported to subcellular sites of actin polymerization via CK-B (pink arrows). The 
ATP is loaded unto G-actin monomers by profilin before incorporation into an actin filament, or used to 
activate the Arp2/3 complex or the Rho GTPase Rho A which in turn also stimulate actin polymerization. 
LPS stimulation induces the expression of the NAD+ synthesizing enzyme NAMPT (turquoise arrows). 
NAD+ can directly activate Cdc42 to affect actin dynamics (brown arrows) or exert a regulatory role by 
influencing cellular metabolism and thereby intracellular pH (purple arrows). NADPH derived mainly 
from the pentose phosphate pathway (PPP) may serve as electron donor in reactions catalyzed by NOX 
or Mical to regulate actin assembly and disassembly in a redox-dependent mechanism (orange and 
green dashed arrows, respectively).
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Interestingly, the flux through the PPP as well as the expression of NOX-1 is increased 
in macrophages upon LPS-stimulation 61, 62. NOX-mediated ROS production may not 
only alter macrophage polarization state 20 but also directly influence actin filament 
properties and function 63 or regulate actin filament depolymerization and severing 
through the activation of slingshot-1L (SSH-1L) that in turn dephosphorylates, and 
activates, cofilin 64 (Figure 1, orange arrows). NADPH is also involved in the oxidation 
of actin by Mical, a redox enzyme that oxidizes methionine residues in actin, 
leading to its disassembly 65, 66 (Figure 1, dashed green arrows). In macrophages, 
re-assembly of actin filaments has been shown to be dependent on the reduction 
of the Mical-oxidized methionine residues by MsrB1 and essential for LPS-induced 
actin cytoskeletal remodeling 67. 
Cellular NADP+ is generated through NAD+ kinase-mediated phosphorylation 
of NAD+ (nicotinamide adenine dinucleotide), a key metabolite/co-factor in 
cellular glucose metabolism and regulator of cellular redox state. The enzyme 
responsible for salvage synthesis of NAD+ from nicotinamide, NAMPT (nicotinamide 
phosphoribosyltransferase), is upregulated in macrophages stimulated with LPS 68 
(Figure 1, turquoise arrows).  Inhibition of NAMPT reduced the levels of cellular 
NAD(H) as well as NADP(H) in macrophages (chapter 5). This reduction in NAD(P)
(H) resulted in irregularities in the actin-based morphology of RAW 264.7 and Maf-
DKO cells, reduced spreading ability, as well as a drop in phagocytic capacity of COZ. 
At this point it is perhaps interesting to note that the global level of NADP(H) in 
macrophages in comparison to the level of NAD(H) is much higher in macrophages 
than in most other cell types, where [NAD(H)] is usually in > 10 fold molecular excess 
over [NADP(H)].  Whether this points to a more elaborate role for NADP+/NADPH than 
just being a redox-cofactor in lipid biosynthesis and protectant against ROS damage 
is not known, but it is tempting to hypothesize that its presence reinforces the 
role of NAD+, via a collective or individual effect on macrophage morphodynamics. 
Thus, the mechanism driving this regulation may involve NADPH-mediated ROS-
signaling to the actin cytoskeleton as described above, but entirely different modes 
of coupling NAD+-linked metabolism to macrophage morphodynamics may also 
exist. One possibility could be intracellular pH (pHi; Figure 1, purple arrows). The 
conversion of glycolysis-derived pyruvate into lactate involves, and is regulated 
by, the conversion of NADH into NAD+ by lactate dehydrogenase. The lactate is 
transported across the cell membrane via MCT1 69, 70, thereby creating a pH gradient 
across the membrane. A local rise in pHi increases the severing activity of cofilin 71, 
resulting in rearrangement of the cortical actin cytoskeleton 72. Although NAD+ 
is closely involved in cellular ATP-production, its role in controlling macrophage 
morphodynamics seems to be independent of this, since global ATP levels were 
not affected when we inhibited NAMPT-mediated NAD+ synthesis in RAW264.7 and 
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Maf-DKO cells with FK866. A last possible principle that I would like to mention is 
that  NAD+ could regulate actin dynamics by activating upstream signaling molecules 
such as Cdc42 73. Although the exact sequence of events has not been elucidated, 
this again could result in the regulation of cofilin activity (Figure 1, brown arrows). 
A central role for cofilin in metabolic regulation of morphodynamics
Taken together, many of the pathways of glucose regulation of cellular actin dynamics 
culminate in the activation or deactivation of cofilin (Figure 1). Cofilin activity is 
regulated by three mechanisms: phosphorylation on Ser3, complex formation with 
phosphatidylinositol 4,5-biphosphate (PtdIns(4,5)P2), and complex formation with 
cortactin 74. Cellular glucose and redox metabolism influences all three mechanisms. 
Phosphorylation (inactivation) and dephosphorylation (activation) are regulated 
by LIMK and SSH, respectively, and as described above the activity of both these 
enzymes is influenced by glucose metabolism. Dephosphorylated cofilin localizes to 
membrane protrusions where it interacts with PtdIns(4,5)P2 or cortactin to form an 
inhibitory complex. In both instances, a local rise in the pHi (which may be greatly 
influenced by glycolytic lactate production and export) releases dephosphorylated 
cofilin from the complex, resulting in increased actin filament severing. The 
barbed-ends of filaments that are released in this way can be used to nucleate 
actin polymerization and support Arp2/3-complex-mediated branching of the actin 
network. Cofilin also mediates depolymerisation of actin filaments further away 
from the plasma membrane, thereby promoting actin filament turnover. LIMK-
mediated phosphorylation of cofilin bound to ADP-G-actin releases it from actin, 
making cofilin available for another activation cycle, and ADP-G-actin for nucleotide 
exchange and incorporation at a new barbed-end. Cofilin, therefore, catalyzes actin 
polymerization and depolymerization through its severing activity. Whether cofilin-
mediated severing results in net filament assembly or disassembly, is determined 
by the relative concentration of active cofilin and ATP-G-actin, and the availability of 
other actin modulating proteins 74. 
In macrophages, a direct role for LIMK-mediated phosphorylation of cofilin in 
phagocytosis has been described 75, 76 and in neutrophils cofilin has been shown to 
translocate to and control membrane ruffle formation 77. Also in other cell types 
cofilin localizes to protrusive membrane structures and regulate motility 78-81. This, 
along with the findings described in this thesis and discussed above, suggest that 
cofilin may indeed be the point of convergence between cellular morphodynamics 
and metabolism.  I therefore strongly suggest to make this protein a focal point for 
further study in a follow-up of my Ph.D. project. 
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Clinical relevance
Macrophages are involved in many aspects of health and disease.  Health 
problems in which they play an important role are related to communicable 
(infectious) diseases as well as non-communicable diseases (autoimmune disease, 
diabetes, cardiovascular disease, and cancer). Therefore, understanding the link 
between metabolism and function opens up new possibilities for macrophages 
as therapeutic targets. By augmenting or inhibiting their activities metabolically, 
disease outcome could be altered. For example, in rheumatoid arthritis (RA) an 
imbalance exists between inflammatory and anti-inflammatory macrophages in the 
synovium 82. Treatment of RA (and other auto-immune diseases) currently mostly 
involve drugs that deplete macrophages from the synovium (or other inflamed 
areas) 82, 83, or immune-suppressors that inhibit the entire immune system. 
Considering the close relationship between metabolism and macrophage 
phenotype, an alternative approach could be to metabolically inhibit or eliminate 
highly glycolytic inflammatory macrophages so that the balance between pro- and 
anti-inflammatory macrophages can be re-established and disease symptoms can 
be limited. Although the secretion of pro-inflammatory cytokines by macrophages 
has been implicated as a major process in the pathogenesis and -physiology 
of autoimmune diseases, the actin cytoskeleton may also play a role herein. 
Autoantibodies against cofilin, Rho-GDIβ protein (regulator of Rho-family GTPases), 
and actin-like proteins have been detected in patients that suffer from various 
autoimmune diseases 84, 85. However, the significance thereof is still unclear. In RA, 
dynamic remodeling of the cortical actin cytoskeleton plays a direct role in joint 
erosion. The inflamed joints are populated by osteoclasts (multinucleated bone 
resorbing cells derived from macrophages) with increased resorbing activity 86-88. 
Bone resorption by osteoclasts entails the formation of a so-called “sealing zone” 
that consists of multiple actin-rich podosomes through which the cell attaches 
to the bone, and acidification of the extracellular microenvironment underneath 
the osteoclast. If the glucose dependency of actin-based protrusive structures of 
LPS-stimulated macrophages can be extrapolated to the formation and function of 
podosomes in osteoclasts, metabolic intervention could offer another approach to 
reduce joint erosion in RA.
Tumor associated macrophages (TAMs) form another subset of target cells for 
applying metabolic therapies. Although TAMs initially exhibit anti-tumor properties, 
they obtain an immune-suppressive (M2) phenotype when the tumor is established 
and promote tumor progression and metastasis as well as angiogenesis 7, 89. In 
addition to secreting cytokines and proteases that promote tumor growth and 
metastasis, macrophage migration promotes tumor cell invasiveness by remodeling 
the extracellular matrix (ECM) 90.  Therefore, metabolic inhibition of macrophage 
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morphodynamics may also be relevant in treating cancer patients. The use of FK866 
as cancer therapeutic is currently being investigated in phase two clinical trials 
and has been shown to effectively reduce cancer cell growth and migration 91-93. 
In order to protect normal tissues from NAD+-depletion, FK866 treatment has 
been combined with nicotinic acid (NA; Vitamin B3) supplementation. The 
expression of the enzyme involved in converting NA into NAD+ (nicotinic acid 
phosphoribosyltransferase; NAPRT) is often lower in tumor cells compared to normal 
cells. Therefore, NA supplementation selectively rescues NAD+-synthesis and, thus, 
survival of normal cells.  Macrophages show a strikingly similar metabolic profile 
to tumor cells. In addition, these cells do not appear to express NAPRT (chapter 5). 
This renders also macrophages very sensitive to FK866 inhibition of NAD+ synthesis. 
As shown in chapter 5 and also in studies by others 94-96, macrophage function is 
thereby significantly inhibited by FK866, even though viability and proliferation 
are unaffected. Treating tumors with FK866 may, therefore, have dual action: 
inhibiting the tumor itself but also the macrophages that promote their growth 
and migration. However, macrophages remain essential agents in the clearance of 
pathogens and apoptotic cells to maintain tissue homeostasis.  Therefore, when 
considering macrophages as therapeutic targets for the treatment of diseases like 
cancer and RA, the method of administration and dosage of metabolic inhibitors 
applied would have to be carefully selected to ensure that the composition of the 
macrophage population in the affected tissue returns to, and is maintained at, a 
state comparable to that of healthy tissue and that susceptibility to infection is kept 
at a minimum.
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Summary
Cell morphology and cell motility are two important characteristics of mammalian 
cells that contribute significantly to their functionality. The cortical actin cytoskeleton 
plays an important role herein. Through polymerization and modification of actin 
filaments, the cell produces protrusive membrane structures that are used to 
adhere to the extracellular matrix, migrate, probe the extracellular environment, 
take up fluid, and capture phagocytic targets. These processes are powered 
by the hydrolysis of significant quantities of ATP. In addition, the properties and 
functionality of the actin filaments as well as the proteins involved in regulating 
their assembly/disassembly are controlled by redox state, intracellular pH and, in 
part, by the physiological state of the cell. Therefore, a close relationship exists 
between cellular morphodynamics and cellular energy metabolism.
Cells of the immune system, especially macrophages, are morphological 
hyperactive cells. These cells are involved in the innate immune response against 
pathogens that enter the body, and in regulating tissue homeostasis by removing 
apoptotic cells and promoting wound healing. Macrophages continuously probe 
their environment for signs of infection or tissue damage. When they encounter 
danger signals, they are activated towards either an inflammatory (M1) or anti-
inflammatory (M2) polarization state. Cells with these polarized phenotypes then 
undergo further different morphological alterations during an immune response. 
Interestingly, activated macrophages also undergo defined metabolic changes 
that are characteristic of the polarization phenotype they assume, whereby M1 
macrophages undergo the most extensive alterations. Given the many links that 
exist between actin-based processes and metabolic effects, the question arises 
whether there is also a coupling between morphodynamic activity and the type and 
rate of energy-redox metabolism in activated macrophages. The research described 
in this thesis addresses this issue and provides new insights on the topic.
In the first experimental chapter (chapter 2) two mouse macrophage cell 
lines of different origin (RAW 264.7 and Maf-DKO) were compared with regard 
to their proliferation rate, morphology, phagocytosis capacity, and carbohydrate 
metabolism. In line with their tumor background, RAW 264.7 cells had a markedly 
higher proliferation rate than Maf-DKO cells. In contrast, Maf-DKO cells were 
morphodynamically more active. These cells formed far more actin-rich membrane 
ruffles and had a significantly higher phagocytic capacity compared to RAW 264.7 
cells. In spite of vast differences in growth rate and morphodynamic activity, the two 
cell lines did not exhibit significant metabolic differences. Both RAW 264.7 and Maf-
DKO cells largely depended on glycolysis while oxidative mitochondrial metabolism 
was minimal. Maf-DKO cells, therefore, share many similarities with both RAW 
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264.7 and primary macrophages and provide a suitable alternative model system 
for further study of the relationship between macrophage morphodynamics and 
metabolism.
Previous research has shown that the ATP that is required for actin polymerization 
at, and formation of, the phagocytic cup in macrophages is dependent on local CK-B-
mediated ATP-generation from creatine phosphate and ADP. In chapter 3, we have 
demonstrated that CK-B is also physically present and involved in the formation 
of actin-rich membrane ruffles in macrophages. In addition, the mechanism of 
CK-B recruitment to the phagocytic cup in activated macrophages was investigated 
by comparing the translocation of different CK-B-mutants or –homologs with 
that of wild type CK-B by using live imaging microscopy. From these studies we 
identified a regulatory role for the C-terminal flexible loop of the CK-B molecule in 
its translocation to the phagocytic cup. Bioinformatics analysis revealed a number 
of residues in this region that are available for interaction with other molecules. 
Substitution of amino acid residues in this region (e.g. Asp326) probably influences 
the conformation of the loop or even the whole CK-B molecule so that interaction 
with other molecules is not optimal and CK-B cannot accumulate at specific sites 
with high actin-based dynamics anymore.
In chapter 4 the importance of glucose for the morphodynamic alteration 
of LPS-stimulated macrophages was assessed. Inhibition of glucose metabolism 
resulted in reduced morphodynamic activity of macrophages (measured as 
spreading ability and phagocytosis capacity) while inhibition of mitochondrial 
oxidative phosphorylation did not negatively affect these processes. Interestingly, 
our results suggested that glucose may also play a non-metabolic role in regulating 
macrophage morphodynamics of LPS-stimulated macrophages, probably by 
modifying molecules in pathways that signal to the actin cytoskeleton.
Finally, in chapter 5 we identified a role for another key compound of cellular 
energy and redox metabolism, NAD+, in LPS-induced morphological change. 
Pharmacological inhibition of the major enzyme involved in NAD+ salvage synthesis 
NAMPT (nicotinamide phosphoribosyltransferase) resulted in depletion of cellular 
NAD+ levels in both RAW 264.7 and Maf-DKO cells. Under these conditions, cell 
morphology, spreading, and phagocytosis were significantly disturbed, while 
proliferation, cell viability and ATP homeostasis appeared unaffected. These 
findings suggest that NAD+ also controls macrophage morphodynamics via an 
ATP-independent mechanism that probably involves the pH- and redox-mediated 
regulation of actin and actin associated proteins (e.g. cofilin).
In conclusion, the research described in this thesis provides new knowledge 
with regard to the coupling between macrophage metabolism and morphodynamic 
behavior and function. A better understanding of the cell biological mechanisms that 
190
drive macrophage activities provides a broader foundation for the development of 
therapies for diseases in which these cells play a key role, such as cancer and auto-
immune disease (e.g. rheumatoid arthritis).
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Samenvatting voor de leek
Verandering in celmorfologie en celmotiliteit zijn twee belangrijke processen voor 
zoogdiercellen. Beide leveren een significante bijdrage tot hun functionaliteit. Het 
corticale actine cytoskelet speelt  in deze dynamiek  van vorm en beweging een 
uiterst belangrijke rol. Door de polymerisatie van monomere actine moleculen 
vormen zich filamenten die het celmembraan vooruit duwen wanneer ze  onder 
het celoppervlak verlengd worden. Door van de actinefilamenten hele netwerken 
te vormen vormt de cel smalle uitlopers (filopodia genoemd) of membraanrimpels 
(‘ruffles’). Ook kan het celfront over een groter oppervlak vooruit worden geduwd 
om een zogenaamde lamellipodium te vormen. De cel gebruikt deze structuren om 
de extracellulaire omgeving af te tasten of zich eraan vast te hechten, om vloeistof 
en voedingstoffen op te nemen, of om vooruit of achteruit te bewegen. De opbouw 
van het actine-netwerk in ieder  van de hierbij betrokken membraanstructuren 
verschilt en wordt gereguleerd door honderden actine-bindende eiwitten (ABPs) 
en signaleringsmoleculen. De vorming, maar ook het modificeren, van actine 
filamenten vormt de basis van alle morfodynamische veranderingen van iedere cel. 
Gezamenlijk vereisen deze processen een aanzienlijke hoeveelheid van de totale 
chemische energie die een cel herbergt, in de vorm van ATP. Daarnaast worden 
de eigenschappen en functionaliteit van de actine filamenten zelf, en de daarbij 
werkzame ABPs, ook nog eens beïnvloed door de intracellulaire pH en de redox 
status van de cel. Alle drie deze factoren (ATP-productie, pH en redoxstatus) worden 
op hun beurt weer bepaald door de metabole staat van de cel. Er bestaan dus 
diverse nauwe banden tussen cellulaire morfodynamica en metabolisme.
Vele types cellen in zoogdieren, en dus ook in het menselijk lichaam, zijn 
morfologisch actief. Voor met name kankercellen en cellen van het immuunsysteem 
is morfodynamiek van uitzonderlijk groot belang. Macrofagen horen tot de groep 
leukocyten (witte bloedcellen) die de eerste lijn van verdediging vormen tegen 
pathogenen (bijv. bacteriën) die het lichaam binnendringen. Ook reguleren ze de 
weefselhomeostase door dode cellen te verwijderen en stimuleren ze weefselherstel. 
Macrofagen komen overal in het lichaam voor en zijn voortdurend bezig om hun 
omgeving te controleren op indringers of op voortekenen van weefselbeschadiging. 
Macrofagen bewegen zich daarbij voort door de weefsels, waarbij ze de actine-
rijke membraanuitsteeksels gebruiken om  veranderingen in de extracellulaire 
omgeving waar te nemen of om bacteriën en dode cellen te binden en op te 
nemen via fagocytose. Wanneer gevaarprikkels (bijv. bacteriële componenten zoals 
lipopolysaccharide (LPS) of signaaleiwitten, cytokines, zoals interleukine 4 (IL-4)) 
waargenomen worden, worden macrofagen daardoor geactiveerd om een andere 
status, met nieuwe kenmerken (een ander fenotype) aan te nemen. Het fenotype 
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dat een geactiveerde macrofaag aanneemt is afhankelijk van de soort prikkel die 
waargenomen wordt. Op die manier worden macrofagen bijvoorbeeld geactiveerd 
(of gepolariseerd) tot een M1- of inflammatoire staat door LPS-stimulatie, of tot een 
M2- of alternatieve (anti-inflammatoire en weefselherstellende) staat door IL-4-
stimulatie. Behalve dat macrofagen in deze twee verschijningsvormen verschillende 
functies hebben tijdens de immuunrespons, ondergaan ze ook verschillende actine-
afhankelijke morfologische veranderingen. LPS-gestimuleerde (M1-) cellen spreiden 
uit en vergroten hun celoppervlak, vormen filopodia en membraanrimpels en 
fagocyteren pathogenen. Tegelijkertijd vertonen ze een verlaagd migratievermogen, 
terwijl IL-4-gestimuleerde (M2-) cellen juist een verhoogde migratieactiviteit 
hebben, maar pathogenen minder goed kunnen fagocyteren.
Opvallend genoeg, ondergaan geactiveerde macrofagen daarbij ook metabole 
veranderingen die kenmerkend zijn voor het betrokken fenotype. M1-macrofagen 
die de meest opvallende morfodynamische veranderingen ondergaan, vertonen 
ook de meest ingrijpende metabolische aanpassingen. Deze kenmerken zich door 
een verhoogde glucose-opname en -verbruik, een verhoogde flux door het pad van 
de zogenaamde pentosefosfaat omzettingen en ook een  verhoogde nicotinamide 
adenine dinucleotide (NAD+-) synthese. Wetende dat actine polymerisatie gedrag 
beïnvloed wordt door het celmetabolisme, kunnen we dus de vraag stellen of 
of er een ook een vergelijkbaar verband bestaat tussen de morfodynamische en 
de metabole veranderingen die plaatsvinden in geactiveerde macrofagen. Het 
onderzoek dat beschreven is in dit proefschrift levert nieuwe inzichten m.b.t. het 
beantwoorden van deze vraag.
Voor het bestuderen van macrofagen in vitro, kunnen deze cellen geïsoleerd 
worden uit bloed en gekweekt worden in het laboratorium. Echter, macrofagen die 
op deze manier verkregen zijn, kunnen niet onbeperkt groeien en vermeerderen 
en moeten dus na verloop van tijd opnieuw geïsoleerd worden. Het gebruik van 
geïmortaliseerde macrofaag cellijnen voorkomt dit probleem en biedt dus een 
goed alternatief. Dit levert weer een ander probleem op. Geïmortaliseerde cellijnen 
zijn namelijk vaak afgeleid van tumorcellen en bezitten daarom een zodanig 
gemodificeerd genoom  dat ze in vele opzichten niet meer dezelfde eigenschappen 
hebben als primaire cellen. Het onderzoek dat in dit proefschrift beschreven is, is 
vooral gedaan op de RAW 264.7 macrofaagcellijn. Aangezien deze cellijn afkomstig 
is van een Abelson leukemie virus-geïnduceerde ascites tumor van een muis 
en dus een kankerachtige oorsprong heeft, heb ik in hoofdstuk 2 een vergelijk 
gemaakt tussen de RAW 264.7 cellijn en een nieuwe macrofaagcellijn waarvan 
aangetoond is dat het geen tumorigene eigenschappen heeft. Deze nieuwe cellijn, 
Maf-DKO genoemd, is afkomstig van muizen met een MafB/c-Maf -deficient 
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hematopoïetische (bloed) systeem. Door de genetische MafB/c-Maf-deficientie 
kunnen deze macrofagen in vitro onbeperkt vermeerderen in aanwezigheid van 
M-CSF (macrofaag colonie-stimulerende factor). Dit  in tegenstelling tot normale 
primaire macrofagen die dit niet kunnen. In de vergelijkende studie is gekeken naar het 
groeitempo, het koolhydraat metabolisme, en morfodynamische karakteristieken. 
In overeenstemming met hun tumor oorsprong hadden RAW 264.7 cellen een veel 
hogere groeitempo dan Maf-DKO cellen. Daarentegen, hadden Maf-DKO cellen veel 
meer actine-rijke membraanruffels en een veel grotere fagocytosecapaciteit dan 
RAW 264.7 cellen. Ondanks deze  verschillen vertoonden de twee cellijnen echter 
opmerkelijk genoeg geen significante matabole verschillen. Het glucoseverbruik 
was hoog en het mitochondriële zuurstofverbruik was minimaal in beide cellijnen. 
Hieruit concludeerden we dat de metabole uitgangskarakteristieken voor RAW 
264.7 en Maf-DKO cellen vergelijkbaar zijn. Dit maakt allebei de macrofaag cellijnen 
geschikt voor verder onderzoek naar de verbanden tussen morfodynamiek en 
metabolisme.
ATP (energie)-productie vindt overal in de cel plaats, maar actine-rijke 
membraanuitsteeksels worden alleen op de buitenrand van de cel gevormd. De 
energie die benodigd is voor actinepolymerisatie onder  en aan (de  binnenkant van) 
het celoppervlak moet dus op de een of ander manier hier terechtkomen. Hiervoor 
beschikt de cel over een speciaal ATP-productie en -transportsysteem genaamd het 
creatine kinase-creatinefosfaat (CK-PCr) fosfageensysteem. Voorafgaand onderzoek 
op ons laboratorium had al aangetoond dat een  specifieke CK-isoform (brein-
type CK; CK-B) betrokken is bij de nieuwvorming van fagosomen, de actine-rijke 
structuren waarmee  macrofagen soortvreemde partikels binden en opslokken. In 
hoofdstuk 3 hebben we aangetoond dat CK-B ook een rol speelt in de vorming van 
actinerijke membraanruffles en andere uitsteeksels op het membraanoppervlak 
van macrofagen. Tijdens fagocytose worden een deel van de in de cel aanwezige 
CK-B eiwitmoleculen gerecruteerd en tijdelijk fysiek gebonden nabij de plaats 
op de celmembraan waar partikels  (in deze geval serum-geopsoniseerde dode 
gistcellen) zich hechten en waar ze uiteindelijk met membraan worden omhuld 
en opgenomen worden. Door deze plaats- en tijdgebonden ophoping van aktief 
CK-B enzyme ontstaat een plaatselijk grote capaciteit voor levering van ATP aan 
de actine polymerisatie-machinerie. Echter, over hoe CK-B gemobiliseerd wordt 
en plaatselijk ophoopt onder het membraan is vrijwel niets bekend. In hoofdstuk 
3 hebben we ook het  mechanisme hierachter verder onderzocht in geactiveerde 
macrofagen. Hiervoor hebben we de re-localisatie van verschillende CK-B-
mutanten of –homologen tijdens fagocytose bestudeerd en vergeleken met het 
gedrag van wild type (normaal) CK-B enzyme met behulp van merking van de 
eiwitten met een fluorescente groep en het volgen van deze eiwitten m.b.v. video-
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fluorescentiemicroscopie. Hiermee konden we aantonen dat een specifiek domein 
van  het CK-B-molecuul, namelijk de zogenaamde C-terminale buigzame lus, 
essentieel is voor de migratie naar het fagosoom. Deze lus bevat het aminozuur 
asparaginezuur op eiwitpositie 326. Wanneer dit aminozuur vervangen wordt door 
alanine, wordt  het CK-B niet meer verplaatst naar de plek op celoppervlak waar 
zich een fagosoom vormt. Analyse m.b.v. een bioinformatieve aanpak  heeft verder 
aangetoond dat diverse residuen in deze C-terminale lus beschikbaar zijn voor 
interactie met andere moleculen. Waarschijnlijk beïnvloedt aminozuur substitutie 
van Asp326 de ruimtelijke oriëntatie van de lus of zelfs van het hele CK-B molecuul. 
Interactie met andere structuren of moleculen in de celregio nabij het fagosoom 
is daardoor niet meer optimaal, waardoor het voor CK-B moeilijk wordt op deze 
specifieke plekken te accumuleren.
In hoofdstuk 4 is een ander aspect van metabolisme onderzocht. Hierbij 
heb ik het belang van glucose voor morfodynamische veranderingen van LPS-
gestimuleerde macrofagen onderzocht. Remming van het glucose metabolisme met 
behulp van 2-deoxy-D-glucose (2-DG) leidde tot een afgenomen LPS-geïnduceerde 
spreiding alsook tot een verlaging van de  fagocytosecapaciteit van RAW 264.7 
cellen. De globale morfologie van de cel was daarbij echter niet merkbaar aangetast. 
De glucose-afhankelijkheid van LPS-gestimuleerde morfodynamische processen 
in macrofagen werd  verder bevestigd door glucose in het incubatiemedium te 
vervangen door galactose. Onder deze omstandigheid was het effect op spreiding 
en fagocytose veel groter (beide processen werden geremd!) en was ook de 
celmorfologie zichtbaar aangetast, overigens zonder dat het cellulaire ATP-niveau 
merkbaar veranderde. Interessant is dat de remmende effecten tegengegaan 
konden worden door een lage concentratie glucose toe te voegen aan het medium. 
Deze bevindingen suggereren dat glucose ook een niet-metabole rol speelt in de 
regulering van morfodynamische veranderingen in LPS-gestimuleerde macrofagen. 
Een mogelijke verklaring kan zijn dat eiwitten die betrokken zijn bij signaaloverdracht 
naar het actine cytoskelet o.i.v. aanwezigheid van glucose gemodificeerd kunnen 
worden en dat hierdoor de dynamiek van de actine-gebaseerde processen anders 
verloopt.
In hoofdstuk 5 is het belang van NAD+, naast ATP de belangrijkste metabole 
co-factor in de regulatie van de cellulaire energie- en redoxhuishouding, in actine-
afhankelijke morfodynamische processen bestudeerd. Door het sleutelenzyme in 
de NAD+-herwinningsynthese (NAMPT; nicotinamide phosphoribosyltransferase) 
te remmen met de drug FK866 werden de cellulaire niveau’s van NAD+ omlaag 
gebracht in RAW 264.7 en Maf-DKO cellen en werden de effecten hiervan voor en na 
LPS activering geanalyseerd. Alhoewel de cellulaire NAD+ niveaus na remming van 
NAMPT nagenoeg uitgeput was en de niveau’s van NADH en NADPH eveneens sterk 
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gereduceerd waren, was de proliferatie en ATP-productie in kortbehandelde cellen 
niet aangetast. Andere eigenschappen, waaronder de celmorfologie, het vermogen 
tot spreiding, en de fagocytosecapaciteit waren echter wel significant veranderd. 
Wij concluderen uit deze bevindingen dat  dat NAD+ de cellulaire morfodynamica 
beinvloedt via een ATP-onafhankelijk mechanisme. Op theoretische gronden achten 
we het waarschijnlijk dat dit gaat via effecten van NAD+ op de pH- en redox-gestuurde 
veranderingen die kunnen optreden in actine en in vele daarmee geassocieerde 
ABPs (bijvoorbeeld cofilin).
Samenvattend, concludeer ik dat morfodynamische veranderingen van LPS-
gestimuleerde macrofagen in sterke mate worden gedreven door ATP dat gevormd 
wordt tijdens de glucose-afbraak in de glycolyse. Het gebruik van deze  ATP 
moleculen wordt lokaal gestimuleerd door ze te produceren via de katalytische 
werking van CK-B enzymemoleculen die lokaal accumuleren. Bij deze accumulatie 
is zeer waarschijnlijk modificatie en regulatie van de C-terminale buigzame lus 
in het CK-B eiwit betrokken. Glucose blijkt echter ook een niet-metabole rol te 
spelen in het reguleren van morfodynamica door bijvoorbeeld signaalmoleculen te 
modificeren. Ten slotte is NAD+, de belangrijkste co-factor in glucose metabolisme 
en regelfactor van cellulaire pH en redoxstatus, van uiterst groot belang voor de 
hier bestudeerde morfofunctionele processen in LPS-geactiveerde  macrofagen. 
De in dit proefschrift beschreven nieuwe kennis levert verbeterd inzicht op inzake 
de koppeling tussen macrofaag metabolisme en morfodynamische functie(s). Een 
beter begrip van de werking van macrofagen – en de beïnvloeding daarvan door 
metabole veranderingen – geeft ons naar verwachting een betere uitgangspositie 
voor het ontwikkelen van therapiën voor ziektes waarbij deze macrofagen een 
sleutelrol spelen, zoals kanker en  auto-immuunziekten zoals reumatoïde artritis.  
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Lekesamevatting
Selmorfologie en -beweeglikheid is twee belangrike eienskappe van soogdierselle 
en lewer ŉ betekenisvolle bydrae tot hul funksionaliteit. Die kortikale aktien 
sitoskelet speel hierin ŉ belangrike rol. Deur die polimerisasie van monomere 
aktienmolekules word ŉ netwerk van aktienfilamente gevorm wat die selmembraan 
laat uitstulp soos wat die filamente verleng word. Op hierdie manier vorm die sel 
uitlopers (ook genoem filopodia) en membraanplooie op die oppervlak, of word 
die selfront uitgestoot om ŉ sogenaamde lamellipodium te vorm. Die sel gebruik 
hierdie strukture om die ekstrasellulêre omgewing af te tas of daaraan vas te heg, 
vloeistowwe en voedingstowwe op te neem en voort te beweeg. Die organisasie 
van die aktiennetwerk in elkeen van hierdie stuwende membraanstrukture 
verskil en word gereguleer deur honderde aktien-bindende proteïene (ABP’e) en 
seinoordragsmolekules. Die vorming, maar ook die modifisering, van aktienfilamente 
vorm die basis van alle morfodinamiese veranderinge wat in selle plaasvind en 
vereis ŉ aansienlike hoeveelheid energie in die vorm van ATP. Daarnaas word die 
eienskappe en funksionaliteit van die aktienfilamente asook die ABP’e beïnvloed 
deur die intrasellulêre pH en die redoksstatus van die sel. Al drie hierdie faktore 
(ATP-produksie, pH en redoksstatus) word bepaal deur die metaboliese status van 
die sel en daarom bestaan daar ŉ noue verband tussen sellulêre morfodinamika en 
metabolisme.
Alhoewel baie seltipes morfologies aktief is, is die aktiwiteit van kankerselle en 
selle van die immunsisteem van uitsonderlike belang. Makrofage is tipe leukosiete 
(witbloedselle) wat ŉ eerste linie van verdediging vorm teen patogene (bv. bakterieë) 
wat die liggaam binnedring en weefselhomeostase reguleer deur dooie selle te 
verwyder en weefselherstel te bevorder. Hierdie selle kom oral in die liggaam voor 
en is voordurend besig om die ekstrasellulêre omgewing te observeer vir indringers 
of vir tekens van weefselbeskadiging. Om dit te doen, kan makrofage in die weefsel 
voortbeweeg en aktien-ryke membraanuitstulpings vorm om veranderinge in die 
ekstrasellulêre omgewing waar te neem en bakterieë of dooie selle op te neem 
d.m.v. fagositose. Wanneer gevaarprikkels (bv. bakteriële komponente soos 
lipopolisakkariede (LPS) of sitkiene soos interleukiene 4 (IL-4)) waargeneem word, 
word makarofage daardeur geaktiveer om ŉ sekere kenmerkende status (fenotipe) 
aan te neem. Die fenotipe wat ŉ geaktiveerde makrofaag aanneem, is afhanklik 
van die prikkel wat waargeneem word. So word makrofage byvoorbeeld geaktiveer 
(of gepolariseer) tot ŉ M1- of inflammatoriese status deur LPS-stimulasie, en tot 
ŉ M2- of alternatiewe (anti-inflammatoriese en weefselherstellende) status deur 
IL-4-stimulasie. Behalwe dat hierdie twee fenotipes verskillende funksies het 
tydens die immuunrespons, ondergaan die selle ook verskillende aktien-afhanklike 
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morfologiese veranderinge. LPS-gestimuleerde (M1-) selle sprei uit en vergroot 
hul seloppervlak, vorm filopodia en membraanplooie, fagositeer patogene, maar 
vertoon verlaagde voortbeweging, terwyl IL-4-gestimuleerde (M2-) selle beter 
voortbeweeg maar patogene minder goed fagositeer.
Opvallend genoeg ondergaan geaktiveerde makrofage ook gedefinieerde 
metaboliese veranderinge wat kenmerkend is van die betrokke fenotipe. M1-
makrofage, wat die mees opvallende morfodinamiese veranderinge ondergaan, 
vertoon ook die mees treffende metaboliese aanpassings. Hierdie aanpassings 
sluit in verhoogde glukose-opname en -verbruik, verhoogde fluks deur die 
pentosefosfaatweg en verhoogde nikotienamied adeniendinukleotied (NAD+)- 
sintese. As in ag geneem word dat aktienpolimerisasie en -modifikasie beïnvloed 
word deur selmetabolisme, ontstaan die vraag dus of daar ŉ verband is tussen die 
morfodinamiese en die metaboliese veranderinge wat plaasvind in geaktiveerde 
makrofage. Die ondersoek wat in hierdie proefskrif beskryf is, bied nuwe insigte in 
die beantwoording van hierdie vraag.
Vir die bestudering van makrofage in vitro kan hierdie selle geïsoleer word uit bloed 
en gekweek word in die laboratorium. Makrofage wat op hierdie manier verkry is, kan 
egter nie onbeperk groei en vermeerder nie en moet dus na verloop van tyd opnuut 
geïsoleer word. Die gebruik van geïmortaliseerde makrofaagsellyne oorkom hierdie 
probleem en bied dus ŉ goeie alternatief. Alhoewel, sellyne is dikwels afgelei van 
geïsoleerde tumorselle en daarom geneties so gemodifiseer dat dit in vele opsigte 
nie altyd meer dieselfde eienskappe vertoon as primêre selle nie. Die ondersoek 
wat in hierdie proefskrif beskryf is, is gedoen op die RAW 264.7-makrofaagsellyn. 
Aangesien hierdie sellyn afkomstig is van ŉ Abelson leukemie virus-geïnduseerde 
askitestumor van ŉ muis en dus ŉ kankeragtige oorsprong het, is dit in hoofstuk 2 
vergelyk met ŉ nuwe makrofaagsellyn waarvan aangetoon is dat dit nie kankeragtige 
eienskappe besit nie. Hierdie nuwe sellyn (Maf-DKO) is afkomstig van muise met ŉ 
MafB/c-Maf-gebrekkige hematopoïetiese (bloed) sisteem. Deur die MafB/c-Maf-
gebrek kan hierdie makrofage in vitro onbeperk vermeerder in die teenwoordigheid 
van M-CSF (makrofaag kolonie-stimulerende faktor) in teenstelling met normale 
primêre makrofage. In die vergelykende studie is gekyk na groeitempo, morfologie, 
fagositose kapasiteit, en koolhidraatmetabolisme. In ooreenstemming met hul 
kankeragtige oorsprong, het RAW 264.7-selle ŉ veel hoër groeitempo gehad as Maf-
DKO-selle. Daarenteen het Maf-DKO-selle veel meer aktien-ryke membraanplooie 
gevorm en ŉ veel groter fagositose kapasiteit gehad as RAW 264.7-selle. Ten spyte 
van hierdie verskille het die twee sellyne geen betekenisvolle metaboliese verskille 
getoon nie. Glukoseverbruik was hoog, maar mitochondriale suurstofverbruik 
was minimaal in albei sellyne. Hieruit lei ons af dat die basiese metaboliese 
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kenmerke van RAW 264.7- en Maf-DKO-selle vergelykbaar is. Dit maak albei 
hierdie makrofaagsellyne geskik vir verdere ondersoek na die verband tussen 
morfodinamiek en metabolisme.
ATP (energie)-produksie vind verspreid deur die hele sel plaas, maar vorming 
van aktien-ryke membraanuitstulpings vind slegs op die buiterand van die sel plaas. 
Die energie wat benodig word vir aktienpolimerisasie onder die selmembraan 
moet dus op die een of ander manier hier teregkom. Hiervoor beskik die sel oor ŉ 
spesiale ATP-transportsisteem genaamd die kreatienkinase-kreatienfosfaat (CK-PCr) 
fosfageensisteem. Voorafgaande ondersoek in ons laboratorium het al aangetoon 
dat ŉ sekere CK-isoform (brein-tipe CK; CK-B) betrokke is by die vorming van die 
aktien-ryke fagositiese kelk in makrofage. In hoofstuk 3 het ons aangetoon dat 
CK-B ook ŉ rol speel in die vorming van aktien-ryke membraanplooie in makrofage. 
Tydens fagositose word CK-B fisies aangetrek na die plek op die selmembraan 
waar die teiken (in hierdie geval serum-geopsoniseerde gisdeeltjies) vasheg en 
opgeneem word. CK-B versamel onder die membraan en kan dus hier ATP lewer 
aan die aktienpolimerisasie-masjinerie. Hoe CK-B egter hier teregkom, is onbekend. 
Dus het ons verder in hoofstuk 3 ook die meganisme hieragter ondersoek in 
geaktiveerde makrofage deur die lokalisering van verskillende CK-B-mutante of 
-homoloë tydens fagositose te vergelyk met wilde tipe (normale) CK-B m.b.v. video-
fluorisensiemikroskopie. Hieruit kon ons aantoon dat ŉ spesifieke area in die CK-B-
molekule essensieel is vir die verplasing daarvan na die fagositiese kelk, naamlik die 
C-terminale buigsame lus. Hierdie lus bevat die aminosuur aspartiensuur op posisie 
326 en wanneer hierdie aminosuur vervang word met alanien, kan CK-B nie meer 
verplaas word na die fagositiese kelk nie. Bio-informatika-analise het aangetoon dat 
verskeie residu’s in hierdie C-terminale lus beskikbaar is vir interaksie met ander 
molekules. Waarskynlik beïnvloed aminosuursubstitusie van Asp326 die ruimtelike 
oriëntasie van die lus of selfs van die hele CK-B-molekule, sodat interaksie met 
ander molekules nie meer optimaal is nie en CK-B dus nie meer op ŉ spesifieke plek 
kan versamel nie.
In hoofstuk 4 is die belang van glukose vir morfodinamiese veranderinge van 
LPS-gestimuleerde makrofage ondersoek. Inhibering van glukosemetabolisme 
m.b.v. 2-deoksi-D-glukose (2-DG) het gelei tot ŉ beperkte LPS-geïnduseerde 
spreidingsvermoë asook ŉ verlaagde fagositosekapasiteit van RAW 264.7-selle, 
alhoewel selmorfologie nie merkbaar geaffekteer was nie. Die glukose-afhanklikheid 
van LPS-gestimuleerde morfodinamiese prosesse in makrofage is bevestig deur 
glukose in die inkubasiemedium te vervang met galaktose. Onder hierdie kondisie 
was die remmende effek op spreiding en fagositose veel groter en was ook die 
selmorfologie geaffekteer, sonder dat sellulêre ATP-vlakke verander het. Interessant 
genoeg kon die remmingseffek omgekeer word deur ŉ lae konsentrasie glukose 
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toe te voeg aan die medium. Hierdie bevindinge suggereer dat glukose ŉ nie-
metaboliese rol speel in die regulering van morfodinamiese veranderinge in LPS-
gestimuleerde makrofage. ŉ Moontlike verklaring kan wees dat molekules wat 
betrokke is in seinoordrag na die aktiensitoskelet deur glukose gemodifiseer word 
en dat die dinamiek van die aktine-gebaseerde prosesse hierdeur anders verloop.
In hoofstuk 5 is die belang van NAD+ (naas ATP die belangrikste metaboliese 
ko-faktor in die regulering van sellulêre energie- en redokshuishouding) in aktien-
afhanklike morfodinamiese prosesse bestudeer in LPS-geaktiveerde makrofage. 
Deur die sleutelensiem in NAD+-herwinningsintese (NAMPT; nikotienamied-
fosforibosieltransferase) te inhibeer, kon die sellulêre vlakke van NAD+ omlaag 
gebring word in RAW 264.7- en Maf-DKO-selle. Alhoewel NAD+ nagenoeg uitgeput 
was en die vlakke van NADH en NADPH ook gereduseer was, was selgroei en 
ATP-produksie nie geaffekteer nie. Selmorfologie, spreiding, sowel as fagositose 
was egter wel opmerklik aangetas. Hieruit kan afgelei word dat NAD+ sellulêre 
morfodinamika reguleer deur ŉ ATP-onafhanklike meganisme. Waarskynlik behels 
hierdie meganisme die pH- en redoksbemiddelde regulering van aktien en ander 
ABP’e (byvoorbeeld cofilin).
Om op te som, morfodinamiese veranderinge van LPS-gestimuleerde makro-
fage word aangedryf deur ATP hoofsaaklik afkomstig van glukose-afbraak deur 
glikolise. Hierdie ATP word lokaal besorg deur CK-B wat hier versamel d.m.v. die 
C-terminale buigsame lus. Glukose blyk egter ook ŉ nie-metaboliese rol te speel in 
die regulering van morfodinamika deur byvoorbeeld seinmolekules te modifiseer. 
Ten slotte is NAD+, ko-faktor in glukosemetabolisme en reguleerder van sellulêre 
pH en redoksstatus, van kardinale belang vir morfofunksionele prosesse in LPS-
gestimuleerde makrofage. Die ondersoek wat in hierdie proefskrif beskryf is, 
lewer nuwe kennis aangaande die koppeling tussen makrofaagmetabolisme en 
morfodinamiese funksie. ŉ Beter begrip van die werking van makrofage verskaf 
ŉ breër fondament vir die ontwikkeling van terapieë vir siektetoestande waarby 
hierdie selle ŉ sleutelrol speel, bv. kanker en outo-immuunsiektes soos rumatoïede 
artritis.
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List of abbreviations
2-DG  2-deoxy-D-glucose
ABP  Actin binding protein
ACMS α-amino-β-carboxy-
muconate-ε-semi-
aldehyde
ADP  Adenosine diphosphate
AMP Adenosine mono-phos-
phate
AMPK AMP-activated protein 
kinase
ANT Adenine nucleotide trans-
locator
Arp2/3  Actin related protein 2/3
ATGL Adipose triglyceride lipase
ATP  Adenosine triphosphate
BCG  Bacillus Calmette–Guerin
CARKL Carbohydrate kinase-like 
protein
CD38 Cluster of differentiation 
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Cdc42 Cell division control pro-
tein 42 homolog
CFU-GM Granulocyte/macrophage 
colony-forming units
CK  Creatine kinase
CK-B Brain-type creatine kinase
CM  Conditioned medium
COZ Complement opsonized 
zymosan
Cr  Creatine
CR3  Complement receptor 3
CSF-1  See M-CSF
CxCL2 Chemokine (C-X-C motif) 
ligand 2
DAD Dia autoinhibitory domain
DMEM Dulbecco’s modified 
Eagle’s medium
DTT  Dithiothreitol
ECM  Extracellular matrix
ETC  Electron transport chain
F6P  Fructose-6-phosphate
FA  Fatty acid
F-actin  Filamentous actin
FBS  Fetal bovine serum
FCCP carbonyl cyanide-p-trifluo-
ro-methoxyphenyl-hydra-
zone
FcγR  Fcγ-receptor
FH-1/2  Formin homology ½
FITC Fluorescein isothiocyanate
FOXO  Forkhead box
G3P Glyceraldehyde-3-phos-
phate
G6P  Glucose-6-phosphate
GAA  Guanidinoacetate
G-actin  Globular actin
GBD  GTPase binding domain
GLUT  Glucose transporter
GSH  Glutathione
GSSG  Reduced glutathione
HIF  Hypoxia-inducible factor
HSC  Haematopoietic stem cell
HXK  Hexokinase
IDO Indolamine 2,3-dioxy-
genase
IFN-γ  Interferon gamma
IgG  Immunoglobulin G
IL-1/4/6/10/13 Interleukin-1/4/6/10/13
iNOS Inducible nitric oxide syn-
thase
ITAM  Ig gene family tyrosine 
activation motive
KLF4  Krüppel-like factor 4
LDH  Lactate dehydrogenase
LDH  Lactate dehydrogenase
LDL  Low density lipoprotein
LPL  Lipoprotein lipase
LPS  Lipopolysaccharide
Mac-1  Macrophage-1 antigen   
  (complement receptor 3)
M-CSF Macrophage colony stimu-
lating factor
MCT1 Monocarboxylate trans-
porter 1
mDia Mammalian  Diaphanous-
related formin
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MPC Mitochondrial pyruvate 
carrier
MPS Mononuclear phagocyte 
system
Mrc-1 Macrophage mannose 
receptor 1
MtCK Mitochondrial creatine 
kinase
MyD88 Myeloid differentiation 
factor 88
NA  Nicotinic acid
NAAN Nicotinic acid adenine 
dinucleotide
NAD+ Nicotinamide adenine 
dinucleotide
NADH Reduced nicotinamide 
adenine dinucleotide
NADK  NAD kinase
NADP+ Nicotinamide adenine 
dinucleotide phosphate
NADPH Reduced nicotinamide 
adenine dinucleotide 
phosphate
NADS  NAD synthase
NAM  Nicotinamide
NAMN Nicotinic acid mono-nucle-
otide
NAMPT Nicotinamide phospho-
ribosyltransferase
NAPRT Nicotinic acid phospho-
ribosyltransferase
NMN Nicotinamide mono-nucle-
otide
NMNAT NAM mononucleotide 
adenylyltransferase
NO  Nitric oxide
NOX  NADPH oxidase
NPF Nucleation promoting fac-
tor
NR  Nicotinamide riboside
NRK Nicotinamide riboside 
kinase 
N-WASp Neuronal isoform of WASp
OXPHOS Oxidative phospho-ryla-
tion
PAMP Pathogen-associated mo-
lecular pattern
PARP Poly-ADP-ribose-poly-
merases
PBMC Peripheral blood mono-
nuclear cell
PBS Phosphate-buffered saline
PBS-G Phosphate-buffered saline 
and glycine
PBS-T Phosphate-buffered saline 
and Tween
PCr  Phosphocreatine
PDGF Platelet derived growth 
factor
PFK2  Phosphofructokinase 2
pHi  Intracellular pH
Pi  Inorganic phosphate
PPi  Pyrophosphate
PI3K  Phosphoinositide 
3-kinase
PIP2 Phosphatidylinositol 
4,5-biphosphate 
PIP3 Phosphatidylinositol 
3,4,5-triphosphate 
PKM Pyruvate kinase (muscle 
isozyme)
PMA Phorbol 12-myristate 
13-acetate
PPAR Peroxisome proliferator-
activated receptor
PPP Pentose phosphate path-
way
PRR Pattern recognition recep-
tor
PtdIns(3,4,5)P3 Phosphatidylinositol 
3,4,5-triphosphate
PtdIns(4,5)P2 Phosphatidylinositol 
4,5-biphosphate
QPRT Quinolinate phospho-
ribosyltransferase
R5P  Ribose-5-phosphate
RA  Rheumatoid arthritis
ROS  Reactive oxygen species
Ru5P  Ribulose-5-phosphate
S7P Sedoheptulose-7-phos-
phate
Scar/WAVE Suppressor of cAMP 
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receptor /WASp family 
verprolin homolgous
SDS  Sodium dodecyl sulphate
SDS-PAGE SDS-polyacrylamide gel 
electrophoresis
SEM Scanning electron micros-
copy
SGLT Na+-dependent glucose 
co-transporters
SRB  Sulforhodamine B
SSH-1L  Slingshot-1L
STAT6 Signal transducer and 
activator of transcription 6
TAMs Tumor associated macro-
phages
TBS-T Tris-buffered saline and 
Tween
TCA  Tricarboxylic acid
TCA  Trichloroacetic acid 
TDO Tryptophan 2,3-dioxy-
genase
TEPM Thioglycollate elicited 
peritoneal macrophages
TG  Triglyceride/
Triacylglycerol
TGFβ1 Transforming growth fac-
tor β1 
TGL  Triglyceride lipase
TLR  Toll-like receptor
TNF  Tumor necrosis factor
Tris Tris(hydroxymethyl)-ami-
nomethane
TSAC Transition state analog 
complex
UDP-GlcNAc Uridine diphosphate N-
acetyl-glucosamine
VDAC Voltage-dependent ion 
channel
WASp Wiskott-Aldrich syn-drome 
protein
WAVE WASp family verprolin 
homolgous
WIP  WASp interacting protein
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Dankwoord
Wie had dat nou gedacht? Er kwam toen toch nog een proefschrift uitrollen!! Maar 
ja, dat kwam niet zomaar - daar moest wel héél veel voor gebeuren! Zo veel, dat ik 
het in mijn eentje écht niet zou hebben gered. Om zover te komen, heb ik de hulp en 
ondersteuning van zoveel mensen gehad. Aan jullie wijd ik dit laatste subhoofdstuk 
van mijn proefschrift. God bracht jullie, met en zonder jullie medeweten, op mijn 
pad en daar ben ik ontzettend dankbaar voor! Lang heb ik er naar uitgekeken om 
dit stukje te gaan schrijven, maar nu het zover is vind ik het toch lastig, want het is 
voor een groot deel ook mijn afscheidsrede en na zes en een half jaar vind ik het nog 
steeds moeilijk om mijn emoties in het Nederlands uit te drukken!
Ruim negen jaar geleden, in  mei 2005 toen ik nog bezig was met mijn 
Masteropleiding, begon ik er al van te dromen mijn promotieonderzoek in Nederland 
te gaan doen en heb ik voor het eerst contact opgenomen met Bé. In de twaalf 
maanden erna werden veel e-mails heen en weer gestuurd en probeerde ik een 
PhD-scholarship te krijgen voor een promotiestudie in het buitenland. Omdat dat 
helaas niet lukte, ben ik in 2006 toch maar begonnen als PhD op het lab waar ik was 
afgestudeerd. En toen, een jaar later, kreeg ik ineens een e-mail van Bé waarin hij 
me uitnodigde te solliciteren voor een aio-functie bij de afdeling Celbiologie...! Na 
nog een paar e-mails en een bezoek aan het lab, hebben we de knoop doorgehakt 
en ben ik eindelijk in januari 2008 begonnen als aio bij de afdeling Celbiologie. Bé en 
Jack, allereerst wil ik jullie bedanken voor de kans die jullie me gaven om mijn droom 
te verwezenlijken! Ten tweede wil ik jullie bedanken voor jullie inzet - zonder jullie 
harde werk was dit proefschrift nooit geworden wat het nu is! Alhoewel ik in totaal 
ruim zes jaar bezig was met mijn onderzoek, heb ik in de laatste twee jaar zeker 
het meest geleerd. Dit was de tijd waarin ik begon te schrijven, waarin de ‘laatste’ 
proeven gedaan moesten worden en dat we steeds vaker moesten overleggen. 
Soms zonk me de moed in de schoenen als ik een werkstuk van jullie terugkreeg 
en ik bij de eerste oogopslag alleen maar groen/rood/paars-gemarkeerde tekst zag! 
Maar als ik er eenmaal doorheen was viel het altijd mee en was ik zelf ook meer 
tevreden met het eindresultaat. Bé, de nuchtere manier waarop je alle soorten 
problemen benaderde zorgde ervoor dat de stressniveaus bij mij niet regelmatig de 
hoogte in schoten en dat ik perspectief behield. Bedankt voor jullie tijd, geduld en 
aanmoediging de afgelopen jaren!
Frank, mijn rechterhand, bedankt voor al de spreading assays die je gedaan 
hebt, de pilot-proeven die je hebt ingezet, en alle cellen die je voor me hebt 
doorgezet als ik er niet zelf kon zijn. Dankzij jou was ik ook niet de enige die op de 
kweek hardop met de radio zat mee te zingen! Fijn dat je ook nog mijn paranimf 
wil zijn! Marieke W, ook jij hebt een grote bijdrage geleverd aan de resultaten die in 
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dit proefschrift zijn opgenomen. Bedankt voor alle ‘laatste proefjes’ die je voor me 
deed! Nooit was het te veel moeite om ‘even’ een blotje te draaien, cellen te fixeren 
en te imagen, of zelfs te TIRFen! Van jou heb ik op het lab echt heel veel praktische 
dingen geleerd. Super dat ook jij mijn paranimf wil zijn! Mietske, als co-auteur van 
alle vier experimentele hoofdstukken wil ik jou bedanken voor alle SEM-plaatjes. 
Uren heb je achter de SEM doorgebracht om plaatjes te schieten van mijn celletjes, 
en zoals je kunt zien, kun je ze overal terugvinden in dit boekje – super bedankt! 
Tijdens de eerste acht maanden van mijn onderzoek had ik ook nog een derde 
begeleider: Helma. Dankzij jou vond ik snel mijn weg op het lab, heb ik 
geleerd ieder experiment tot in de details te plannen en het protocol volledig 
uit te schrijven. Ook wil ik jou,  Saskia en Hanka bedanken voor jullie grote 
bijdragen aan het CK-B- hoofdstuk. Hopelijk wordt dat nu ook snel geaccepteerd 
en gepubliceerd!
Huib en Jan, bij jullie kon ik terecht voor alle andere algemene lab-dingen 
die ik niet wist. Altijd waren jullie bereid me te helpen, dus ook aan jullie heel 
erg veel dank! Dan mijn kweek-buddies: Walther, Rinske, Anke, Anchel, Susan en 
Ingeborg, samen met jullie was het altijd gezellig op de kweek! Bedankt voor al 
de keren dat jullie tijdens een weekend mijn cellen doorzetten en ’s middags laat 
of ’s ochtends vroeg medium wilden verversen of LPS bij de cellen wilden doen, 
omdat ik er vanwege Stephan niet zelf kon zijn. Nogmaals: promoveren doe je 
niet alleen! Ook mijn U-genoten: Remco, Stefi, Claire en Michiel wil ik bedanken 
voor de gezellige sfeer op het lab, informatieve discussies en de praktische tips 
die ik van jullie kreeg. Hetzelfde geldt voor mijn mede-aio’s: Lieke, Mirthe, Irene, 
Annika, Marieke dV, Monique, Samuel, Bettina, Olga, Pavel en Antoine. Het was 
fijn om af en toe frustraties te kunnen delen met andere ‘lotgenoten’ en tips te 
geven en te krijgen over allerlei praktische en logistieke kwesties! Also Ganesh 
from upstairs, thanks for your help with the O
2
 assays! Behalve Bé en Jack zijn er 
ook drie andere ‘belangrijke mensen’ die ik wil bedanken: Rick, Wiljan en Ineke. 
Alhoewel jullie niet mijn directe begeleiders waren, heb ik van jullie ontzettend veel 
geleerd tijdens de literatuurpresentaties en werkbesprekingen en kon ik bij jullie 
ook terecht voor vragen en advies. Magda, onze lieve secretaresse, dank je wel 
voor je vriendelijkheid, de administratieve ondersteuning, dat je een paar keer oma 
wilde spelen voor Stephan en dat ik jouw koffiemok mocht ‘lenen’ voor 5 jaar...! Alle 
andere collega’s: Mariska, Katarina, Linda, Cindy, Marina, Anna, Gert-Jan, Esther, 
Julia en de Moldiertjes, met elk van jullie had ik op een andere manier contact en 
dat was ook wel belangrijk om me helemaal thuis te voelen op de 6e verdieping. 
Dank daarvoor!
Ook buiten het lab had ik heel veel mensen die om me heen stonden en zonder 
wier hulp en ondersteuning promoveren niet mogelijk was. Allereerst, Stephans 
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lieve oppassers: Stynie, Arieke, Carin, Martine en Jan-Douwe, ik kan jullie niet 
genoeg bedanken voor de maanden die jullie vrijwillig (!) op Stephan hebben gepast 
zodat ik zorgeloos achter mijn computer kon gaan zitten schrijven! Zonder jullie had 
ik dit boekje nooit af kunnen maken! Johan Dirk, Bouwien en kinderen, van jullie 
hebben we de afgelopen jaren heel veel steun gekregen, praktisch en emotioneel. 
Bedankt voor jullie onbaatzuchtige liefde en alle gezellige sinterklaasavonden! 
Onze Bijbelkring, bedankt voor jullie belangstelling, medeleven en de geestelijke 
ondersteuning. Yvonne, jij in het bijzonder bedankt voor het schrijven van mijn CV 
en het nakijken van dit stuk! Roema, vir jou wil ek dankie sê vir die aanmoediging 
wat ek van jou gekry het (via Skype) en van al die besoekies elke keer as  jy vir jou 
eie PhD-navorsing na België toe moes gaan. Hopelik sal ons mekaar nou weer meer 
gereeld sien!
Mijn lieve (Nederlandse) familie, Jan en Joke, Pieter en Gerda, Johan en Elly, 
jullie vingen me op toen ik naar Nederland kwam en werden hier mijn pleegouders! 
Ik ben jullie erg dankbaar voor alle liefde, telefoontjes en bezoekjes die ik (wij) van 
jullie kreeg (kregen). Het was soms lastig om uit te leggen waarom het maar niet 
opschoot met mijn studie, maar jullie bleven altijd geïnteresseerd en hadden altijd 
een bemoedigend woord. Ik zal jullie gaan missen! 
Na zes en een half jaar is het tijd om terug te keren naar Zuid-Afrika, naar onze 
andere familie die we heel erg hebben gemist! Al my boeties en sussies, julle wag 
al lank dat ons moet terugkom en sodat julle Stephan kan sien en hy met sy nefies 
en niggies kan speel. Uiteindelik is dit sovêr - dankie vir julle begrip, belangstelling 
en geduld! Evette, dankie vir jou harde werk om hierdie boekie so mooi te maak en 
ook vir al die kere wat jy kom kuier het en jou nefie vermaak het sodat ek kon werk!
Pa Evert en Ma Elsie, dankie vir julle vertroue, liefde, gebede, aanmoediging en 
al die kuiers hier in Nederland! By julle kom ek altyd tuis en kan ek ontspan en net 
myself wees. Ek is dankbaar vir alles wat ek by julle geleer het, maar veral dat ek in 
alles op God moet vertrou. My skoonouers, Pa Fanie en Ma Lorraine, dankie dat julle 
nie vir ’n oomblik in my getwyfel het nie en enduit in my bly glo het! Julle was vir my 
’n groot bron van bemoediging!
Liewe Pieter, ek kom woorde kort as ek wil sê hoe ongelooflik lief ek vir jou is en 
hoe ontsettend dankbaar ek is dat die Here jou vir my gegee het as man! Jy het baie 
opgeoffer om saam met my Nederland toe te kom en my te help om my droom te 
verwesenlik. Elke keer as ek van frustrasie, moedeloosheid, of telleurstelling in trane 
was, het jy my weer gerusgestel, perspektief gegee en herinner dat niks buite God 
omgaan nie. Dankie vir al die vrolike toebroodjies, die (onverwagse) besoekies in die 
lab en al die ander klein bederfies waarmee jy my altyd weer opgebeur het!  Ek is 
baie lief vir jou!
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Die mense wat ek lief het 
Kom groei op my soos mos 
Daar laat ek hul na hartelus gedy 
En loop ek deur die wêreld 
- beskut teen die koue - 
Die snoesigheid self: 
Ek met my moskombersie
En as daar ’n oorlog kom 
Word die mense wat ek lief het 
’n Ekstra liefdeslaag om my 
So marsjeer ek deur die wêreld 
Gepantser teen die vuur 
Die onaantasbaarheid self: 
Ek met my menskombersie
....
Stephan Bouwer 
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Curriculum Vitae
Gerda Venter is op 11 april 1982 geboren te Krugersdorp in Zuid-Afrika. Met haar 
ouders verhuisde zij naar Vereeniging, waar zij zowel de basis- als de middelbare 
school doorliep. In 2000 behaalde Gerda haar Matrieksertifikaat (diploma 
middelbare school) aan de Drie Riviere Hoërskool in Vereeniging. Van 2001 tot 
en met 2003 studeerde zij Biologische Wetenschappen aan de Potchefstroomse 
Universiteit vir Christelike Hoër Onderwys, nu de Noordwes Universiteit (NWU). 
Daar behaalde zij cum laude haar Bachelor of Science diploma. Aansluitend volgde 
zij een Bachelor of Science honours studie aan de afdeling Biochemie van de NWU, 
onder begeleiding van prof. Harry Kotzé en prof. Piet Pretorius. Zij liep hier ook stage 
en haalde haar diploma hier eveneens cum laude. Vervolgens begon Gerda aan haar 
Master opleiding en liep bij de afdeling Biochemie weer stage onder begeleiding van 
de eerder genoemde leraren. In 2006 behaalde zij haar Master of Science diploma. 
Tijdens haar Bachelor en Master opleiding maakte Gerda kennis met de wereld van 
de cellulaire energie en redox metabolisme en wist zij dat ze in deze richting verder 
wilde met een promotiestudie, het liefst in Nederland. Omdat dat niet meteen lukte 
is zij later in 2006 aan een promotiestudie begonnen op het Mitochondrieel Research 
Laboratorium van prof. Francois van der Westhuizen, opnieuw aan de afdeling 
Biochemie van de NWU. Daarnaast werkte zij tijdelijk als docent Biochemie en gaf 
college aan tweedejaars farmacie- en verpleegkundestudenten. In 2007 kreeg Gerda 
wél de gelegenheid om in Nederland als junioronderzoeker aan een promotieproject 
te beginnen. Nadat alle onderwijstaken in Zuid-Afrika waren afgerond startte zij in 
2008 in Nijmegen met haar promotieonderzoek aan de afdeling Celbiologie van het 
Radboud UMC, onder begeleiding van prof. dr. Bé Wieringa en dr. Jack Fransen. De 
resultaten van dit onderzoek worden in dit proefschrift beschreven.
